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Table 1:  Biomedical Measures and Recommended Levels 
 
Measure Name Recommended Level 
BG Type 2 Blood Glucose Type 2 4-7 mmol/L  
(pre-prandial) 
Under 8.5 mmol/L  
(post-prandial) 
(Diabetes.co.uk 
[accessed April 2015]) 
HbA1c Glycated Haemoglobin 48mmol/mol (6.5%) 
(no recommendation 
given for pre- and post- 
prandial) 
Diabetes.co.uk 
[accessed April 2015) 
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Abstract:  
Background 
Smoking cigarettes is a well-documented cause of ill-health and is associated  
(Cigarette smoking among people with diabetes increases the risk of developing 
long-term complications. Although smoking cessation is considered important for 
all, it is especially significant for people with diabetes and is recommended 
throughout the literature. Few studies have investigated the impact of a smoking 
cessation intervention tailored to the needs of people with Type 2 diabetes. This 
study attempts to address this.  
Aims 
The overall aim was to assess the impact of a smoking cessation psychological 
intervention for people with Type 2 diabetes and whether the intervention had a 
positive impact on their glycated haemoglobin levels.  
Methodology 
Design: This was a quantitative longitudinal smoking cessation psychological 
intervention with no control group.  
Participants: Participants were 31 adult patients (n=14 males, n=17 females) with 
Type 2 diabetes who regularly smoked cigarettes.  
Primary Outcome Measures: Using a minimum data set and validated scales, 
glycated haemoglobin (HbA1c) and carbon monoxide (CO) levels were recorded 
and the Perceived Control of Diabetes Scale (PCDS) and Smoking Locus of 
Control Scale (SLoCS) administered to investigate changes in participants 
perceptions of their diabetes and smoking behavioural control across the 
subscales.   
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Secondary Outcome Measures: Readiness to stop smoking (likes, dislikes, 
motivation and confidence), concerns relating to smoking, awareness of smoking 
cessation products and services and knowledge of health risks associated with 
smoking and diabetes were measured for comparison. Participant weight (kg) 
was also measured as a precaution.   
Procedure: Participants were recruited in Falkirk Royal Infirmary at their annual 
diabetes review. Measures were recorded at baseline immediately prior to the 
health intervention. This was repeated at 12-month follow-up. 
Data Analysis: Data were analysed at T1 and T2 with SPSS 17 using within-
factors repeated measures ANOVA.   
Results: Positive effects post-intervention were found for:  HbA1c (p<0.0005) 
and CO (p<0.0005) levels, PCDS (p<0.0005) and SLoC (p<0.0005) Internality 
subscales and for dislikes (p<0.003), motivation (p<0.0005, confidence 
(p<0.0005) and knowledge of associated health risks (p<0.0005). No participants 
stopped smoking during this study. 
Conclusion: The results demonstrate a positive impact on health behaviour 
change showing an increase in the likelihood that participants will take greater 
control of their glycated haemoglobin levels and smoking behaviours and will be 
more motivated and confident to do so. With no control group the design does not 
control for all factors that may have contributed to these changes.   
 
Keywords: Smoking cessation, glycated haemoglobin levels, health behaviour 
change 
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Chapter 1 - Introduction 
The interest for this research was fostered during Health Psychology Stage 1 
training at University of Stirling. A work-based placement in smoking cessation 
clinics in Forth Valley led to Maudsley Training in smoking cessation 
techniques with Professor Peter Hajek who is a widely published academic 
and renowned world leader in smoking cessation. Hajek’s techniques were 
developed during his tenure at the Maudsley Hospital in London (Hajek, 
1994). The Stage 1 placement led to two NHS funded posts. The first was an 
audit of smoking cessation provision across Forth Valley by primary and 
secondary care and pharmacy and was in collaboration with University of 
Stirling. The second post was as a smoking cessation specialist advisor.  
 
During a lecture on applications of health psychology within the NHS, the 
lecturer advised that the prevalence of diabetes was predicted to increase 
substantially and that it could be a field to consider for research or applied 
psychology.  
 
This inspired a literature search on PubMed, Cinahl, NES and other relevant 
sites using MESH terms such as ‘Diabetes; Health Promotion; Lifestyle; 
Behavior Therapy; Counseling; Diabetes Complications; Treatment Outcome. 
The review and parameters are discussed more fully in Chapter 2. One 
important finding was a definition of diabetes care and who should be 
involved. With an increasing prevalence in the development of diabetes 
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among the population of Scotland The Scottish Health Plan – Our National 
Health: A plan for action, a plan for change (Scottish Executive Health 
Department, 2000) – acknowledged the need to make a significant impact on 
diabetes care and committed to producing a Scottish Diabetes Framework 
(SDF, Scottish Executive Health Department, 2001) to contain the growth of 
diabetes and guide the changing landscape of diabetes care over the next ten 
years. The SDF worked alongside the SIGN clinical guideline on the 
management of diabetes and the clinical standard for diabetes care (Scottish 
Intercollegiate Guidelines Network 55, 2001). The SDF was published in 
March 2002 and as the prevalence of diabetes continued to increase by 4% 
per year, was superseded by the Scottish Diabetes Framework Diabetes 
Action Plan 2006 (Scottish Executive, 2006) and continued on in the Diabetes 
Action Plan 2010 Quaity Care for Diabetes in Scotland (Scottish Executive, 
2010), aligned with SIGN 116 (SIGN 116, 2011).  The SDF set out seven first 
stage priorities: Patient Information, Education and Empowerment; Heart 
Disease; Eye Care; Strategy, Leadership and Team working; Education and 
Training for Professionals; Information Maintenance & Technology and 
Diabetes Registers; Implementation and Monitoring. The Diabetes Action Plan 
2010 built on these by adding: Improve quality of care and outcomes; 
Enhance Diabetes Managed Clinical Networks; Increase diabetes research; 
Support initiatives to promote healthier lifestyles; Improve dissemination of 
diabetes information. Diabetes Care in Forth Valley is structured and informed 
by the SDF and subsequent action plans. 
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Another important finding that permeated throughout the literature review was 
a recommendation that people with diabetes be given specialist smoking 
cessation support tailored to their needs. This prompted a systematic 
literature review (SLR), discussed more fully in Chapter 2, on smoking 
cessation interventions designed for this population which produced very little 
material. A full copy of the review is included at the end of the thesis (pg. 221) 
(The SLR was submitted to the British Journal of Health Psychology in 2010 
for peer review and was rejected for publication on the grounds of being too 
specific and not generalizable to the wider public). Diabetes Care in Falkirk 
Royal Infirmary was approached with a request to run a research project 
aimed at delivering a specialist smoking cessation intervention to patients.  
 
Permission was granted with an invitation to shadow the diabetes consultants 
to introduce diabetes care and departmental processes and procedures. 
During shadowing it became evident that many patients found it challenging to 
maintain their glycated haemoglobin levels (HbA1c) within the recommended 
levels of 6.5% (NICE, 2009) and diabetes-related complications had 
developed as a result. HbA1c is an average measurement of the previous 2-3 
months of blood glucose per litre of blood. At the time NICE (2009) 
recommended HbA1c be measured in percentages although the International 
Federation of Clinical Chemistry (IFCC) felt the measurements were 
conflicting and confusing for people with diabetes. The major concern was 
that a 1% increase in HbA1c could appear small to the person yet in clinical 
terms had serious implications for increased risk of complications (IFCC, 
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2004). After developing a working group (Sacks, 2005) and trialing the 
proposed changes with 30 assays from across the world, the IFCC (2008) 
introduced mmol/mol (6.5% = 48mmol/mol) as the new HbA1c measure for 
reporting (Nordin & Dybkaer, 2007). NICE acknowledges this in CG87, 
Management of Type 2 Diabetes (2009) and advises the changes will be 
included in the update due for release in 2015. 
 
The Diabetes UK (DUK) website (accessed August 2014) refers to both 
methods of reporting and includes a converter for people familiar with the 
previous format (DUK, 2014). The utility of this is unclear almost seven years 
after the new system was introduced. It also refers to mmol/l, referencing 
NICE 2008, which conflicts with the evidence presented above.  
 
Control was often mentioned in consultations as it is in smoking cessation 
sessions. Smoking cessation is based on control of health behaviours and 
cravings and shadowing highlighted a common link between the two. 
Questions arose as to whether patients struggling to control glycated 
haemoglobin levels after the direct approach from healthcare, would achieve 
more satisfactory glycated haemoglobin levels by an indirect approach? 
Would learning to control smoking behaviours transfer to controlling glycated 
haemoglobin levels or other risk factors for long-term complications? Was 
control therefore a transferable skill? 
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These questions led to the development of an exploratory study measuring 
the efficacy of a smoking cessation intervention for patients with Type 2 
diabetes. To facilitate the study the researcher developed the Diabetes and 
Smoking Cessation Education Programme (DSCEP). The DSCEP was based 
on previous involvement in smoking cessation interventions and was guided 
by the Lead Smoking Cessation Specialist Nurse and Lead Diabetes 
Specialist Nurse from Falkirk Royal and Infirmary with advice from supervisors 
at Queen Margaret and Stirling Universities. 
 
The research investigated smoking locus of control and perceived behavioural 
control of diabetes using the Smoking Locus of Control Scale (SLoCS) 
(Georgiou & Bradley, 1992) and the Perceived Control of Diabetes Scale 
(PCDS) (Bradley, 1993). The DSCEP provided education on health risks 
associated with diabetes and smoking and how these risks could be 
minimized by stopping smoking. It was delivered using motivational 
interviewing techniques and was aligned with the Intervention Method during 
Consultation (Rollnick, Butler & Stott, 1997). It was anticipated the DSECP 
would encourage a cognitive shift in participants from an external locus of 
control to an internal locus of control, thus eliciting positive health behaviour 
change. The preferred outcomes were for patients to stop smoking and for 
their glycated haemoglobin levels to have reached recommended levels. 
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Chapter 2 is a critical review of the smoking and diabetes literature. It includes 
a discussion on the psychology of smoking behaviours and of self-managing 
diabetes and on the utility of psychology to understanding these behaviours. 
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Chapter 2 - Review of Smoking and Diabetes Literature 
Action on Smoking and Health (ASH) Scotland is an independent charity 
whose aim is to reduce harm caused by tobacco use. ASH Scotland is the 
leading advisor on tobacco strategies, stop smoking interventions and training 
and influencing public attitudes to tobacco and smoking. ASH advises, ‘In the 
light of the growing evidence demonstrating that smoking is an independent 
risk factor for diabetes and that it is also an aggravating factor for diabetes 
complications, smoking cessation advice should be a routine component of 
diabetic care’ (ASH Scotland, 2002). In order to develop an intervention to 
address this, it is important to understand patient perceptions about their 
control of diabetes and smoking behaviours. 
 
2.1 Smoking – an overview 
Smoking is recognized as the most important preventable cause of ill-health 
and premature death in Scotland, directly linked to more than 13,000 deaths 
every year. It is associated with diseases of the heart and blood vessels, 
lungs, stomach, kidneys and other organs and it is estimated that NHS 
Scotland spends over £300 million every year on treating smoking-related 
diseases (Scottish Public Health Observatory, 2012). 
 
The health statistics of people with diabetes who smoke give cause for 
concern. The major cause of morbidity and mortality associated with diabetes 
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is from the risk of atherosclerotic macrovascular disease which increases if 
the individual smokes cigarettes (Law & Wald, 2003; Doll, Peto, Boreham & 
Sutherland, 2004; SIGN 97, 2007; SIGN 116, 2011; British Heart Foundation, 
2012; DUK, 2012).  
 
Cigarette smoking has been reported as a significant risk factor for death by 
coronary heart disease in people with Type 2 diabetes in the Finnish 
Prospective Study (Tuomilehto, Rastentve, Jousilati, Sarti & Vartainien, 1996), 
the Paris Prospective Study (Fontbonne & Eschwège, 1991) and the Multiple 
Risk Factor Intervention Trial (MRFIT Research Group, 1982). Former 
cigarette smokers with Type 2 diabetes are 1.54 times more likely to be 
diagnosed with coronary artery disease (Miegs, Singer, Sullivan, Dukes, 
D’Agostino, et al., 1997).  Similar results were reported adding to the evidence 
base that smoking increases the risk of morbidity and mortality from 
macrovascular complications (Dean, Mathews, Dolben, Carolan, Luzio & 
Owens, 1994; Hanefield, Fisher, Julius, Schulz and Ziegelasch, et al., 1996). 
 
Several studies have documented the relationship between smoking and the 
development of nephropathy in Type 2 diabetes (Chuahirun, Khanna, Kimball 
& Wasson, 2003; Chuahurin, Simoni & Hudson et al., 2004). Smoking is also 
documented as a risk factor for both the development and progression of 
various types of neuropathy (Tesfaye, Chaturvedi, Eaton, Ward, Manes et al., 
2005; Booya, Bandarin, Larijani, Pajouhi, Nooraei & Lofti, 2005).  
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While previous studies have suggested a positive relationship between 
cigarette smoking and retinopathy (Reichard, 1992; Morgando, Chen, Patel, 
Herbert & Kohner, 1994), subsequent research has not found evidence to 
support this relationship (Eliasson, 2003; Sinclair, Delvecchio, Malamut & Li, 
2005).  On their website The Royal National Institute for Blind People (RNIBP) 
do not correlate Type 2 diabetes and retinopathy with smoking. Their position 
is that good diabetes control, which includes maintaining weight and stopping 
smoking, significantly reduces the risk of developing retinopathy. It is not clear 
if this statement denotes statistical significance and to what value or 
percentage. RNIBP also state that nerve damage, cardiovascular and kidney 
disease are more common in smokers with diabetes. This can lead to 
hardening of the arteries which raises blood pressure and glycated 
haemoglobin levels making diabetes harder to control (RNIBP, 2014). 
 
Although smoking is a well-established risk factor for cardiovascular and other 
diseases, Ahmed and Memon, (2008) argued that there is conflicting evidence 
regarding the effect of smoking on glycated haemoglobin control (Ahmed & 
Memon, 2008). They investigated smoking and its relationship with blood 
pressure and blood glucose in patients with coronary heart disease in Karachi. 
Thirty participants were assigned to the control group and had no evidence of 
coronary heart disease. A further 120 participants with coronary heart disease 
were sub-divided into Stable Angina, Unstable Angina, Acute Myocardial 
Infarction and Old Myocardial Infarction groups. The study reports no 
significant statistical difference between the smokers and the control group in 
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terms of haemoglobin, haematocrit and serum blood glucose and concludes 
that smoking history is not related to diabetes.    
 
This is not supported by a study of 103 Iranian women in Tehran, 10% of 
whom smoked cigarettes (Ghazanfari, Niknami, Ghofranipour, Larijani, Agha-
Alinejad & Montazeri, 2010) or by the RNIBP (2014), DUK (2014) or ASH 
Scotland (2014) who all associate smoking with the deleterious effects of 
diabetes.   
 
The risks of not self-managing diabetes effectively are clear. So too are the 
consequences of smoking, whether living with diabetes or not, and the 
increased risks if diabetes is present (DUK, 2014; ASH Scotland, 2014). To 
design an intervention to encourage positive health behaviour change, it is 
critical to understand the psychology underpinning cigarette smoking. 
 
The following section discusses the psychology of cigarette smoking in an 
attempt to understand why people initiate and maintain the behaviour in light 
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2.2 Psychology of Smoking 
Smoking is a complex behaviour involving biological, psychological and social 
processes. Recruitment to smoking is more prevalent among adolescents. 
This is not a coincidence as tobacco companies are heavily reliant on young 
people becoming addicted to smoking cigarettes to increase their market 
shares. In a systematic review of 19 longitudinal studies conducted across the 
USA, Australia, Spain Germany and England it was suggested that to 
succeed, tobacco marketing must appeal to young people’s sensibilities and 
target key concerns such as identity, social, peer and parental approval and 
adventure seeking thus fulfilling psychological and social needs (Lovato, 
Watts & Stead, 2012). 
 
In a review of 7 randomised controlled trials (RCTs) conducted across the 
USA, Germany, the Netherlands, Canada and Finland it was found that 
adolescent smoking usually continues into adult smoking with the majority 
already addicted to the behaviour by 18 years of age. Uptake of smoking at 
this early stage provides more life-years for tobacco use, is associated with 
heavier tobacco use and increased likelihood of tobacco-related morbidity and 
mortality (Johnston, Liberato & Thomas, 2012).  By focusing on RCTs the 
reviewers have limited the information to synthesize and could have included 
the findings from reviews as a further stream to report. They have also 
eliminated studies because the investigators did not provide an incentive as 
part of the intervention, which again could have been another information 
stream to include in the Cochrane review (2012). 
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One of the ingredients of cigarettes is nicotine. It is used industrially as an 
insecticide and has highly addictive properties when ingested (Attar-Zadeh, 
2013). When taken in small quantities nicotine delivers a range of psycho-
physiological effects including tranquilization, weight loss, increased alertness 
and cognitive function (Rose, 1996). The nicotine paradox (Nesbitt, 1973) 
attempts to explain the conflict between relaxation and stimulation and 
concludes that smoking delivers nicotine which relieves withdrawal symptoms 
thus returning the smoker to a state of contentment (Hughes, 1991; Foulds & 
Ghodse, 1995).   
 
Over time, a physical dependence occurs. Several tobacco companies have 
openly admitted that smoking is highly addictive. In 1997 the Ligget Group, 
formerly known as the Ligget & Myers Tobacco Company based in Durham, 
North Caroline, USA, admitted it had increased the nicotine content in 
cigarettes to boost their addictive properties (Porter, 1997).  The nicotine 
regulation model of smoking describes a regulatory mechanism that monitors 
nicotine levels in the brain. When levels fall below what the individual feels is 
comfortable, they smoke to top-up their nicotine levels thus alleviating feelings 
of withdrawal (Schachter, Silverstein, Kozlowski, Herman & Leibling, 1984). 
 
In 1995, Hajek and colleagues challenged this theory and highlighted that 
some smokers will smoke nicotine-free cigarettes and abstain for lengthy 
periods, when for example, on a long-haul flight or hospital stay. They further 
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argued that light smokers typically smoke five or less cigarettes per day which 
would be insufficient to maintain a high level of nicotine, (Hajek, West & 
Wilson, 1995). It was later suggested that these findings could be attributed to 
the psychosocial environment and its ability to protect very light smokers from 
nicotine dependence and higher tobacco consumption (Lindström & 
Östergren, 2001).  
 
A more recent study in Finland among adult twins (Korhonen, Broms, 
Levalahti, Koskenvuo & Kaprio, 2009) supports these views and highlights 
that few studies exist that have explored the characteristics of light/intermittent 
smokers. They note that in the USA while regular smoking rates decreased 
from 24% (1999) of the population to 21% (2006) intermittent smoking rates 
increased from 18% to 20% respectively. The same was not found in Finland 
across the same time frame with intermittent rates remaining constant at 6%. 
Worryingly the authors note that evidence on health consequences of 
intermittent smoking is limited and suggest this may be attributed to 
intermittent smokers being excluded from studies due to the dose-response 
relationship of the health effects of smoking for many diseases. They 
conclude their study suggesting that intermittent smokers are less dependent 
on tobacco and use less tobacco products, have healthier lifestyles, have 
higher levels of education and possess better mental health profiles 
(Korhonen, Broms, Levalahti, Koskenvuo & Kaprio, 2009). 
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The notion that smokers are more likely to have additional behavioural and 
cognitive issues such as anxiety is much debated. The Nicotine Addiction 
Model (Schachter, 1978) focuses on explaining the maintenance of the 
smoking behaviour after acquisition.  In one study in the USA the intensity of 
electric shock the participant was able to tolerate was used as a behavioural 
measure of anxiety (Steffy, Michenbaum & Best 1970). The results 
demonstrated that heavy smokers tolerated a higher intensity of shock and 
were therefore considered less anxious when allowed to smoke than when not 
allowed to smoke.  It can be argued that rather than non-smokers exhibiting 
less anxiety, smokers are constantly exposed to withdrawal symptoms, 
increasing their feelings of anxiety. The study failed to account for the 
sedative properties of smoking and of the psychological and social influences 
on tobacco use (Pomerlau, 1979; Royal College of Physicians, 2000; van 
Gucht, Van den Bergh, Beckers & Vansteenwegen, 2010). 
 
Eysenck, Tarrant and Woolf (1960), found smokers rated highly on measures 
of extraversion. This personality trait has been associated with sensation 
seeking behaviours and found to be more prevalent in young adult 
populations (Bradley & Wildman, 2002), findings supported by Lovato, Watts 
and Stead, (2012). Sensation seeking is described as a quest for novel and 
intense experiences that may pose a risk to the sensation seeker. It is 
suggested that sensation seekers have lower levels of tonic arousal and seek 
intense stimulation to increase levels of cortical arousal. This suggestion 
supports findings from a study that found higher sensation seeking scores in a 
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group of smokers compared to a group of non-smokers (Carton, Houezec, 
Lagroue & Jouvent, 2000). 
 
These findings are not supported in a study of 130 male psychology 
undergraduate students at Nebraska University, USA. The report suggests 
neuroticism is the key personality characteristic that determines smoking 
uptake in young neurotic males and suggests smoking may be used as a 
buffer to alleviating symptoms of depression (McChargue, Cohen & Wrath 
Cook, 2004), consistent with the view that neuroticism is a precursor to 
depression (Jorm, Christensen, Henderson, Jacomb, Korten & Rodgers, 
2000).  
 
Bonas (2005) suggests that people smoke as a result of behaviour learned 
from others in a position of influence, for example, friends and family and 
media icons and that smokers learn to respond to conditioned stimuli and use 
smoking as an escape or avoidance mechanism in response to particular 
aversive states (Bonas, 2005). 
 
Although the literature draws differing conclusions on the uptake of smoking in 
adolescents and continuation of the behaviour into adulthood, it universally 
establishes that smoking has biological, psychological and social factors 
(Johnston, Liberato & Thomas, 2012).  
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The present study explores the efficacy of a smoking cessation intervention 
for people with diabetes. In order to develop an effective intervention it is 
important to have an understanding of the disease and of its implications for 
long-term health. The following section is a critical discussion of diabetes and 
the psychology of self-management. 
 
2.3 Diabetes – an overview 
Diabetes is a chronic, long term condition that is concerned with the 
production and uptake of the hormone insulin. Insulin is produced in the 
pancreas and enables cells to absorb glucose which is turned into energy. In 
diabetes the pancreas does not produce enough insulin or the body is unable 
to use the insulin effectively and cannot regulate blood glucose levels. This 
causes glucose to accumulate in the blood, which can lead to long-term 
complications (Tierney, McPhee & Papadakis, 2002; Rother, 2007).  
 
Acute complications including hypoglycaemia (low blood glucose levels), 
diabetic ketoacidosis (the chemical balance of the body becomes too acidic) 
or hyperosmolar hyperglycaemic state (related to diabetic ketoacidosis where 
high blood glucose levels can lead to dehydration resulting in a high risk of 
complications, coma and death) occur if the disease is not adequately 
controlled. Serious long-term complications include cardiovascular disease, 
chronic renal failure and stroke (Donnan, Fisher, Macleod & Davis, 2008), and 
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various types of nerve damage, which can cause erectile dysfunction and 
poor wound healing (Mailloux, 2007).  
 
Because diabetes affects blood circulation, feet and fingertips are particularly 
susceptible to the effects of the condition. Poor wound healing can lead to 
gangrene, and in some cases, to amputation. Appropriate treatment of 
diabetes, including education on the effects of blood pressure control and 
lifestyle factors such as smoking (Aveyard & West, 2007) and body weight 
(Barnard, Cohen, Jenkins, Turner-McGrievy, Gloede, Jaster, et al., 2006), 
may help to reduce the risk of developing most of the chronic complications. 
Diabetes is the most significant cause of adult blindness in the non-elderly 
and the leading cause of non-traumatic amputation in adults, in the developed 
world. In the United States of America diabetic nephropathy is the most 
common condition associated with renal dialysis (Mailloux, 2007). 
 
There are many types of diabetes recognised by the medical profession. The 
two most commonly known are Type 1 and Type 2 diabetes (DUK, 2012; 
SIGN 2011; Tierney, McPhee & Papadakis, 2002).  
 
2.3.1 Type 1 Diabetes 
The term "Type 1 diabetes" has universally replaced several former terms, 
including childhood-onset diabetes, juvenile diabetes, and insulin-dependent 
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diabetes mellitus (IDDM). Although Type 1 can affect children or adults it 
represents the majority of cases in children (DUK, 2014; Rother, 2007). It is 
characterized by the loss of the insulin-producing beta cells of the islets of 
Langerhans in the pancreas leading to a deficiency of insulin and can be 
further classified as immune-mediated or idiopathic. The majority of Type 1 is 
of the former where beta cell loss is a T-cell mediated autoimmune attack. To 
date there is no known preventive measure against Type 1 (DUK, 2014). 
  
The principal treatment of Type 1, even in its earliest stages, is the delivery of 
artificial insulin via injection combined with careful monitoring of blood glucose 
levels using blood testing monitors. The average glucose level for people with 
Type 1 should be as close to normal, 48mmol/mol, as is safely possible. 
Values above 75mmol/mol are often uncomfortable resulting in frequent 
urination. Although not immediately life-threatening this can lead to 
ketoacidosis which could lead to coma or death and will require medical 
attention (Kitabchi, Umpierrez, Murphy & Kreisberg, 2006).  Treatment must 
be continued indefinitely in essentially all cases and although insulin 
replacement can be burdensome, need not significantly impair normal 
activities if sufficient patient training, awareness, appropriate care, discipline in 
testing and dosing of insulin is taken (DUK, 2014).  
 
In contrast, some GPs suggest 53-58mmol/mol for those experiencing 
frequent low blood glucose levels or hypoglycaemia as this can lead to 
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seizures or episodes of unconsciousness and must be treated immediately. 
The person or child must stop what they are doing immediately and eat or 
drink something sugary. Although it is not clear from the literature how to treat 
very young children who perhaps cannot articulate feeling unwell, DUK 
recommend a finger prick test in all cases (DUK, 2014). 
 
Treatment emphasis is now also placed on lifestyle adjustments such as diet 
and exercise though these cannot reverse the progress of the disease. Apart 
from the common  subcutaneous injections (Marks & Miller, 2006), it is also 
possible to deliver insulin by a pump, which allows continuous infusion of 
insulin 24 hours a day at pre-set levels, and the ability to programme doses of 
insulin as needed at meal times  (DUK, 2014; Lenhard, & Reeves, 2001).  
 
2.3.2 Type 2 Diabetes 
Similarly to Type 1, the term "type 2 diabetes" has replaced several former 
terms, including adult-onset diabetes, obesity-related diabetes, and non-
insulin-dependent diabetes mellitus (NIDDM). Type 2 tends to be diagnosed in 
older adults and recently has become more prevalent in younger people 
across all ethnicities accounting for 85-90% of all cases (DUK, 2014). Type 2 
is characterized differently to Type 1 and is due to insulin resistance or 
reduced insulin sensitivity, combined with relatively reduced insulin secretion 
which in some cases becomes absolute. The defective responsiveness of 
body tissues to insulin almost certainly involves the insulin receptor in cell 
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membranes (DUK, 2014; Ward and Lawrence, 2000). As yet the specific 
defects have not been identified. 
 
In the early stages of Type 2 the predominant abnormality is reduced insulin 
sensitivity, characterized by elevated levels of insulin in the blood. At this 
stage hyperglycaemia can be reversed by a variety of measures such as diet, 
exercise and lifestyle modifications. Medication that improves insulin 
sensitivity or reduce glucose production by the liver can also be prescribed as 
an adjunct. As the disease progresses, the impairment of insulin secretion 
worsens, and therapeutic replacement of insulin often becomes necessary 
(DUK, 2014).  
 
In some cases people can spend many years in a state of pre-diabetes, a 
condition that occurs when a person's glycated haemoglobin levels are higher 
than normal but not high enough for a diagnosis of type 2 diabetes (Lilly & 
Godwin, 2009).  
 
2.3.3 Prevalence of Type 2 Diabetes 
The prevalence of diabetes worldwide is increasing beyond previous 
estimates. It is correlated with an ageing population that is becoming 
increasingly obese as a result of a sedentary lifestyle and reduced physical 
activity (Boyle, Honeycutt & Narayan, 2001). Type 2 diabetes represents 90% 
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of all cases and despite efforts to manage risk factors, develop new treatment 
strategies and administer new therapies, people with Type 2 diabetes in the 
UK have a threefold increased risk for cardiovascular mortality (3.25 [2.87-
3.68] adjusted for smoking) (Taylor, Heneghan, Farmer, Fuller, Adler, Aronson 
& Stevens, 2013), highlighting challenges for health care. Adopting a healthier 
lifestyle is central to preventing and managing the disease (NICE PH38, 
2012).  
 
The World Health Organisation (WHO) has estimated that the prevalence of 
Type 2 diabetes will increase to 300 million people worldwide by 2025 (King, 
Aubert & Herman, 1998). Arguably, these figures are underestimated 
(Saydah, Loria & Eberhardt, 2001; Taubert, Winkelman & Schlieffer, 2003). 
The Yorkshire and Humber Public Health Observatory (2010) reported the 
number of people over 16 years of age in England with diagnosed and 
undiagnosed diabetes to be 3.1 million accounting for 7.4% of the population. 
It is not clear in the report how the undiagnosed cases were accounted for. 
The report estimates these figures will increase to 4.6 million and 10% 
respectively by 2030 and that 90% will be Type 2 diabetes with many already 
having prediabetes (Danaei, Finucane, Lu, Singh, Cowan, Paciorek, et al., 
2011). Diabetes UK (2012) estimate this figure could be as high as 850,000 
adults in England. 
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Because of its silent onset∗, many people will already have detectable signs of 
one or more long-term complications by the time Type 2 diabetes is 
diagnosed. The life expectancy of a patient is reduced by approximately 8-10 
years and they are five times more likely to develop cardiovascular disease 
and experience stroke resulting in death in nearly 70% of cases compared to 
those without the disease (DUK, 2012; SIGN 116, 2011).  
 
The cost to the NHS in England of treating Type 2 diabetes and its 
complications is currently £8.8 billion per year, 8% of its total budget. Indirect 
costs resulting from loss of productivity and premature death are estimated to 
be £13 billion (Hex, Bartlett, Wright, Taylor & Vardley, 2012). The NHS has 
already seen substantial financial increase to treat diabetes. Drug prescribing 
rose from £514 million to £725 million from 2005/06 to 2010/11 respectively 
(NHS Information Centre for Health and Social Care, 2011) and this is 
expected to continue with estimates rising from £15 billion to £20 billion for 
direct and indirect costs respectively by 2036/37 (Hex et al., 2012). 
 
In Scotland Type 2 diabetes is an increasing health problem across all age 
groups.  In response to the document ‘Towards a Mentally Flourishing 
Scotland, (2009)’, DUK reported the prevalence of diabetes as 4% but warned 
this figure was expected to increase to at least 5% by 2010 (McGinley, 2008). 
These estimates have not yet been achieved although figures are steadily 
                                                          
∗ To celebrate their 75th Anniversary in 2009, Diabetes UK launched the ‘Silent Assassin’ campaign. 
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increasing toward the projected percentage. At the beginning of 2012, the 
Scottish Diabetes Survey reported approximately 250,000 people registered 
with diabetes, compared with approximately 240,000 in 2010, 4.7% and 4.6% 
of the population respectively. Type 2 diabetes was diagnosed in 88% of all 
cases (DUK, 2012). Type 2 diabetes and the associated long-term 
complications are costing the NHS in Scotland £1bn per year to manage. This 
equates to approximately 10% of the total NHS Scotland budget (DUK, 2012; 
Robison, 2008).   
 
The causes and mechanisms of Type 2 diabetes are the subject of many 
theories. Fat concentrated around the waist in relation to abdominal organs is 
known to contribute to insulin resistance. Central obesity is active hormonally, 
secreting adipokines, a group of hormones known to impair glucose tolerance 
(MacDougald, Ormond & Burant, 2007; Diabetes UK, 2012).  
 
Other factors include ageing and genetic predisposition (DUK, 2012; 
Rosenbloom & Silverstein, 2003). Environmental exposures may also 
contribute to increased prevalence, for example, a positive correlation has 
been found between the concentration of bisphenol A, a constituent of 
polycarbonate plastic, in urine and the increased prevalence. The authors 
suggest this may be associated with avoidable morbidity and warrants further 
investigation (Lang, Galloway & Scarlett, 2008). 
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Patient education, understanding and active participation in the management 
of the condition is vital. People who maintain good glycated haemoglobin 
control present with less long-term complications of diabetes and the 
complications are not so severe (DCCTRG, 1995; Nathan, Cleary & Backlund, 
2005). Other health problems and lifestyle choices can accelerate the 
deleterious effects of diabetes, in particular weight gain and obesity. In an 
attempt to counter this, a collaborative study is currently running between the 
University of Glasgow and Newcastle University. Results are due in 2018. The 
study builds on the findings of a preliminary trial at Newcastle University 
investigating direct routes to Type 2 remission. Under close medical 
supervision, participants’ food intake was reduced to 800 calories per day and 
comprised liquid diet drinks and non-starchy vegetables. Within one week 
levels of fat in the liver had reduced significantly. By the end of the study fat 
levels in the pancreas had also decreased and insulin production had 
returned to normal. Although some participants gained weight, Type 2 
remission was maintained at 2-month follow-up (Lim, Hollingsworth, Aribisala, 
Chen, Mathers, Taylor, 2011). 
 
Although this study may offer hope in the future diabetes currently has no 
known cure. It is managed mostly in the community by the individual with 
support from primary care with the focus on managing or reducing the risk of 
complications and relies on patient education, dietetic support, sensible 
exercise and self-monitoring (Perlmutter, 2008).  
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As Boyle, Honeycutt and Narayan (2001) reported, the role of lifestyle and 
behavioural factors in patients with Type 2 diabetes, such as smoking, has 
been shown to contribute to poor self−management and more rapid disease 
progression. Changing these behaviours can reduce the risk of developing 
diabetes and delay the onset of long−term complications (Canga, de-Irala, 
Vara, Duaso, Ferrer & Martinez-Gonzalez, 2000; Glasgow, 2000). 
 
In order to change behaviour it is important to understand the psychology 
underpinning the behaviour. The following section discusses the psychology 
of self-managing diabetes and how it can affect glycated haemoglobin levels. 
 
2.4 Psychology of Diabetes  
Diabetes is a complex condition that places high behavioural demands on the 
individual living with the disease. While access to well-trained healthcare 
professionals is a key aspect of diabetes care the burden of care remains with 
the individual.  Although many people cope well with their condition, the rates 
of psychological issues, such as depression, anxiety and stress, and poor 
quality of life are much higher among those with diabetes than in the general 
population (Ali, Stone, Peters, Davies & Khunti, 2006; Das-Munshi, Stewart, 
Ishmail, Bebbington, Jenkins & Prince, 2007).  
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In a study exploring the psychosocial problems and barriers to improved 
diabetes management (the DAWN Study), Peyrot, Rubin, Lauritzan, Snoek, 
Matthews & Skovlund, (2005) report that 41% of participants demonstrated 
low levels of psychological wellbeing as measured against the WHO-5 
Wellbeing Index. The study reports that only 12% of the Type 2 population 
had received psychological support in the preceding five years.  The study 
failed to compare the low levels of psychological wellbeing among its 
participants to those of the general population.  
 
These findings are important for clinicians and patients as poor psychological 
well-being can have a negative impact on their ability to self-manage their 
diabetes. For example, adherence to medication can be reduced resulting in 
poor outcomes (Gonzalez, Safren, Cagliero, Wexler, Delahanty, Wittenberg, 
et al., 2007; Gonzalez, Safren, Cagliero, Wexler, Miegs & Grant, 2008; 
Gonzalez, Peyrot, McCarl, Collins, Serpa, Mimiaga, et al., 2008; Gonzalez, 
McCarl, Wexler, Cagliero, Delahanty, Soper, et al., 2010). In addition to the 
severe impact of psychological problems, undetected depression can result in 
increased healthcare costs and expenditure (Egede & Zheng, 2003), lost 
productivity due to absence from work (Egede, 2007) and increased mortality 
(Katon, Rutter & Simon et al., 2005). 
 
Treatment for psychological issues such as anxiety and depression has been 
shown to reduce symptoms and improve blood glucose control and quality of 
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life (Lustman & Clouse, 2005; NICE, 2009) as well as improve psychological 
wellbeing (Ismail, Winkley & Rabe-Hesketh, 2004; Winkley, Ismail, Landau & 
Eisler, 2006) and reduce healthcare costs (Simon, Katon, Lin, Rutter, 
Manning, von Korff, et al., 2007). In addition, understanding the individual’s 
health beliefs, attitudes toward their condition and levels of confidence and 
motivation to self-manage diabetes may lead to the development of 
interventions that could help them control their blood glucose levels and 
improve their ability to cope with the disease (Ruggiero, 2000; van der Ven, 
2003; Collins, Bradley, O’Sullivan & Perry, 2009). 
 
There is continued debate as to the cause of psychological distress in people 
who self-manage diabetes. To inform this debate, longitudinal studies need to 
investigate causal factors further and identify whether psychological distress is 
due to the fear of developing long-term complications, the risk of 
hypoglycaemia or to diabetes-related abnormalities in neurohormonal and 
neurotransmitter functioning (Grigsby, Anderson, Freedland, Clouse & 
Lustman, 2002).  
 
Nonetheless, research on the subjective experiences of people with diabetes 
have highlighted a relationship between psychological distress and blood 
glucose control both directly through the hyperglycaemic effects of stress 
hormones and indirectly through the disruption of self-management 
techniques (Rubin & Peyrot, 1992).  
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Riazi, Pickup and Bradley (2004) defined stress as hassle that people deal 
with in every-day situations. In their study they demonstrate the individual 
differences in stress-reactivity and suggest that this should be considered 
when evaluating the research and clinical use of stress-management 
interventions.  No large population data are available to inform this debate. 
 
Research on diabetes-related emotional distress has consistently reported 
that worrying about developing long-term complications and feeling guilty and 
anxious when self-management is not effective, are the most distressful 
(Snoek, Pouwer, Welch & Polonsky, 2000). Meltzer & Egleston, (2000) report 
two significant findings in their study on patient perceptions of their risk of 
developing diabetes-related complications. Firstly they found that patients 
over-estimated their risk of developing complications and secondly, that 
patients overestimated the reduction in risk for complications produced by 
intensive interventions. These results have important implications. Meltzer and 
Egleston (2000) suggest that overestimating the likelihood of developing 
complications could lead to increased levels of anxiety, the effects of which 
were discussed previously in the Peyrot, Rubin & Lauritzan, et al., (2005) 
study. If patients are unaware of their actual risk, they may not make informed 
decisions regarding risk reduction and lifestyle choices required to maintain 
their quality of life (Meltzer & Egelston, 2000). No full discussion of over-
estimation of potential benefits of interventions was included in this study. 
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Overestimation has its benefits especially when perceptions of vulnerability to 
illness and efficacy of interventions motivate an individual to self-manage their 
diabetes more effectively. The absence of these components, crucially belief 
in the efficacy of interventions, can lead to increased levels of fear resulting in 
feelings of hopelessness and denial (Frijling, Robo, Keus et al., 2004).  
 
Historically the treatment of diabetes has been based on the medical model 
with little attention paid to the psychological component of patient care, in 
particular, patients’ self-management behaviours. With this framework, 
success was judged by patient compliance and adherence to treatment 
(Funnel, Anderson, Arnold, Barr, Donnelly, Johnson, et al., 1991). Since 
diabetes care is different from the treatment of acute illness, a new conceptual 
framework was required to inform the behavioural, clinical and educational 
approaches (Glasgow & Anderson, 1999; Funnel & Anderson, 2000; 
Anderson & Funnel, 2000). 
 
Empowerment, as a conceptual framework, recognizes that individuals are 
responsible for the self-management of their diabetes and redefines the 
patient-healthcare professional relationship (Funnel & Anderson, 2000). 
Empowerment is defined as a process of helping people discover and develop 
their level of responsibility for their own lives and to gain control of their 
diabetes. This responsibility is required because of three crucial 
characteristics of the disease.  
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Firstly, the key choices the individual makes affecting their health and well-
being are made by the person with diabetes and not by health professionals. 
Secondly, the consequences of these choices, for example, development of 
long-term complications, are attributed to the person with diabetes and not the 
health profession. And thirdly, individuals are in control of the daily self-
management of their diabetes. They can accept or reject any advice and 
education from the health professionals regardless of the importance or 
relevance of the information provided (Fuller & Anderson, 2000). 
 
Part of the challenge of self-managing diabetes is the feeling of not being in 
control. With diabetes, where the ability to self-manage determines outcomes, 
conflict and frustration can result, particularly when psychological health and 
well-being, goals and lifestyle are not taken into account.  
 
Empowerment responds to these issues. With its roots in community and 
counselling psychology (Combs, Avila & Purkey, 1978; Rapport, 1987) and 
adult education (Wallerstein & Bernstien, 1988), it is aligned with the 
biopsychosocial model of disease and illness and acknowledges the whole 
person. The approach enables recipients to gain more power and control over 
their lives and to increase the number of choices available to them. With 
regard to diabetes, empowerment is viewed as collaboration among equals 
(Engel, 1977). The knowledge required to make informed decisions about 
diabetes falls into two categories. The first category includes knowledge about 
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diabetes and its treatment. The second category is based on self-awareness 
of needs, beliefs, values and goals and encourages people to examine the 
emotional, social, intellectual and spiritual elements of their lives in relation to 
the decision they make about self-management (Anderson, Funnell, Barr, 
Dedrick & Davis, 1991). 
 
Since its introduction to the diabetes literature in 1991, empowerment has 
been researched in practice and controlled trials and shown to be an 
efficacious and practical approach to diabetes self-management and care 
(Funnel & Anderson, 2003). Within the healthcare setting there has been a 
shift towards collaborative working with patients (Glasgow, Hiss, Anderson, 
Friedman, Hayward, Marrero, et al., 2001; Williams & Zeldman, 2002; 
Glasgow, Funnell, Bonomi, Davis, Beckham & Wagner, 2002), patient-centred 
care (Renders, Valk, Griffin, Wagner, Ejik & Assendelft, 2001; Wagner, 
Grothaus, Sandhu, Galvin, McGregor, Artz, et al., 2001; Funnel & Anderson, 
2003), collaborative goal setting (Funnel & Anderson, 2003; Mensing, 
Boucher, Cypress, Weinger, Barta, Hosey et al., 2000), theory-based 
education and increased self-management skills (Funnel & Anderson, 2003) 
and psychosocial issues (Lustman, Freedland, Griffith & Clouse, 2000; Rubin, 
2001). Simultaneously, this has resulted in a shift away from adherence and 
compliance (Funnel & Anderson, 2000; Anderson & Funnel, 2000) and 
information transfer (Norris, Lau, Smith, Schmid & Engelgau, 2002; Barlow, 
Wright, Sheasby, Turner & Hainsworth, 2002). 
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To self-manage diabetes effectively, individuals are required to set goals, 
make effective decisions relevant to their lifestyle, whilst being mindful of 
metabolic, psychosocial and personal factors (Funnel & Anderson, 2004). 
Included in this process needs to be information on therapeutic options, 
strategies for behaviour change, problem solving and coping with the 
psychosocial demands of living with a chronic, long-term condition.  
 
To allow self-management to occur, the paternalistic and maternalistic roles 
that the healthcare profession traditionally assumed, which were often more 
akin to a parent-child relationship, need to adapt to partnership working 
(Funnel & Anderson, 2004). This can pose challenges for the patient-health 
professional relationship. Control is passed to the patient and not everyone 
can cope with this responsibility. Some patients may feel overwhelmed. Not all 
professionals are able to relinquish control of the treatment process. 
Consultants and nurses may be required to acknowledge equality in the 
relationship and act as partners who are responsible to patients rather than for 
patients. In addition, they may find a discrepancy with the goals the patient 
sets for their well-being as opposed to the goals they feel would help patients’ 
self-manage diabetes more effectively, reducing the risks of long term 
complications developing. For example a patient could decide that eating 
excessive amounts of sugary foods helps them cope with self-management 
whereas the consultant or nurse would be inclined to advise against this. It 
can also be difficult to address the negative emotions often associated with 
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diabetes and consultations can be lengthened if these emotions present 
(Levinson, Gorawara-Bhatt & Lamb, 2000). 
 
Unfortunately Funnel and Anderson fail to account for the two main types of 
diabetes and the effect empowerment has on self-management of either of 
them. Similarly the Diabetes Empowerment Scale (Anderson, Funnel, 
Fitzgerald & Marrero, 2000) fails to acknowledge the difference and discusses 
diabetes as a single condition.  
 
One study does investigate the effect of empowerment on self-management 
of Type 1 diabetes. The authors note that although educational programmes 
have been shown to improve metabolic control in Type 1 diabetes, the effects 
of interventions aimed at promoting empowerment have received little 
attention. Ninety participants ≤65 years of age took part over a 2-year period 
with 54 participants assigned to the intervention group. The study found that 
the educational empowerment-based intervention significantly (p<0.005) 
improved the psychosocial aspects and self-management abilities of patients 
with Type 1 diabetes and suggests “it is the way forward to a normal life” 
(Forlani, Zannoni, Tarrini, Melchionda & Marchensi, 2006, pg.2). Reported in 
these terms it is a sweeping and subjective suggestion difficult to quantify. 
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In relation to Type 2 diabetes one study assessed the empowerment score of 
patients in Isfahan, Iran and found that diabetes empowerment levels showed 
a significant relationship between variables such as level of education 
(p<0.001), gender (p<0.007), age (p<0.001) and duration of diabetes 
diagnosis (p<0.001). Furthermore ordinal regression analyses revealed that 
having a higher education/diploma (p<0.005) and optimal/borderline HbA1c 
(p<0.0051) were significant factors in empowering patients with Type 2 
diabetes. The authors conclude by suggesting that patients can be 
empowered to self-manage their diabetes more effectively if they are informed 
and educated (Tol, Shojaeezadeh, Sharifirad, Alhani, & Tehrani, 2012). They 
fail to suggest how to empower patients whom unfortunately do not have a 
higher education and who struggle to control their HbA1c. 
 
Nevertheless, empowerment has been shown to be effective in shifting the 
focus from blood glucose levels to acknowledgment of the person as an 
individual (Funnell & Anderson, 2003, 2004; Renders, Valk & Griffin et al., 
2003). This has been achieved by using reflective listening techniques and 
open questioning to understand how the person is feeling, for monitoring and 
redefining goals, discussing how the individual perceives their diabetes and 
what they wish to achieve from their consultation (Heisler, Bouknight, 
Hayward, Smith & Kerr, 2003).  
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Psychological interventions should continue to develop emotional and 
behavioural tools and provide the education and skills to help people cope 
with diabetes-related issues (Vileikyte, Rubin & Leventhal, 2004). This may 
offer individuals an alternative to smoking, which is a well-known coping 
mechanism for managing stress (Erblich, Bovbjerg & Diaz, 2012).   
 
The following section discusses the efficacy of psychology in diabetes care 
and gives an overview of the psychological models available to investigate 
behaviour change.  
 
2.5 The Role of the Psychologist in Diabetes Care 
Evidence that psychological and behavioural factors significantly affect the 
management and outcomes of diabetes continues to grow and as a result, 
psychologists are increasingly becoming an integral part of traditional diabetes 
care. This has been a slow process. The Minding the Gap survey reports that 
85% of people in the UK with diabetes have either no access to psychological 
care or access to a general mental health service provider (Trigwell, Taylor, 
Ismail, Nicholson, Alibhai, Gosden, et al., 2008).  
 
Psychologists can support patients to become more empowered by working in 
close partnership with them to build confidence and increase motivation, self-
awareness and levels of self-efficacy. Health behaviour change is one of the 
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key roles of health psychology as it attempts to move individuals from 
negative behaviours to positive behaviours via these mechanisms. Health 
psychology has developed models and theories to investigate health 
behaviour change and to advise health care teams on strategies to 
incorporate psychological principles into patient care to enhance clinical 
outcomes. These models can be applied to smoking cessation and diabetes 
self-management to inform the development of complex interventions aimed 
at reducing long-term complications.  
 
2.6 Biospsychosocial Models and Theoretical Frameworks 
Diabetes is considered as a physiological condition. More recently, the 
concept of health and disease has developed from a biological model to 
include psychological and social factors (Sridhar & Madhu, 2002). This 
biopsychosocial construct (Engel, 1977) posits that disease results from a 
dynamic interaction between biological, psychosocial, developmental and 
socio-cultural factors (Sridhar, 2002). 
 
The biopsychosocial model of health is based in part on social cognitive 
theory (Bandura, 1988) and implies treatment of disease processes, for 
example Type 2 diabetes, requires the health care team to take into account 
biological, psychological and social influences on patients’ functioning 
(Halligan & Aylward, 2006). 
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The model suggests it is important to work with the three components in 
conjunction with each other. The empirical literature suggests that patient 
perceptions of health and threat of disease, including barriers to their social or 
cultural environment, can influence their willingness to engage in health-
promoting or treatment behaviours, such as adherence to medication, healthy 
diet and physical activity (DiMatteo, Haskard & Williams, 2007).  
 
McLaren (2004, 2006) described the model as ‘a disingenuous framework to 
cloak what was essentially psychosomatic illness and notes that the Journal of 
Psychosomatics uses the terms ‘biopsychosocial’ and ‘psychosomatic’ 
interchangeably. He states that whilst biology, psychology and sociology are 
factors of mental health together they do not equate to a scientific model. In 
his report ‘New Labour and the Welfare State, (2007)’, Rutherford advised that 
‘the model to apply for returning people to work is the biopsychosocial one’. 
Without clear scientific rigor Rutherford cautioned that the model may be 
subject to exploitation by governments to deny the public access to health and 
social care. In an earlier report, Epstein and Borrell-Carrio (2005) suggest the 
interpretations are conflicting.  
 
Although the biopsychosocial model does not provide a simple, testable 
model that gives a clear explanation of the interactions or variance accounted 
for by each component, it has been a useful guide for theoretical and 
empirical investigation. Much of the literature has identified social-cognitive 
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variables, for example self-efficacy in managing chronic diseases, such as 
Type 2 diabetes, that may influence uptake of healthy behaviours and 
adherence to medication (Carlson, Norman, Feltz, Franklin, Johnson & Locke, 
2001; Allen, 2004). These models underpin health psychology and include the 
Theory of Planned Behaviour (TPB) (Ajzen, 1988), the Transtheoretical or 
Stages of Change Model (Prochaska & DiClemente, 1984), the Health Belief 
Model (HBM) (Rosenstock, 1966; Becker, 1974) and Locus of Control (Rotter, 
1966).  
 
Theoretically based frameworks lay the foundation upon which factors 
affecting diabetes self-management behaviours can inform psychology. Social 
cognition models allow for the investigation of how people make sense of 
themselves and others and have been used to help understand psychosis 
(Kuipers, Garety, Fowler, Freeman, Dunn & Babbington, 2006).  The models 
can also be applied in an attempt to predict health behaviours.  
 
2.6.1 Theory of Planned Behaviour (TPB) 
The TPB examines the relationship between attitudes, behavioural intentions 
and behaviour and assesses perceived behavioural control (Ajzen, 1988). The 
model has been applied to the prediction of health-behaviours, including 
smoking, which can have serious consequences for people with diabetes, with 
varied outcomes. Godin, Valois, LePage and Desharnais, (1992) found the 
TPB to be a useful predictor of smoking behaviour and intentions in two 
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prospective studies. The first study was among the general population and the 
second was among pregnant women. Perceived behavioural control emerged 
as the strongest predictor of behavioural intentions in both studies, with 
behavioural intentions relating to smoking status at 6-month follow-up.  
 
More recently the TPB has been used in a study to explain physical activity in 
an adult population with Type 1 and Type 2 diabetes. The findings added to 
the evidence base of the utility of the TPB in designing physical activity 
interventions with suggestions that the principles would be transferable to 
other health interventions (Plotnikoff, Lippke, Courneya, Birkett & Sigal, 2010).  
 
Whilst the TPB has been useful in broadening the understanding of a variety 
of health-related behaviours, its main weakness is that it focuses on 
perceptions of behavioural control and not with actual behavioural control 
(Connor & Sparks, 2001). 
 
2.6.2 Health Belief Model (HBM) 
Central to health behaviours are health beliefs. The HBM focuses on threat 
perceptions and behavioural evaluation. Threat perception is associated with 
two beliefs, perceived susceptibility to illness and anticipated severity of the 
consequences of the illness. Behavioural evaluation is also associated with 
two distinct sets of beliefs, the efficacy of specific health behaviours and the 
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barriers to performing those behaviours (Rosenstock, 1966). Becker, Haefner 
and Maiman, (1977) later added another two constructs, cues to action and 
health motivation, bringing the total HBM constructs to six. 
 
The HBM has been applied in research more often than other social cognitive 
models and in three main areas, health promoting (e.g. diet) and health risk 
(e.g. smoking) behaviours, sick role behaviours and clinical utility.  Even so, 
there have been issues with this model. For example, applications of the HBM 
have not included all components in the measurement process and 
components are often combined under a single construct rather than 
measured separately (Gianetti, Reynolds & Rihen, 1985). There has also 
been a general failure to check the reliability and validity of the constructs, 
throughout the literature (Sheeran & Abraham, 1996).  
 
The HBM was used to underpin a trial aimed at improving medication self-
management in a population with co-existing diabetes and kidney disease. 
Although the authors claim “the major strength of this trial is that it is one of 
the first published studies to tackle the problem of competing co-morbidity 
management where consumers are required to consult with multiple health 
practitioners and take multiple prescribed medications”, they fail to 
acknowledge the utility of the HBM to predict patient outcomes (Williams, 
Manias & Walker, 2010, pg7).  The only mention of the HBM is to advise the 
model was used to underpin the development of a DVD involving an 
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interactive psychosocial approach to motivate patients to take their 
medication. The study was beset with issues but did suggest that 
management of co-morbidities is increasing and may benefit from 
interventions to improve patient outcomes particularly with regard to an 
evidence-based approach to patient care. There was no discussion of the 
efficacy of the DVD on patient outcomes. 
 
Despite the fact that Rosenstock (1974) suggested a relationship between 
health beliefs and psychological stages in decision-making, and the weakness 
highlighted in the literature, the HBM has not been re-conceptualised. This 
lack of evolution led to rejection of the HBM for conceptual frameworks that 
were developing throughout the 1980’s. These included work on locus of 
control (Wallston & Wallston, 1982) and perceived control derived from 
attribution theory, which had been shown to be a determinant of health 
behaviour (King, 1982).  
 
Research based on psychological theory has highlighted the importance of 
patients’ personal beliefs regarding their illness and treatment and the impact 
these beliefs have on their self-management of a range of chronic illnesses, 
including diabetes (Petrie, Weinman, Sharpe & Buckley, 1996; Leventhal, 
Meyer & Nerenz, 1980). This report shows that patients’ illness beliefs cluster 
around five dimensions: 
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(1) Identity: including the disease label and associated beliefs about the 
symptoms of the disease 
(2) Timeline: beliefs about the course and duration of the disease 
(3) Consequences: the effects of the disease 
(4) Cause: the perceived cause(s) of the disease 
(5) Cure/control: including beliefs about recovery from the illness or ability to 
control an existing condition (Leventhal, Meyer & Nerenz, 1980).  
 
Beliefs have been demonstrated as central to understanding the strategies 
patients adopt to cope with their condition. For instance, research on illness 
beliefs and diabetes has indicated that patients who believe they are in control 
of their illness are more inclined to engage with the healthcare system to seek 
treatment and make positive lifestyle modifications (Hampson, Glasgow & 
Foster, 1995). 
 
Furthermore, patients have beliefs about the importance of taking medication 
and concerns about the possible long-term effects. These beliefs have shown 
to be strong predictors of adherence to medication (Horne, Weinman & 
Hankins, 1999; Horne, 2003), which is essential if patients with diabetes are to 
reduce the risk of developing long-term complications and for maintaining 
quality of life (Cox & Gonder-Frederick, 1992; DCCTRG, 1993). Nevertheless, 
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a patient with positive coping strategies engaging with treatment can easily be 
blocked by another psychosocial dimension known as locus of control. 
 
2.6.3 Locus of Control  
Locus of Control is a construct considered important to personality (Rotter, 
1966).  Derived from Locus of Control of Reinforcement, it was developed to 
connect behavioural and cognitive psychology.  Rotter suggested behaviour 
was directed by reinforcements or rewards and punishments. These 
contingent actions were thought to help identify the causes of certain 
behaviours and guide beliefs on the attitudes and behaviour people adopt 
(Rotter, 1966).   
 
Thus, locus of control is described as a unidimensional continuum, ranging 
from external at one end to internal at the opposite end. A high internal locus 
of control indicates people believe events result from their own behaviour and 
actions. Conversely, a high external locus of control indicates people believe 
powerful others, fate, or chance determines events (Rotter, 1966). 
 
Locus of control is the framework of social learning theory of personality 
(Rotter 1966), but its immediate background was developed by Rotters’ 
students who studied two types of expectancy shifts: 
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typical expectancy shifts - belief that success or failure will be followed by a 
similar outcome  
atypical expectancy shifts - belief that success or failure will not be followed by 
a similar outcome.  
 
Work in this field led psychologists to suggest that people who exhibit typical 
expectancy shifts were more inclined to attribute outcomes to their abilities. 
People who exhibit atypical expectancy shifts were more inclined to attribute 
outcomes to chance. This was interpreted as saying that people could be 
divided into two specific groups, those who attribute outcomes to ability (an 
internal cause) compared with those who attribute outcomes to luck (an 
external cause) (Rotter, 1966).  
 
Rotter (1975) cautioned that internality and externality were not an either/or 
typology but rather, characterized opposite ends of a spectrum. Individuals 
with an internal locus of control are more inclined to attribute outcomes to their 
own control. Conversely, individuals with an external locus of control are more 
inclined to attribute outcomes to external circumstances or chance. This has 
obvious implications for differences between internals and externals in terms 
of their achievement motivation, suggesting that internal locus is linked with 
higher levels of Need for Achievement (McClelland, 1958). Because they 
locate control outside of themselves, people with an external locus of control 
feel they have less control over their fate and tend to be more stressed and 
Matriculation Number: 05008241  Professional Doctorate in Health Psychology  
Doctoral Thesis 2015   54 
prone to clinical depression (Benassi, Sweeney & Dufour, 1988; cited in 
Maltby, Day & Macaskill, 2007). 
 
Abramson, Seligman and Teasdale (1978) introduced the concept of 
attributional style. This concept expands on Weiner’s (1986) work, advising 
that a further dimension of globality-specificity should be considered alongside 
internality-externality and stability (Weiner, 1974). Abramson et al., (1978) 
suggest the way people explain success and failure in their lives relates to 
whether they attribute these to internal or external factors, to whether factors 
are short-term or long-term and whether they affected all situations.  
 
Attributional theorists originated in social psychology. They focus on ways 
past events influence how and why people explain actions and behaviours in 
the way they do. Locus of control theorists explore the differences in 
individuals’ explanatory styles and focus on expectations of control over future 
events.  
 
Weiner (1986) argues for an attributional theory of motivation and emotion 
and suggests thinking gives rise to feelings which guide actions. If the action 
has a positive impact on the individuals’ feelings about themselves, they will 
be motivated to perform the action again. Conversely, if the action has a 
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negative impact on feelings about themselves, the individuals will be less 
inclined to repeat the action (Weiner, 2007, 2006, 1986). 
 
The most prominent application of locus of control has been in health 
psychology (Wallston, Wallston & DeVellis, 1978).  Furnham and Steele 
(1993) conducted a literature review and found scales that measure general 
health and scales that measure more specific health domains such as obesity 
and mental health. Bradley, Lewis Jennings and Ward, (1990), conducted a 
study of scales to measure perceived control for people with tablet-treated 
diabetes from which Furnham and Steele (1993) note the link between locus 
of control and self-management of the condition.  They review reports that an 
internal locus of control tends to result in the patient managing his or her own 
treatment quite successfully (Bradley, Lewis, Jennings & Ward, 1990).  
 
In their literature review on health locus of control, Norman and Bennett 
(1996) concluded some of the findings were ambiguous. In the case of 
jogging, Norman and Bennett report some studies found internal health locus 
of control to be linked to increased exercise. Nevertheless several studies 
found little or no relationship between exercise and internal health locus of 
control. With regard to the relationship between internal health locus of control 
and breast self-examination, weight control and preventative health 
behaviours the findings were inconsistent. Some studies reported a 
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relationship between the behaviours and locus of control whilst others did not 
(Norman & Bennett, 1996).  
 
These inconsistencies led Wallston (1989, 1992) to modify social learning 
theory noting that health locus of control beliefs were key to performing a 
health behaviour but inadequate on their own. It is argued the findings may be 
due to the degree participants value their health and belief that their behaviour 
would improve their health and self-efficacy to perform the behaviour (Norman 
& Bennett, 1996). 
 
Norman and Bennett (1996) highlight that powerful others health locus of 
control, as well as internal health locus of control, may be linked with smoking 
cessation. They argue that a stronger association is found when health locus 
of control is assessed for specific behaviour. They refer to several studies 
which have used health-related locus of control scales in particular areas, 
including smoking cessation (Georgiou & Bradley, 1992), diabetes (Ferraro, 
Price, Desmond & Roberts, 1987) and tablet-treated diabetes (Bradley, Lewis, 
Jennings & Ward, 1990). Norman and Bennett (1996) also argue that health 
locus of control is better at predicting health-related behaviour if studied in 
combination with health value, i.e. the value people attach to their health, 
providing further support for their earlier suggestion that health value is an 
important moderating variable in the health-locus of control relationship 
(Norman & Bennett, 1996).  
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The Smoking Locus of Control Scale (SLoCS) (Georgiou & Bradley, 1992) 
and the Perceived Control of Diabetes Scale (PCDS) (Bradley, 1993) were 
developed from previous work by Wallston, Wallston, Kaplan and Maides, 
(1978) on locus of control measurements and on developments in measures 
of attributional style (Peterson, Semel, von Baever, Abrahmson, Metalsky & 
Seligman, 1982). As discussed in the preceding text (pg. 41), attributional 
style derives from attributional theories that predict an individual’s explanation 
for past events is more likely to influence their expectations of their future 
behaviour (Weiner, 1986).  Locus of control scales differ as they are 
concerned with measuring expectations of future events.  
 
In contrast to the views proposed by the attributional theorists, Norman and 
Bennett’s (1996) argue in favour of health-specific locus of control measures 
supporting Bradley’s (1985) review of the literature. The review suggests 
researchers have acknowledged the concept of perceived control of diabetes 
as important in understanding a patient’s motivation to self-manage their 
condition.  An individual signifying an internal locus of control would be 
expected to be more motivated to adhere to treatment and follow a 
demanding treatment regimen than an individual signifying an external locus 
of control (Bradley, 1985).  
  
The PCDS (Bradley, 1993) attempts to measure ways in which individuals 
explain the short and long-term outcomes of their diabetes, and was originally 
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aimed at people with Type I diabetes.  The scale was not only concerned with 
perceptions of locus of control but also with perceptions of responsibility and 
foreseeability and with perceptions of control by the individual’s doctors and 
others.  The rationale for subsequent modification for Type 2 diabetes was to 
understand individual differences in preferences for treatment regimens and 
differences in the degree of diabetes control achieved.  
 
The PCDS (Bradley, 1993) was developed because of its relevance to 
diabetes and because generic measures were not sensitive to disease-related 
adjustments.  Researchers recognized that notions of perceived control over 
diabetes are likely to be important in understanding patients’ motivation to 
manage their diabetes. An individual with diabetes who attributes diabetes 
control to good or bad luck would not be expected to be as well motivated to 
follow a demanding treatment regimen as a person who favours an internal 
locus of control and attributes good blood glucose control to their own efforts 
(Bradley, 1985). The scales were designed to have a similar format to 
Peterson, Semel & von Baever et al.’s (1982) Attributional Style 
Questionnaire.  
 
Comparison of the perceptions of control of diabetes between health care 
professionals and patients highlighted a bias in the professionals’ perceptions, 
whereby they were less inclined to attribute negative outcomes to medical 
factors, which may have had a negative impact on the patient-health care 
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professional relationship.  The PCDS (Bradley, 1993) has attempted to 
redress this discrepancy by measuring attributions and has been found to be 
significantly associated with HbA1c (glycated haemoglobin level), percentage 
ideal body weight, well-being and treatment satisfaction with Type 2 diabetes 
(Bradley, Lewis, Jennings & Ward, 1990).  
 
Because the scale measures psychological processes rather than outcomes, 
Bradley suggests the scale is more constructive in research aimed at 
assessing the effectiveness of interventions such as education programmes 
seeking to modify perceptions of control to achieve desired health outcomes 
(Bradley, 2003).  
 
In a study analyzing psychological conditions required to adopt a healthy 
lifestyle, the Health Locus of Control construct (HLC), was related to health-
promoting behaviours in a population of healthy people. There was a positive 
correlation between an internal locus of control and adherence to a healthy 
diet. These findings demonstrate the utility of the HLC construct when 
investigating health behaviour (Wilczynska, Bargiel-Matusiewicz, Troc & 
Niebroj, 2013). 
 
The models also provide key components on which behaviour change 
interventions can focus to be effective. These include beliefs, perceptions, 
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goal-setting, problem solving, coping strategies, perceived control and 
motivation.  
 
Weiner (2007) links an internal locus of control more closely to the concept of 
motivation. In an example related to two students failing an important exam, 
Weiner describes how the first student, who fails the exam unexpectedly, feels 
unhappiness followed by a search for causality leading to a belief in their own 
lack of aptitude. Perceived lack of aptitude is an internal, stable and 
uncontrollable cause leading to a reduction in self-esteem, low expectancy of 
future success and hopelessness.  
 
The second student also feels unhappiness. This student has had past 
success and attributes the failure to lack of effort. This internal, stable yet 
controllable cause facilitates positive motivators such as regret, guilt, hope 
and expectancy and motivates this student to apply more effort in the future 
(Weiner, 2007).    
 
Weiner’s (2007) example suggests that to change behaviour, the individual 
first has to be motivated. One method used in behaviour change therapies 
which is designed to evoke an individual’s motivation is motivational 
interviewing (Miller & Rollnick, 2002).  
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2.7 Motivational Interviewing  
Motivational Interviewing (MI) evolved from experience in the treatment of 
problem drinkers, and was first described by Miller (1983). The basic concept 
and approach were subsequently augmented by Miller and Rollnick (1991; 
2002) in a more detailed description of clinical procedures. However, a clear 
definition of motivational interviewing was missing. 
 
Miller and Rollnick’s (2002) theory draws inspiration from Carl Rogers’ (1951) 
work on non-directive counselling. The examination and resolution of 
ambivalence is the key principle of non-directive counselling, and the 
counsellor is intentionally directive in pursuing this goal (Rogers, 1951). In 
comparison to nondirective counselling, MI is more focused and goal-directed. 
 
More recently, Miller and Rose (2009) have attempted to develop a theory of 
motivational interviewing and conclude that after three decades of research, 
MI is an evidence-based psychotherapeutic methodology. Miller and Rose 
(2009) also conclude that, in practice, MI is relatively brief and augments other 
treatment methods, is specifiable and applicable to a wide range of behaviour 
change, and is learnable by most health professionals. A testable theory of 
the underpinning mechanisms of MI is emerging, with measurable 
components that are both relational, based on the relationship between the 
client and the practitioner and technical, based on the skilled use of MI 
techniques (Miller & Rose, 2009).  
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A state of ambivalence is often found to be central to the individual’s 
behaviour, which can lead to a lack of motivation. Friction can occur if 
ambivalence is confused with denial or resistance (Miller & Rollnick, 2002).  
 
People struggling with addictions often recognize the risks, costs and harm 
associated with their behaviour and for various reasons, can be attracted to 
their behaviour. For example, they want to smoke and do not want to smoke. 
They want to change whilst simultaneously do not want to change (Miller & 
Rollnick, 2002).  
 
When people get stuck in an ambivalent state, problems can persist and 
intensify. It is a normal part of the process of change and successfully 
resolving ambivalence is a key skill in effective MI. 
 
In the quest to resolve ambivalence MI is guided by four key principles: 
a. Express empathy    b. Develop discrepancy 
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2.7.1 A - Express Empathy 
Miller and Rollnick suggest a client-centred and empathic counselling style is 
one of the fundamental and defining characteristics of MI, underpinned by an 
attitude of acceptance by the counsellor. Acceptance is different from 
agreement or approval and it is suggested that acceptance of people as they 
are, gives them the freedom to change. Such an attitude combined with 
respect, builds a working therapeutic partnership that helps develop clients’ 
self-esteem, which further promotes change. In this type of relationship, the 
client is not seen as uniquely pathological. Rather, their situation is 
understood as having become ‘stuck’ through understandable psychological 
processes (Miller & Rollnick, 2002).  
 
2.7.2 B - Develop Discrepancy 
MI is purposefully directed towards the resolution of ambivalence in the quest 
for change. It is aimed at getting people ‘unstuck’ and helping them move 
toward positive health behaviour change. A second general principle of MI is 
to create and magnify a discrepancy between present behaviour and the 
broader goals and values. Miller and Rollnick emphasise discrepancy is 
related to the importance of change and not the amount of change (Miller & 
Rollnick, 2002). 
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Discrepancy can be triggered by awareness of and dissatisfaction with the 
costs of an individual’s present behaviour and by perceived advantages of 
positive behaviour change. When behaviour is seen as conflicting with 
important personal goals, change is more likely to occur. Many individuals 
seeking consultation already perceive discrepancies between what is actually 
happening and what they want to happen, yet are still ambivalent.  
 
MI methodology aims to elicit awareness of discrepancy within the individual. 
When skillfully done, MI changes the person’s perceptions of discrepancy 
without creating a sense of being pressured or coerced and results in the 
individual voicing concerns, reasons for change, self-efficacy and intentions to 
change (Miller & Rollnick, 2002).  
 
2.7.3 C - Roll with Resistance 
The least desirable situation in MI is for the counsellor to advocate for change 
while the individual argues against it. Not only is the ambivalent person 
unlikely to be persuaded, direct argument can and does send the person in 
the opposite direction. Hayley made the analogy of psychological judo 
whereby an attack is not met with direct opposition as in boxing but relies on 
using the attacker’s momentum to good advantage (Hayley, 1963).  
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MI should not be combative. It is not about winning and losing with an 
opponent to be outsmarted or defeated. An individual’s resistance can be 
reframed to generate new momentum toward behaviour change with the 
object in motion not a body, as Hayley suggested, but a perception. MI views 
resistant behaviour as an indication for the counsellor to change their 
approach and since it is such an interpersonal relationship, the way the 
counsellor responds will influence the degree to which resistance increases or 
diminishes (Miller & Rollnick, 2002). 
 
2.7.4 D - Support Self-Efficacy 
Self-efficacy refers to person’s belief in their ability to carry out and succeed 
with a specific task. It is a key element in MI for change and is a reasonably 
good predictor of treatment outcome (Miller, 1985; Frank & Frank, 1991).  
 
One of the goals of MI is to enhance the individuals’ confidence in their 
capabilities to cope with barriers and to succeed in change.  It asserts the 
client is responsible for deciding and directing their own change and assumes 
the ability to change is within their capabilities (Miller & Rollnick, 2002). 
 
Motivational interviewing has been used effectively in a wide range of 
behavioural and health-related problems. These include alcohol and drug 
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misuse (Miller, Zweben & DiClemente & Rychtarik, 1994) and bulimia nervosa 
(Treasure & Schmidt, 1997).  
 
Noonan and Moyers (1997) reviewed eleven clinical trials investigating a 
range of behavioural issues and concluded MI was an effective clinical 
intervention.  Nine studies found MI more effective than no treatment, 
standard care, extended treatment or being on a waiting list before receiving 
the intervention. Two studies did not support MI as an effective intervention. 
Noonan and Moyers (1997) suggest this may be due to the individual being 
given advice in an authoritarian manner and the clinician not receiving 
adequate training. Overall, the review supports the use of MI as an effective 
intervention. 
 
Dunn, DeRoo, and Rivara (2001), conducted a systematic review of twenty-
nine randomized trials of brief interventions that used MI principles to change 
behaviour in four specific areas. These include substance misuse, smoking, 
HIV-risk reduction and diet and exercise. The strongest evidence for efficacy 
was found in alcohol and drug misuse, where MI appeared more effective for 
problem drinkers and improved the rate of entry and retention in intensive 
substance misuse treatment. In an article critiquing MI, Vansteenkiste and 
Sheldon, (2006) discuss the promises and limitations of MI, reporting reduced 
efficacy for the technique with regard to HIV risk behaviours and smoking 
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cessation. Whilst they fail to offer an explanation as to why this may be the 
case they do allude to the fact that MI is more effective if skillfully applied.   
 
Burke, Arkowitz and Dunn (2002), reviewed twenty-six qualitative studies. The 
authors concluded the research supported the efficacy of MI for alcohol 
problems, drug addiction, hypertension, and bulimia as well as encouraging 
compliance in patients with diabetes. Mixed support was found for the 
effectiveness of MI with regard to smoking cessation, increasing physical 
activity and enhancing dietary adherence in patients with hyperlipidemia. 
 
Subsequently, Burke, Arkowitz and Menchola (2003) investigated the efficacy 
of MI by conducting a meta-analysis of controlled clinical trials exploring 
substance misuse, diet and exercise, smoking cessation and HIV risk-
reduction. The empirical studies and reviews were investigating adaptations of 
motivational interviewing (AMIs). AMIs ranged from brief advice, behaviour 
change counselling and motivational interviewing. Brief advice is an 
opportunistic situation typically lasting five to ten minutes where the 
practitioner takes the leading role and provides information. Behaviour change 
counselling can last between five and thirty minutes and involves the 
individual by establishing goals, building motivation for change and 
exchanging information.  Motivational interviewing lasts between thirty and 
sixty minutes and is designed to build a relationship between the individual 
and the practitioner to resolve ambivalence, set goals and elicit change talk.  
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Burke, Arkowitz and Menchola (2003) found no support for the efficacy of 
AMIs for smoking cessation and found no studies investigating the efficacy of 
motivational interviewing in its original form. Treasure (2004) reported mixed 
results for the efficacy of MI in smoking cessation with moderate effect sizes 
of between 0.25 and 0.57 found in adaptations of MI.  
 
In a more recent meta-analysis and systematic review of controlled trials 
exploring substance misuse, cigarette consumption, diabetes self-
management and weight loss, Rubak, Sandbæk, Lauritzen and Christensen 
(2005) reported a significant effect of MI for combined effect estimates for 
body mass index, total blood cholesterol, systolic blood pressure, blood 
alcohol concentration and standard ethanol content. No significant effects 
were found for daily cigarette consumption or blood glucose control.  
 
In addition, MI was found to have a significant and clinically relevant and 
equal effect on physiological (72%) and psychological (75%) diseases. 
Physicians and psychologists obtained an effect in approximately 80% of the 
studies, while other healthcare providers obtained an effect in 46% of the 
studies. When using MI in brief encounters of approximately 15 minutes, 64% 
of the studies showed an effect. These findings suggest that MI in a scientific 
setting outperforms traditional healthcare advice (Rubak, Sandbæk, Lauritzen 
& Christensen, 2005). 
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The authors note studies do not include epidemiological measures such as 
questionnaires or clinical measures such as blood pressure, blood glucose 
and weight and suggest that future MI research should, wherever possible, 
measure effect by epidemiological and physiological as well as clinical direct 
measures to ensure the reliability of the results.  
 
Motivational Interviewing has been shown to be effective in some settings, 
including healthcare. Nevertheless it is important to appreciate that MI may 
not be appropriate in all situations. Miller concluded the only limitations of MI 
lie with the aptitude of the individuals who try to incorporate MI techniques into 
their therapeutic sessions (Miller, 1983), a conclusion supported by Noonan 
and Moyer (1997) and Vansteenkiste and Sheldon, (2006).  
 
The expertise of the therapist or counsellor is important. However MI requires 
more than an adept counsellor to be effective. In relation to their work on 
eating disorders, Treasure and Schmidt (1997) and Treasure and Ward 
(1997), note that for MI to be effective there has to be an equal balance of 
power between the individual and the therapist, which is not always the case. 
The authors also advise the duration and amount of MI sessions can have an 
impact on the efficacy of MI techniques (Treasure & Schmidt, 1997; Treasure 
& Ward, 1997). 
 
Matriculation Number: 05008241  Professional Doctorate in Health Psychology  
Doctoral Thesis 2015   70 
In spite of the appeal of MI, there is insufficient evidence regarding the 
mediating processes by which these techniques have an effect (Burke, 
Arkowitz & Dunn, 2002).  
 
There are clearly mixed reviews for the efficacy of MI across a broad range of 
health conditions and settings (Burke, Arkowitz & Dunn, 2002; Burke, Arkowitz 
& Menchola, 2003; Treasure, 2004). There is also evidence to suggest the 
efficacy of MI is determined by the skills of the practitioner and the timeline of 
the intervention. A Cochrane Review of 14 randomized controlled trials 
between 1997 and 2008 investigating the efficacy of MI for smoking cessation 
found MI versus brief advice resulted in a significant increase in smoking 
cessation (RR 1.27; 95% CI 1.14 to 1.42) when delivered by GPs (RR 3.49; 
95% CI 1.53 to 7.94) or trained counsellors (RR1.27; 95% CI 1.12 to 1.43) 
and when conducted in sessions lasting longer than 20 minutes ((RR 1.31; 
95% CI 1.16 to 1.49). The review also found positive outcomes whether MI 
was delivered in a single session or over multiple sessions (Lai, Cahill, Qin & 
Tang, 2010). 
 
Miller openly admits that although based on Roger’s (1951) non-directive 
counselling technique, MI lacks a formal theoretical framework (Miller & Rose, 
2009). The principles and practice of MI have mostly developed over the 
years from clinical practice and experience. Whilst such practical experience 
has helped shape MI, a unifying theoretical framework would offer the 
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possibility of reaching a deeper understanding of the processes involved 
which could help to inform future developments in MI’s methodology and 
application.  
 
Nonetheless, MI has been used effectively in smoking cessation programmes 
by ASH Scotland, NHS Scotland and extensively in health interventions by 
Miller and Rollnick and based on this was incorporated into this research as a 
tool to facilitate health behaviour change.  
 
The roles of lifestyle and behavioural factors in patients with Type 2 diabetes, 
for example smoking, have been shown to contribute to poor self-
management and more rapid disease progression. Changing these 
behaviours can reduce the risk of developing diabetes and delay the onset of 
long-term complications (Canga, de Irala & Vana et al., 2000). To develop an 
intervention to address this, it is important to understand patients’ perceptions 
of their diabetes control and of their smoking behaviour. 
 
Health locus of control has been shown to be related to whether an individual 
changes their health behaviour and furthermore, to the communication style 
they require from the health professional. It is generally assumed that those 
who believe that they have control over their health will be more likely to 
perform a range of health promoting behaviours (Ogden, 2000). 
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Patient ambivalence to behaviour change is a common problem faced by 
health care professionals (Rollnick, Heather & Bell, 1992). The main focus of 
MI is directing behaviour change by helping patients to explore and resolve 
ambivalence about their behaviour change (Rollnick & Miller, 1994). 
Consultations are more successful when there is a sharing of ideas (Tuckett, 
Boulton & Olsen, 1985). MI appears consistent with a number of models of 
health behaviour including Locus of Control (Rotter, 1966).  
 
The greatest support for the efficacy of MI applied to health behaviour change 
is from smoking cessation studies (Valanis, Lichenstein, Mullolly; Labuhn, 
Brody, Severson, et al., 2001; Eammons, Hammon, Velicer, Evans & Monroe, 
2001; Stotts, DiClemente & Dolan-Mullen, 2002). These findings should be 
interpreted with caution as they can be dependent on study quality, treatment 
fidelity, therapist training and publication bias and may contribute to the mixed 
outcomes reported in the literature (Lai, Cahill, Qin & Tang, 2010). 
 
In a study investigating the locus of control in Type 1 and Type 2 diabetes, 
and the differences between patients receiving different types of care, for 
example, group or one-to-one intervention, the results showed patients self-
managing Type 2 diabetes scored higher on the internal locus of control scale 
(Trento, Tomelini, Basile, Borgo, Passera, Miselli, et al., 2008). These findings 
support earlier studies. Gillibrand & Stevenson (2006) investigated the 
application of the extended health belief model to the experiences of young 
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people living with diabetes and found that high internal locus of control beliefs 
predicted the young person would perceive the benefits as outweighing the 
costs of adhering to their self-management requirements.  
 
Similarly an investigation of adherence to treatment by patients with Type 2 
diabetes found a high internal locus of control was the key predictor of health 
behaviours (O’Hea, Grothe, Bodenlor, Boudreaux, White & Brantley, 2005). 
 
In light of the evidence presented in this chapter it seemed relevant to develop 
a study and intervention based on diabetes and smoking cessation. The initial 
emphasis was glycaemic control. However, mindful of the challenges of the 
direct approach witnessed during shadowing, it seemed appropriate to try to 
reframe the approach. A review of successful initiatives aimed at changing 
attitudes, knowledge and behaviour, reported on seven case studies from a 
range of topics including: HIV/AIDS initiative promoting condom use; the 
Scottish Smokefree public places campaign; greener transport initiatives; 
tobacco-counter marketing; responsible gambling; speeding campaigns and 
gay and lesbian mental health initiatives. The report suggests the skills gained 
in these initiatives are transferable to tackling the increase in alcohol 
consumption across the UK and that reframing the issue and social norms 
were integral to changing behaviour (Stead, Gordon, Holme, Moodie, 
Hastings & Angus, 2009). 
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Shaped by the literature review the following aims and research question 
guided the investigation. 
 
2.8 Aims and Research Question 
Primary Aims 
To investigate the impact a smoking cessation intervention may have on: 
1. Glycated haemoglobin levels (HbA1c) 
2. Perceived Control of Diabetes in patients with Type 2 diabetes 
3. Smoking Locus of Control in patients with Type 2 diabetes 
4. Carbon Monoxide levels (ppm) as an indicator of cigarette use 
 
Secondary Aims 
To investigate the impact a smoking cessation intervention may have on: 
1. Readiness to stop smoking (likes, dislikes, motivation and 
confidence) 
2. Concerns about stopping smoking and remaining a smoker 
3. Awareness of smoking cessation products and services 
4. Knowledge of health risks associated with smoking and diabetes 
5. Weight (kg) 
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Research Question 
Does gaining control of smoking behaviours have a positive impact on 
glycaemic control in patients with Type 2 diabetes? 
 
The following chapter describes the study design and methodology and 
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Chapter 3 - Study Design and Methodology 
3.1 Study Rationale 
The aim of this study was to investigate the impact of a smoking cessation 
psychological intervention on glycaemic control in patients with Type 2 
diabetes who were regular cigarette smokers. Earlier discussions described 
how patients were finding it a challenge to maintain glycated haemoglobin 
levels within the recommended levels of 48mmol/mol (IFCC, 2008) despite 
regular annual reviews and additional support from the dedicated diabetes 
team. 
 
This prompted the current reframing approach (Stead, et al., 2009) shifting the  
focus from glycaemic control itself to smoking cessation in an attempt to 
investigate whether controlling behaviour in one area of the patients life would 
transfer to controlling behaviour in another area of the their life.  
 
3.2 Study Design   
Drawing upon the theoretical underpinnings of quantitative research the study 
was a longitudinal, non-randomised, pre-post intervention. This design was 
chosen to broaden understanding of the impact of a smoking cessation 
intervention by using validated scales (Perceived Control of Diabetes Scale 
and Smoking Locus of Control Scale) and a minimum data set (MDS) 
described in more detail in section 3.6 (pg. 83). The intervention consisted of 
two components. The first component utilized the scales and MDS to gather 
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pre-intervention data, including glycated haemoglobin and carbon monoxide 
levels, before commencement of the Diabetes and Smoking Cessation 
Education Programme (DSCEP). This programme was developed by the 
researcher to facilitate and inform the research, based on clinical experience 
and best practice, and is discussed more fully in section 3.8 (pg. 95). The 
original study design incorporated 3, 6, 9 and 12-month follow up. None of the 
participants returned to the study at 3, 6 or 9-month follow-up despite 
reminder letters. Therefore the second component was conducted 12-months 
later and only utilized the PCDS, SLoCS, and elements of the MDS to gather 
post-intervention data. These included HbA1c and CO levels, likes and 
dislikes of smoking, levels of motivation and confidence to stop smoking, 
concerns regarding stopping smoking and remaining a smoker, awareness of 
smoking cessation products and services and knowledge of health risks 
associated with smoking and diabetes.  No data were collected regarding 
cigarette use at this point. 
 
3.2.1 Rationale and benefits for Quantitative Methodology 
A quantitative approach was chosen in this instance in an attempt to 
summarise outcomes and to offer the intervention to as many participants as 
were willing to take part within the timeframe. This promoted reliability of the 
data, offering an inclusive interpretation of the research problem (Foss and 
Ellefsen, 2002). It also heightened confidence in the validity of the data and 
subsequent interpretation (Connor et al., 2001). Qualitative investigation was 
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beyond the scope of this study and consequently led to a lack of contextual 
information that a mixed methodology approach may well have provided.   
 
3.3 Participant Recruitment 
Participants were recruited from patients as they attended Falkirk Royal 
Infirmary for their annual diabetes review. A large notice was placed at 
reception advising that the study was ongoing and that patients may be 
approached and invited to participate. Permission had previously been 
granted by senior diabetes consultants for the researcher to access patient 
case notes solely to identify which patients had Type 2 diabetes and were 
current cigarette smokers. This was on the understanding that the case notes 
would not be removed from the dedicated station within the department. 
 
3.4 Sample Description 
3.4.1 Inclusion Criteria 
Participants in the study were required to be all adults over 25 years of age 
self-managing Type 2 diabetes and identified as regular cigarette smokers.   
 
3.4.2 Participants 
The sample comprised 29 adults with Type 2 diabetes who regularly smoked 
cigarettes. They were all patients of Falkirk Royal Infirmary and therefore 
resident within the catchment area of Falkirk District. 
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3.4.3 Exclusion Criteria 
On the advice of the lead diabetes specialist nurse the research excluded the 
following: patients with Type 1 diabetes; patients newly diagnosed with Type 2 
diabetes as it was felt they may need time to adjust to the condition and 
management of it; patients with Type 2 diabetes who had progressed to 
injecting insulin; and patients under the age of 25 years as they were 
managed in the Children and Young Peoples clinic in Stirling Royal Infirmary. 
 
3.5 Procedure 
3.5.1 Ethical Issues 
The ethics application was initially submitted to the NHS Research Ethics 
Committee based in Ninewells Hospital, Dundee in July 2007. The Committee 
declined ethical approval on the grounds that there was no control group and 
therefore changes could not be attributed to the intervention with any 
certainty. An appeal was sent to Lothian Research Ethics Committee. LREC 
voiced the same concerns regarding the lack of a control group but 
nevertheless granted ethical approval in August 2007 on the following five 
recommendations: 
• Making the language in some questions more understandable to a lay 
person 
• Including non-English speaking participants and supporting them with 
the services of an interpreter 
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• Re-writing the participant information sheet and participant consent 
form to comply with the NRES format 
• Explaining on the participant information sheet that the study was a 
research project and not part of the service evaluation undertaken by 
NHS Forth Valley 
• Correcting the inconsistency between the application form and the 
participant consent form where the application form refers to the study 
and the consent form refers to the Diabetes and Smoking Cessation 
Education Programme 
 
The application should have been presented to NHS Forth Valley Research 
and Development Department simultaneously. This was misunderstood and it 
became a follow-on application process, adding to the timeframe. In total the 
study took sixteen months to gain approval and involved the efforts of the 
researcher, diabetes consultants and academic supervisors and Dean of 
School at Queen Margaret University, to move it forward. 
 
The delay meant Stirling Royal Infirmary could not accommodate the study 
leaving no scope to include a control group. The only availability left was a 
Friday morning in Falkirk Royal Infirmary. This left insufficient time to recruit 
participants to an intervention and control group and to run the study. 
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Although the main decision to exclude a control group was pragmatic, it was 
also considered unethical not to offer the intervention to all of the participants. 
This was based on concerns previously raised by Schwartz, Chesney, Irvine 
and Keefe, (1996). They and Freedman (1996) questioned the equity of not 
delivering the intervention to a no-treatment control group, saying the ethical 
principle is central to the protection of human research participants. This 
resulted from clinical research evidence gathered over a number of years 
demonstrating reducing psychological morbidity and prolonged survival 
among diabetes patients who had received a psychosocial intervention. 
 
The research proposal was also submitted to the Psychology Ethics Panel at 
Queen Margaret University in November 2006, with ethical approval received 
in February 2007. Participants who met the inclusion criteria were treated in 
accordance with the British Psychological Society Guidelines for Ethical 
Research and Code of Conduct for treatment of participants (British 
Psychological Society, 2006), the Ethical Standards in Public Life (Scotland) 
Act (2000) and NHS Forth Valley Governance documents including the Code 
of Conduct. These documents acted as a guide to help ensure participants 
were treated respectfully with regard to consent, confidentiality and data 
protection, were provided with sufficient and accurate information to make an 
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3.5.2 Confidentiality and Informed Consent 
All participants were given an identification number and data coded in order to 
maintain anonymity. Paperwork was also colour-coded to tell at a glance the 
time point it related to. For example, and ID of DSCEP/F/01/01 on white paper 
translated as participant 1, T1 in Falkirk. DSCEP/F/01/02 on pink paper 
translated as the same participant at T2. Information was stored in locked 
filing cabinets with access restricted to those directly involved with the study. 
Data gathered from the intervention were entered into the researchers’ secure 
electronic database at Queen Margaret University and password protected. 
 
To ensure informed consent participants were provided with a written 
information letter (Appendix A, pg. 174) outlining the study and were 
encouraged to ask questions. They were informed of their right to withdraw at 
any time. All participants provided written consent (Appendix B, pg. 177) and 
agreed to a letter being sent to their GP informing of their participation in the 
study (Appendix C, pg. 178). The Participant Information Letter and 
Participant Consent Form were developed in accordance with the Data 
Protection Act (1988) and BPS Code of Ethics (2009) and with guidance from 
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3.6 Description of Primary Outcome Measures  
3.6.1 Glycated Haemoglobin Levels (HbA1c)   
People with diabetes are encouraged to monitor their blood glucose levels at 
various intervals throughout the day using the finger-prick test. A blood 
glucose monitor pops a needle into the end of the finger drawing a droplet of 
blood. The droplet is monitored by the device producing a number in 
percentages, which the individual records either on the disc provided or in a 
booklet. This type of monitoring aids diabetes self-management on a day-to-
day basis at home.  
 
Blood glucose levels can fluctuate minute to minute therefore a more 
comprehensive measure is that of HbA1c since it changes slowly. This is 
done in a clinical setting and can reveal how high glycated haemoglobin levels 
have been over the past 2 – 3 months.  The recommended levels are 6.5%- 
7.5% (48 -53mmol/mol).  
 
HbA1c is the result of glucose in the blood fastening irreversibly to a specific 
part of the haemoglobin found in red blood cells and circulates for the lifespan 
of the cell it has bonded to. There is a correlation between the two since 
higher glucose levels result in higher HbA1c levels. As HbA1c increases, so 
does the risk of microvascular and macrovascular complications of diabetes 
(American Diabetes Association, 2009). Regular clinical monitoring of HbA1c 
can highlight an individual’s glucose control over a set period of time, draw 
attention to their level of risk and emphasize their response to changes in 
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treatment regimen. The process also allows HbA1c levels to be set for the 
individual and treatment adjusted to facilitate this. 
 
Nicotine is an appetite suppressant and when smoking reduction or cessation 
is achieved, appetite can return. In addition, smoke inhaled into the mouth 
creates substances that coat the tongue, suppressing the sense of taste. This 
too can return. An increased appetite combined with a renewed sense of taste 
is challenging when trying to stop smoking and can often lead to weight gain, 
discussed more fully in Section 3.7.7, (pg 94). These measures were recorded 
on the Minimum Data Set (Appendix D, pg 179). 
 
3.6.2 Perceived Control of Diabetes Scale (PCDS) 
The Perceived Control of Diabetes Scale (Bradley, 1993) (Appendix E, pg. 
183), measures patient perceptions of their diabetes control based on past 
events. Bradley, Lewis, Jennings and Ward, (1990) applied Wallstons’ 
typology (Wallston & Wallston, 1982) to the responses of a Sheffield sample 
of tablet-treated patients completing the PCDS. The sample provided the data 
for the psychometric analyses of the scales and for the application of 
Wallstons’ typology. The data also provides support for the validity of the 
scales. The alpha coefficients reported for this study are consistent with the 
findings from previous studies (Bradley, 2003).  
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The scale includes six scenarios: 
• Imagine that you have recently become unacceptably overweight. Write 
down the single most likely cause of becoming overweight 
• Imagine that for several days you have found high levels of sugar when 
you tested your blood or urine. Write down the single most likely cause of the 
high sugar levels 
• Imagine that you have been able to keep your weight at an acceptable 
level for a period of several weeks and you have felt fit and well. Write down 
the single most likely cause of this period of good weight control and general 
sense of well-being 
• Imagine you have successfully avoided the complications of diabetes 
such as problems with your feet. Write down the single most likely cause of 
avoidance of diabetic complications such as problems with your feet 
• Imagine you have reduced your weight to a satisfactory level after a 
period when you gained too much weight. Write down the single most likely 
cause of this weight reduction 
• Imagine you have managed your diabetes successfully, living life as 
you wished while also keeping your glucose (sugar) levels under control. 
Write down this single most likely cause of managing your diabetes 
successfully 
Each scenario includes seven subscales: 
• Internality - a measure of the extent to which a participant perceives 
that they are in control of their diabetes 
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• Treatment - examines whether the participant perceives aspects of 
their diabetes to be due to treatment they have been recommended by their 
doctor 
• Externality - describes an external locus of control and is a measure of 
the extent to which a participant perceives their diabetes control is in the 
hands of significant others or circumstances other than themselves 
• Chance - examines whether the participant perceives aspects of their 
diabetes to be due to chance, luck or fate 
• Patient Control - examines participant’s perception of their diabetes 
control 
• Doctor Control - examines whether the participant perceives their 
diabetes to be under the control of their doctor 
• Foreseeablilty - examines whether the participant has the insight to 
predict aspects of their diabetes 
 
Ratings for each subscale are summed across all the scenarios to obtain 
subscale total scores, for example, Internality (Scenario 1) + Internality 
(Scenario 2) + Internality (Scenario 3), etc. The six scores from the six 
scenarios give a possible range of scores from 0 to 36, where higher scores 
give greater weight to Internality, Treatment, Externality, Chance, Patient 
Control, Doctor Control and Foreseeability.   
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3.6.3 Smoking Locus of Control Scale (SLoCS) 
The Smoking Locus of Control Scale (Gerogiou & Bradley, 1992) (Appendix F, 
pg. 189) refers to expectations of control over future events. The SLoCS asks 
eleven questions to be answered by circling the responses: strongly disagree, 
moderately disagree, slightly disagree, slightly agree, moderately agree and 
strongly agree. The even numbered questions measure the construct of 
Internality and the odd numbered questions measure the construct of 
Externality over a continuum. Reliability for the scale had been demonstrated 
in earlier work by Georgiou and Bradley (1992) and informed the development 
of the Multidimensional Locus of Control scale (Wallston, Wallston & DeVellis, 
1978).  
 
The questionnaire asked participants 11 questions and scored them on a six-
point rating scale: 
0 = Strongly Disagree 
1 = Moderately Disagree 
2 = Slightly Disagree 
3 = Slightly Agree 
4 = Moderately Agree 
5 = Strongly Agree. 
Questions 1, 3, 5, 7, 9 and 11 measured Externality and questions 2, 4, 6, 8 
and 10 measured Internality. Scores ranged from 0 – 55 in total, 0 – 30 for 
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Externality and 0 – 25 for Internality. An increase in scores along the 
Internality/ Externality continuum between baseline and 12-month follow-up 
indicates a change in locus of control for smoking behaviours.   
 
3.6.3a Internality 
The Internality subscale measures an individual’s tendency to believe that 
they are in control of their smoking behaviour. Evidence suggests that those 
with an internal locus of control are more inclined to engage with health 
promoting behaviour, adhere to treatment and take part in interventions 
(Maltby, Day & Macaskill, 2007).  
 
3.6.3b Externality 
The externality subscale measures an individual’s tendency to believe that 
significant others, not themselves, are in control of their smoking behaviours, 
for example, health professionals, family and friends. Evidence suggests that 
individuals with an external locus of control are more likely to engage with 
negative health behaviours, are less inclined to adhere to treatment regimens 
and medication and engage with health interventions (Maltby, Day & 
Macaskill, 2007). 
 
3.6.4 Carbon Monoxide Monitoring 
Smoking status was validated using a carbon monoxide (CO) monitor 
(Bedfont Pico+ Smokerlyser) and recorded on the MDS (Appendix D, pg 179). 
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The Smokerlyser is designed as a simple screening test for cigarette use, 
giving an instant reading of CO levels in both parts-per-million (ppm) and 
percentages. Participants were asked to take a deep breath and hold it for 10 
seconds before blowing hard into the monitor on the third beep. The CO 
breath test will give the same results as a carboxyhaemoglobin blood test, is 
much less invasive and can be used by non-medical personnel. It also gives 
an immediate result which is beneficial to the patient.  CO monitoring has 
been shown to be an effective tool in predicting smoking habits and motivating 
people to maintain their quit attempt. The process helps the person to quit by 
providing visible proof of damaging CO levels and charting their progress 
during cessation therapy (Low, Ong & Tan, 2004). CO testing is mandatory in 
the smoking cessation clinics in Forth Valley. 
 
3.7 Description of Secondary Outcome Measures 
3.7.1 Scottish Smoking Cessation Minimum Data Set (MDS) 
Information including smoking status, smoking history and smoking patterns 
was recorded on the Scottish Smoking Cessation Minimum Data Set (MDS) 
(Appendix D, pg. 179) at baseline and 12-month follow-up. The MDS was 
developed by Partnership Action on Tobacco and Health (PATH, 2010) which 
is a partnership of ASH Scotland, NHS Scotland and the Scottish 
Government, to capture and monitor data relevant to cessation attempts 
across Scotland.  
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A semi-structured interview captured the remainder of the information using 
motivational interviewing techniques and recorded the following information: 
• Tobacco use 
• Readiness to stop smoking including likes, dislikes and levels of 
motivation and confidence to stop smokinbg 
• Concerns regarding stopping smoking and remaining a smoker 
• Awareness of smoking cessation products and services 
• Knowledge of the health risks associated with smoking and diabetes 
 
3.7.2 Tobacco Use 
The Fragerstrom Small Test for Nicotine Dependence (Heatherton, Kozlowski, 
Frecker & Fragerstrom, 1991) (Appendix G, pg. 191), was used as a baseline 
measure in an attempt to gauge participant levels of nicotine addiction. A 
more comprehensive test is available that attempts to determine whether the 
addiction is psychological, pharmacological or behavioural. The small test was 
sufficient for this purpose and helped in the discussion regarding appropriate 
pharmacotherapy. The scores range from 1-10 with 1 indicating lower levels 
of addiction and 10 indicating higher levels of addiction. For example, smoking 
more often in the mornings indicates a higher level of addiction and may 
warrant a nicotine replacement product with higher nicotine content. The items 
and scoring mechanism are explained more fully in Appendix G (pg. 191) 
(Heatherton, Kozlowski, Frecker & Fragerstrom, 1991; West, 2004). The 
following items were measured at baseline: 
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• time to first cigarette on waking 
• how easy/hard it would be to abstain for one day 
• hardest cigarette to give up 
• do you smoke more during the morning 
• do you need to smoke if confined to bed 
• do you wake during the night to smoke 
 
3.7.3 Readiness to Stop Smoking 
Rollnick, Mason and Butler (2005) believe that readiness is a useful starting 
point from which to understand patient motivation to change behaviour and 
that the concepts of importance and confidence help to explain a patient’s 
level of motivation or readiness to change.  For example, if participants rated 
themselves as 1 on the motivation and confidence rating scales, they were 
asked what they thought would need to happen to help them increase their 
levels. 
 
3.7.3a Likes and Dislikes of Smoking Behaviour 
These questions were added to the MDS (Appendix D, pg. 179) to record 
what the participants liked and disliked about their smoking behaviour. It was 
anticipated that likes would outweigh dislikes at baseline but that this would 
change post-intervention with participants recording more dislikes at the end-
point.  
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3.7.3b Motivation and Confidence to Stop Smoking 
Motivation and confidence appear inextricably linked in relation to stopping 
smoking (Miller & Rose, 2009) therefore it was important to measure both 
levels. Smoking cessation depends on the balance between the person’s 
motivation to stop smoking and their confidence to complete the task. 
Motivation is important because strategies to assist with smoking cessation 
will not work in people who are not highly motivated. Heavy smokers may 
show low motivation because they lack confidence in their ability to stop 
smoking. Equally lighter smokers may show low motivation because they 
believe they can stop anytime they choose (West, 2004). They are perhaps 
more confident. Motivation to stop smoking can vary considerably and be 
strongly influenced by environment. This last point was important to remember 
as it could impact the outcome of the study. 
 
This part of the intervention focused on readiness to change behaviour and 
asked participants what they liked about smoking and what they disliked about 
it. This information was recorded qualitatively and recoded in SPSS 17 to be 
analyzed quantitatively. With regard to likes, ‘relaxes me’ was recoded to =1, 
‘social activity’ was recoded to =2, ‘me time’ was recoded to =3, ‘ice-breaker’ 
was recoded to =4, ‘turn to in crisis’ was recoded to =5, ‘only pleasure’ was 
recoded to = 6 and ‘like the taste and feel’ was recoded to =7. In the case of 
dislikes, cost was recoded as =1, smell was recoded as =2 and risk to health 
was recoded as =3. Participants were asked to rate their motivation to stop 
smoking and their confidence to stop smoking on two separate rating scales 
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of 1 - 10 (1 = not at all motivated/confident to stop smoking, 10 = fully 
motivated/confident to stop smoking). 
 
3.7.4 Concerns about Smoking and Stopping Smoking 
Participants were asked to discuss any concerns they had about remaining a 
smoker and also concerns they may have about stopping smoking and 
staying stopped. These items were recorded qualitatively and recoded in 
SPSS 17 to be analyzed quantitatively. For concerns about smoking ‘cost’ 
was recoded to =1. For concerns about stopping smoking ‘mood swings’ was 
recoded to =1, ‘no concerns’ was recoded to =2 and ‘weight gain’ was 
recoded to =3. 
 
3.7.5 Awareness of Smoking Cessation Products and Services 
As this was a smoking cessation intervention it was appropriate to ascertain 
participants’ knowledge of smoking cessation products and services available 
to them to aid a quit attempt.  At baseline they were asked to name all of the 
products they were aware of and to identify local or national smoking 
cessation services, for example, clinics, Smokeline. Although this study was 
not a test of memory, these questions were asked again at 12-month follow-
up to ensure participants had retained information on the broad range of 
smoking cessation products and services available. It was also an opportunity 
to introduce developments in both areas, such as Champix, e-cigarettes and 
vapourisers.    
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3.7.6 Knowledge of Health Risks Associated with Smoking and Diabetes 
In order for the researcher to gain an understanding of participants’ 
awareness of the health risks associated with diabetes and smoking, a section 
was added to the minimum data set to capture this information. This question 
was asked at baseline and 12-month follow-up to ensure participants were still 
aware of the implications and potential long-term complications of smoking 
with diabetes. 
 
3.7.7 Weight Gain and Diabetes 
Weight gain for someone self-managing diabetes can be problematic. It can 
alter the body’s metabolism and ability to process sugars and fats. This can 
have a negative impact and increase the risk of developing long-term 
complications such as poor circulation and heart disease. It can also lead to 
progression from self-managing diabetes through diet and exercise to relying 
on insulin. Weight gain can also lead to fluctuations in HbA1c, which is 
particularly harmful. 
 
Since weight and HbA1c measuring were beyond the scope of this study, 
levels were recorded retrospectively on the MDS from participant’s case 
notes. Weight was recorded in % normal immediately after the intervention as 
BMI measurement was beyond the scope of this study. HbA1c was provided 
by the lead diabetes specialist nurse when the results were returned from the 
laboratory, approximately 3-4 weeks after the intervention. 
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3.8 Diabetes and Smoking Cessation Education Programme (DSCEP) 
So called because it was initially designed to be delivered at four time-points 
over a 12-month period. This proved problematic and will be discussed more 
fully in chapter 4. 
 
Prior to the DSCEP there was no education programme or smoking cessation 
intervention that was specifically tailored to, or addressed the needs of, 
individuals with diabetes in Forth Valley.  This is despite the fact that access 
to specialist smoking cessation advice has been shown to significantly reduce 
the prevalence of smoking (West & Owen, 2012; Simpson, Hippisley-Cox & 
Sheikh, 2010) and that NICE (2008) encourages behaviour change 
interventions for smokers.   
 
Using motivational interviewing techniques, the DSCEP facilitated a 
discussion on the individual’s smoking history and smoking patterns, for 
example, daily cigarette consumption, age when started smoking, time to first 
cigarette on waking, and smoking in relation to self-managing diabetes and 
potential long-term complications.  Aligned with behaviour change techniques, 
this discussion helped build rapport and was followed by the education 
programme. This provided participants with information and literature on 
smoking cessation techniques, products and services, described in more 
detail in section 3.8.2 (pg. 97) and focused on the risk to health of continued 
smoking with Type 2 diabetes. It also discussed the implications of weight 
gain, which is common in stopping smoking. 
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The DSCEP attempted to motivate patients to stop smoking and to self-
manage their glycated haemoglobin levels more effectively (Michie, Hyder, 
Walia & West, 2011a; Michie, van Stralen & West, 2011b) and anticipated that 
gaining control of smoking behaviours would be a skill set participants could 
transfer to controlling glycated haemoglobin levels. 
 
To guide the DSCEP the researcher used the Intervention Method during 
Consultation (Rollnick, Butler & Stott, 1977) discussed in the following section. 
 
3.8.1 Intervention Method during Consultation  
The Intervention Method during Consultation technique (Rollnick, Butler and 
Stott, 1977) (Appendix H, pg. 193), was adopted from their paper on helping 
smokers make decisions. The technique is based on three phases: 
• Phase I – quick assessment, building rapport, measure motivation and 
confidence on scale of 1-10 
• Phase II – patient identifies problems and solutions, question 
participant on how to move them from low levels of motivation and confidence 
to higher levels, useful strategies (discuss likes, dislikes and health risks) 
• Phase III – patients set manageable goals and follow-up,  
All three phases are based on discussion using motivational interviewing 
techniques. 
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3.8.2 Materials Used to Support DSECP 
A leaflet was developed in text and pictorial format to illustrate the health risks 
of smoking with diabetes (Appendix I, pg. 194). ASH Scotland fact sheet 23, 
'Smoking and Diabetes', highlights the risks associated with diabetes and 
smoking (Appendix J, pg. 201). ASH fact sheet 11, 'What happens when you 
stop smoking', discusses what people may experience in terms of withdrawal 
and recovery, when they stop smoking (Appendix K, pg. 207).  
 
A list of pharmacotherapies was provided to give participants information on a 
range of products available to help them stop smoking, ‘NRT, Zyban & 
Champix Information fact sheet (Appendix L, pg. 212). This was supported 
with information on techniques to stop smoking, NHS 'How to Stop Smoking 
and stay stopped' booklet (Appendix M, pg. 220). A leaflet describing the local 
smoking cessation support available was also provided, NHS leaflet 'Ready to 
stop smoking? Where to find help near you!' (Appendix N, pg. 220). 
 
On completion of the study and data analyses, participants received a debrief 
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3.9 Summary of the procedure 
Patients were identified as having Type 2 diabetes and smoking cigarettes 
regularly from their case notes. They were approached in reception while 
waiting for their annual diabetes review and given an introduction and 
information letter describing the study. On agreeing to participate and before 
the intervention began patients were again asked if they had read the 
Information Letter and fully understood the study requirements. On 
confirmation of this they were asked to sign and date the Consent Form. At 
the end of the intervention a letter was sent to the participants’ GP advising of 
their involvement in the study. 
 
During the discussion with the participant the researcher populated the 
SLoCS and PCDS with participant responses to each question in turn. This 
was followed by population of the MDS with demographic and smoking related 
information. 
 
Using motivational interviewing techniques and Phase I of the ‘Intervention 
Method during Consultation’ (Appendix H, pg. 193) for guidance (Rollnick, 
Butler & Stott, (1977), a discussion followed around the scores participants 
gave themselves for confidence and motivation to stop smoking.  Phase II 
asked what would need to happen to move the participant to a higher score 
and to say what could work in order to achieve this. This phase also 
highlighted useful strategies for keeping the discussion moving and included 
health risks, services and products.  Phase III encouraged participants to set 
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manageable goals related to stopping smoking and asked what the facilitator 
could do to help the participant achieve these goals.  
 
At the end of the intervention participants were provided with supporting 
literature for reference. 
 
At 12-month follow-up the SLoCS, PCDS and MDS were completed for 
comparison.  Participants were thanked for taking part in the study and 
advised that, on completion of the data analyses, they would be sent a debrief 
letter outlining the study rationale and findings.  
 
3.10 Statistical Analysis 
Data were analysed in SPSS 17 using one-way repeated measures ANOVA, 
within−factors and included post-hoc analysis with Bonferroni adjustment, 
reducing the likelihood of a Type 1 error arising. This methodology was 
chosen in line with the original study design whereby it was anticipated 
repeated measures data would be collected across the five time points. Nine 
participants returned at 6-month follow-up. These data were excluded from 
the final analyses on the advice of academic supervisors. The study 
concentrated on baseline (T1) and 12-month follow-up (T2) data and reported 
Wilks’ Lambda and the associated probability value. Wilks’ Lambda was 
chosen as it is the most commonly reported statistic (Pallant, 2010). 
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The non-parametric equivalent of the one-way repeated measures ANOVA is 
the Friedman Test. No non-parametric analyses were run despite them being 
less stringent as they tend to be less sensitive and can fail to detect 
differences between conditions that actually exist (Pallant, 2010).   
 
Using partial eta squared, the study aimed for 90% power, and an alpha level 
of 0.05. A medium effect size, ES= 0.3 was selected (Cohen, 1992). To 
achieve this required twenty-nine participants (n=29).  
 
Assuming an average attrition rate of 50%, (Bijleveld & van der Kamp, 1998) 
the total number of participants required was forty-five (n=45). Thirty-one 
(n=31) participants entered and completed the study. This was perhaps due to 
the nature of the clinic since patients who diligently attended appointments 
tended to return at 12-months for their annual review and subsequent 
intervention follow-up.  
 
With no control group differences cannot conclusively be attributed to the 
intervention (National Centre for Technology Innovation, 2007).  The following 
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Chapter 4 – Results 
This chapter begins by presenting the descriptive statistics and follows with 
the outcomes of the primary and secondary analyses. 
 
4.1 Descriptive Statistics 
Thirty-one participants (n=31) took part at T1 and completed at T2. 
Participants were 14 males (45%) and 17 females (54%). Ages ranged from 
25–81 years with a mean age of 51.84 years. None were educated beyond 
secondary level and all self-managed their diabetes with diet and exercise or 
were tablet-treated. Demographic data is presented in Table 2. 
Table 2: Participant demographic data at T1 
___________________________________________________________________ 
Demographic Data   n =       % 
___________________________________________________________________ 
Participants    31    100 
 Male    14    45  
 Female    17    55 
Ethnic Origin 
 White Scottish   31    100 
Education Level 
 Secondary   31    100 
Employment Status 
 Full-time   13    42 
 Part-time   6    19 
 Retired    8    26 
 Unemployed   4    13 
Attrition 
 Completed at T1  31    100 
 Completed at T2  29    93 
__________________________________________________________________  
N= Number of participants 
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4.2 Primary Outcomes 
4.2.1 Glycated Haemoglobin (HbA1c)   
 
HbA1c means and standard deviations are presented in Table 3. As these 
measurements were beyond the scope of this study HbA1c was recorded 
retrospectively from participants’ case notes.  
 
There were significant effects between T1 and T2 for HbA1c, Wilks’ Lambda = 
.50, F (1, 30) = 30.80, p<0.0005, multivariate partial eta squared = .50. 
 
Table 3: Mean and Standard Deviation for HbA1c (mmol/mol) pre and post smoking 
cessation intervention (n=31) 
_______________________________________________________________________ 
Outcome Measure  T1   T2    
    Mean (SD)  Mean (SD) 
_______________________________________________________________________ 
  





4.2.2 Perceived Control of Diabetes Scale 
The PCDS (Bradley, 1993) is comprised of seven subscales applied to predict 
behaviour changes between time points. The subscales are Internality, 
Treatment, Externality, Chance, Patient Control, Doctor Control and 
Foreseeability. The means and standard deviations are reported in Table 4. 
The alpha coefficients for these scales are well below the generally accepted 
level for internal consistency. The closer the coefficient is to 1 the greater the 
internal consistency of the items in the scale (Gliem & Gliem, 2003). This 
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contradicts earlier guidance by Kline (1986) who suggests the minimum ideal 
coefficient for a tablet-treated Type 2 sample is 0.2. Bradley et al., (1990) 
previously reported coefficients of 0.16 and explained the low item-total 
correlation demonstrated the degree of control patients felt over one aspect of 
their diabetes bore little resemblance to control they felt they had over other 
aspects of their diabetes management.  
 
 
Table 4: Means and Standard Deviations for 7 subscales of Perceived Control of 
Diabetes Scale pre and post smoking cessation intervention (n=31) 
____________________________________________________________________ 
Outcome Measure T1   T2   Cronbach 
   Means (SD)  Means (SD)  Alpha 
____________________________________________________________________ 
Internality  20.65 (3.39)  23.23 (2.77)  0.24   
Treatment  22.00 (6.36)  30.32 (6.77)  0.11  
Externality  16.84 (4.59)  14.84 (5.87)  0.21 
Chance   14.44 (4.18)  11.88 (2.33)  0.47 
Patient Control  21.81 (4.99)  23.65 (2.65)  0.07 
Doctor Control  15.90 (3.55)  12.52 (1.98)   0.32 




‘To what extent was the cause due to something about you?’ 
There was a statistically significant change in perceptions of internality 
between T1 and T2 with participants demonstrating an increase in internal 
locus of control, Wilks Lambda = 0.74, F (1, 30) = 10.68, p < 0.003), 
multivariate partial eta squared = 0.26.  
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4.2.2b Treatment 
‘To what extent was the cause due to treatment recommended by your 
doctor?’ 
There was a statistically significant change in perceptions of treatment 
between T1 and T2, Wilks Lambda = 0.46, F (1, 30) = 34.96, p < 0.0005), 
multivariate partial eta squared = 0.54.  
 
4.2.2c Externality 
‘To what extent was the cause something to do with other people or 
circumstances?’ 
Following a shift in Internality, there may be an expectation of a shift in 
Externality. There is a difference in the Externality means in the expected 
direction, suggesting that participants are demonstrating a decrease in 
external locus of control. The shift is not statistically significant.  
 
4.2.2d Chance 
‘To what extent was the cause due to chance?’ 
There was a statistically significant change in perceptions of behavioural 
control between baseline and 12-month follow-up, Wilks Lambda = 0.74, F (1, 
30) = 10.63, p < 0.003, multivariate partial eta squared = 0.26.  
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4.2.2e Patient Control 
‘To what extent was the cause controllable by you?’ 
No statistically significant effects were found. 
 
4.2.2f Doctor Control 
‘To what extent was the cause controllable by your doctor?’ 
There was a statistically significant change in perceptions of behaviour being 
under doctor control between baseline and 12-month follow-up, Wilks Lambda 
= 0.48, F (1, 30) = 32.99, p < 0.0005), multivariate partial eta squared = 0.52.  
 
4.2.2g Foreseeability 
‘To what extent do you think you could have foreseen the cause of the high 
sugar levels?’ 
No statistically significant effects were found. 
 
4.2.3 Smoking Locus of Control Scale  
The SLoCS (Georgiou & Bradley, 1992) comprises two subscales, externality 
and internality. Questions 1, 3, 5, 7, 9 and 11 measured Externality and 
questions 2, 4, 6, 8 and 10 measured Internality. An increase in scores along 
the Externality- Internality continuum between T1 and T2 indicates a change 
in locus of control for smoking behaviours.  Means and standard deviations for 
the External and Internal subscales are presented in Table 5: 
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Table 5: Means and Standard Deviations for Smoking Locus of Control Subscales pre 
and post smoking cessation intervention (n=31) 
____________________________________________________________ 
Outcome Measure T1  T2  Cronbach   
   Means (SD) Means (SD) Alpha 
_______________________________________________________________________ 
External  16.29 (3.62) 16.48 (2.91) 0.57 





There are significant changes in participants internal locus of control between 
baseline and 12-month follow-up Wilks Lambda = 0.58, F (1, 30) = 22.03, p < 
0.0005), multivariate partial eta squared = 0.42.  
 
4.2.3b Externality 
There were no statistically significant effects on the Externality subscale. 
 
 
4.2.4 Carbon Monoxide (CO) Levels 
Positive effects were found for CO, Wilks Lambda = .36, F (1, 30) = 54.39, 
p<.0005, multivariate partial eta squared = .65. The results showed lower CO 
levels at T2. Means and standard deviations are presented in Table 6. 
 
Table 6: Mean and Standard Deviations for CO levels (in ppm) (n=31) 
_______________________________________________________________________ 
Outcome Measure  T1   T2    
    Means (SD)  Means (SD) 
_______________________________________________________________________ 
  
CO    19.97 (6.25)  12.77 (3.98)  
_______________________________________________________________________ 
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4.3 Secondary Outcomes 
4.3.1 Tobacco Use  
The results for Tobacco Use are presented in Table 7. Fourteen participants 
(43.8%) smoke their first cigarette within five minutes of waking. Thirteen 
participants (42%) smoke between 11-20 cigarettes per day and 2 participants 
(7%) smoke more than 31 per day. Nineteen participants (61%) said it would 
be hard or very hard to abstain from smoking for a whole day while 11 (35%) 
thought it would be easy or very easy. 28 participants (91%) do not waken 
during the night to smoke cigarettes and 21 (69%) do not smoke more in the 
morning.  When asked what would be the hardest cigarette(s) to give up, 20 
(62%) said it would be the first of the day. If confined to bed, 18 participants 
(58%) reported having to smoke in bed. When asked if they would find it 
difficult not smoking in a restricted area, 25 (81%) said they would not. This 
contradicts previous findings where participants indicate a high level of 
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Table 7: Minimum Dataset (MDS) of Smoking Patterns and History at T1.  
________________________________________________________________ 
MDS Questions      T1  (%)   
________________________________________________________________ 
When do you smoke your first   5    14  (45) 
cigarette after waking? (mins)  10-15   4    (13) 
     15-60   13  (42) 
Average number cigarettes   1-10  7    (22) 
smoked per day?   11-20  13 (42) 
     21-30  9 (29) 
     31+  2 (7) 
How easy/hard is it to abstain   very easy 4 (13) 
for a full day    easy  7 (23) 
     hard  11 (36) 
     very hard 8 (25) 
     don’t know 1 (3) 
Do you wake in the night to smoke? yes  3 (9) 
     no  28 (91) 
Do you smoke more in the morning? yes  10 (31) 
     no  21 (69) 
What is your hardest cigarette   first one 20 (64) 
to give up?    after dinner 6 (19) 
     last one  2 (6) 
     don’t know 3 (9) 
Would you need to smoke if   yes  18 (58) 
confined to bed?   no  13 (42) 
What age did you start smoking? (yrs) 10-15  3 (10) 
     16-20  23 (74) 
     21+  5 (16) 
Is it difficult not smoking in a   yes  6 (19) 
restricted area?    no  25 (81) 
________________________________________________________________ 
Note. N = Number of participants at T1 
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4.3.2 Readiness to Stop Smoking 
The study measured ‘likes’ and ‘dislikes’ of smoking behaviour and levels of 
motivation and levels of confidence to stop smoking. The means and standard 
deviations are reported in Table 8.  
 
Table 8: Means and Standard Deviations for number of likes and dislikes of smoking 
identified by participants and levels of motivation and confidence to stop smoking (on 
rating scale of 1-10) (n=31) 
__________________________________________________________________________ 
Readiness   T1   T2    
    Means (SD)  Means (SD) 
__________________________________________________________________________ 
Likes    4.74 (2.19)  4.64 (1.30)  
Dislikes    2.81 (2.29)  4.23 (2.47)  
Motivation   3.81 (2.19)  6.29 (2.56)  




4.3.2a Likes of Smoking 
Participants were asked directly, “what do you like about smoking?” In all 
cases, participants advised that they had never been asked this question 
before or had never given any thought to what they liked about smoking 
cigarettes. 
Responses included: 
• It relaxes me 
• It is a social activity among friends  
• It gives me ‘me’ time  
• It acts as an ice-breaker when in the company of strangers  
• It is something I turn to in times of crisis 
• It is my only pleasure 
• I like the taste and the feel of cigarettes 
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At T2 many of the participants reported that this had changed. They advised 
that they did not like smoking very much after all and believed they smoked 
out of habit or nicotine addiction. The effect was not statistically significant.  
 
4.3.3b Dislikes of Smoking 
Participants were asked directly, “what do you dislike about smoking?”, and 
responded with the following: 
• Cost 
• Smell 
• Risk to health  
 
At T1, the response in all cases was cost and smell. Risk to health was 
reported last in all cases. This changed at T2 with the majority of participants 
reporting that they disliked everything associated with their smoking 
behaviour. 
 
‘Dislikes’ of smoking behaviour reported significant effects between time 
points, Wilks Lambda = .74, F (1, 30) = 10.55, p<.003, multivariate partial eta 
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4.3.3c Motivation to Stop Smoking 
Participants were asked to rate their level of motivation to stop smoking on a 
10-point rating scale (1=not motivated at all, 10=highly motivated). Levels 
increased significantly in a positive direction between T1 and T2, Wilks 
Lambda = .50, F (1, 30) = 30.24, p<.0005, multivariate partial eta squared = 
.50.  
 
4.3.3d Confidence to Stop Smoking 
Participants were asked to rate their level of confidence to stop smoking on a 
10-point rating scale (1= not at all confident, 10= highly confident). There were 
also positive changes in levels of confidence to stop smoking between the 
time points, Wilks Lambda = .66, F (1, 30) = 15.69, p<.0005, multivariate 
partial eta squared = .34.  
 
4.3.4 Concerns about Smoking and Stopping Smoking 
4.3.4a Smoking 
Participants were asked directly, “what concerns you about remaining a 
smoker?” Concerns expressed were the cost and health risks. In almost all 
cases participants were concerned with weight gain and mood swings, often 
associated with stopping smoking. With regard to concerns about remaining a 
smoker, there were no significant effects between T1 and T2. 
 
Matriculation Number: 05008241  Professional Doctorate in Health Psychology  
Doctoral Thesis 2015   112 
4.3.4b Stopping Smoking 
Participants were asked directly, “what concerns you about stopping 
smoking?”  Responses included: mood swings, nothing and weight gain. At T2 
the responses had not changed but the levels to which they were a concern 
had changed significantly, Wilks Lambda = .79, F (1, 30) = 8.05, p<.008, 
multivariate partial eta squared = .21. The means and standard deviations are 
reported in Table 9: 
 
Table 9: Means and Standard Deviations for number of concerns identified by 
participants about smoking and stopping smoking pre and post smoking cessation 
intervention (n=31) 
_________________________________________________________________________ 
Concerns   T1   T2    
    Means (SD)  Means (SD) 
_________________________________________________________________________ 
Smoking   7.26 (2.44)  5.58 (2.14)  




4.3.5 Awareness of Smoking Cessation Products and Services  
At T1 participants were asked if health care professionals had discussed 
smoking in relation to their diabetes with them previously. Thirteen 
participants (41%) advised they had not. The question was asked again at T2 
with statistically significant effects. Participants were aware of smoking 
cessation pharmacotherapy and services and gave multiple answers. A 
summary of product and service awareness is presented in Table 10. 
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The differences in awareness of smoking cessation products between T1 and 
T2 were statistically significant with participants able to recall most of the 
products available. Results show that differences between conditions are 
unlikely to have arisen by sampling error (F (1, 30) = 85.2, p<0.0005); an 
overall effect size of 0.759 shows a variation of approximately 76%. 
 
Table 10:  Awareness of Smoking Cessation Products and Services demonstrated by 
participants 
__________________________________________________________________________ 
Awareness   T1    T2  
    (n=31)   %  (n=31)    %              
__________________________________________________________________________ 
Products  
NRT Patch   29  94  31  100 
NRT Gum   11  35  31  100 
NRT Inhalator   8  26  25  81 
NRT Lozenge   1  3  18  58 
NRT Microtab   3  10  10  32 
NRT Nasal Spray  0  0  17  55 
Zyban    0  0  31  100* 
Champix   1  3  31  100* 
__________________________________________________________________________ 
Services 
Hospital   6  19  31  100 
Drop-in clinic   7  22  31  100 
GP    10  31  31  100  
Pharmacy   1  3  31  100 
Smokeline   5  16  24  77 
No knowledge   8  26  0  0 
_________________________________________________________________________ 
*Although the participants could not identify Zyban and Champix by name, they did recall that 
tablet products were available. 
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Similarly, awareness of smoking cessation services also resulted in 
statistically significant effects. Results show that differences between 
conditions are unlikely to have arisen by sampling error (F (1, 30) = 41.72, 
p<0.0005); an overall effect size of 0.607 shows an approximate variation of 
61%.  
 
Means for awareness of products and services have increased in a positive 
direction and are presented in Table 11. 
 
Table 11: Means and Standard Deviations for Awareness of Smoking Cessation Products and 
Services identified by participants 
_________________________________________________________________________ 
Awareness  T1   T2     
   Means (SD)  Means (SD) 
_________________________________________________________________________ 
Products  7.86 (5.38)  17.00 (0.00)  




4.3.6 Associated Health Risks  
At T1 participants were asked to list the health risks associated with smoking 
and diabetes. The responses showed that: 
• 25 participants believed themselves to be at risk of lung cancer  
• 7 participants were aware of the risk to circulation  
• 11 participants were aware of the risk of CHD and CVD 
• 4 participants were aware of the risk of stroke  
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None of the participants were aware of the risk of: 
• retinopathy associated with smoking 
• neuropathy associated with smoking 
• nephropathy associated with smoking 
None of the participants: 
• had heard of atherosclerosis 
• were aware that smoking has been shown to have direct links to the 
onset of Type 2 diabetes (Rimm, Manson & Stampfer, 1993; Rimm, Chan, 
Stampfer, Colditz & Willett, 1995; Kawakami, Takatsuka, Shimizu & Ishibashi, 
1997; Will, Galuska, Ford, Mokdad & Calle, 2001). 
 
By T2 these responses had become more diabetes specific, for example, 
nephropathy, neuropathy, eye damage and foot disease and the effects were 
statistically significant (F (1, 30) = 16.82, p<0.0005) with 38% variation. The 
means presented in Table 12 have increased suggesting participants were 
more aware of the health risks associated with smoking and diabetes by the 
end of the intervention. 
 
Table 12: Means and Standard Deviations of number of associated health risks 
identified by participants (n=31) 
______________________________________________________________________ 
Outcome Measure  T1   T2    
    Means (SD)  Means (SD) 
_______________________________________________________________________ 
  
Health Risks   8.50 (3.67)  10.64 (0.93)  
_______________________________________________________________________ 
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4.3.7 Weight (kg) 
There were no significant effects for weight with only 0.24kg of a difference in 
means reported at T2. Although weight was a secondary measure it was 
important to monitor it in the event participants did stop smoking. The changes 
in metabolism smoking cessation can cause could have had a detrimental 
effect on glycated haemoglobin levels (Sherman, 2005).  
 
4.4 Summary of Primary and Secondary Outcomes 
Table 13 provides a summary of the results. With regard to the primary 
outcomes positive effects were found in HbA1c levels and for the PCDS – 
internality, treatment, chance, and doctor control subscales. This followed for 
the SLoC Internality subscale and for CO levels. No significant effects were 
found for the PCDS – externality, patient control and foreseeability subscales 
or for the SLoC – externality subscale. 
 
Consequently the secondary outcomes reported significant effects with regard 
to the readiness components of dislikes, motivation and confidence. This 
followed for concerns about stopping smoking, and awareness of smoking 






Matriculation Number: 05008241  Professional Doctorate in Health Psychology  
Doctoral Thesis 2015   117 
Table 13: Summary of significant and non-significant effects between T1 and T2 
Primary Outcomes Statistically Significant  Non-significant 
HbA1c (mmol/mol) P<0.0005  
Perceived Control of Diabetes Scale:   
Internality p<0.003  
Treatment p<0.0005  
Externality  ns 
Chance p<0.003  
Patient Control  ns 
Doctor Control p<0.0005  
Foreseeability ns 
Smoking Locus of Control Scale: 
Internality p<0.0005 
Externality ns 
Carbon Monoxide (ppm) p<0.0005 
Secondary Outcomes   
Readiness to stop smoking:   
Likes  ns 
Dislikes p<0.003  
Motivation p<0.0005  
Confidence p<0.0005  
Concerns:   
Smoking  ns 
Stopping p<0.008  
Awareness:   
Products p<0.0005  
Services p<0.0005  
Health Risks p<0.0005  
Weight (kg)  ns 
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Chapter 5 – Discussion of Study Findings  
This research question asked ‘Does gaining control of smoking behaviours 
have a positive impact on glycaemic control in patients with Type 2 diabetes?’ 
The aim was to explore the impact of a longitudinal smoking cessation 
intervention tailored to participants with Type 2 diabetes who regularly 
smoked cigarettes. The study had two strands of investigation, primary 
outcomes and secondary outcomes.  
 
Primary outcome measures used were HbA1c levels (mmol/mol), the 
Perceived Control of Diabetes Scale (PCDS) (Bradley, 1993), the Smoking 
Locus of Control Scale (SLoCS) (Georgiou & Bradley, 1992) and CO levels 
(ppm). 
 
A Minimum Data Set (MDS, Appendix D, pg. 179) was utilized to record 
secondary outcomes including smoking related information such as; readiness 
to stop smoking (likes, dislikes, motivation & confidence), concerns about 
smoking and stopping, awareness of smoking cessation products and 
services (Attar-Zadeh, 2013) and knowledge of health risks associated with 
smoking and diabetes. Weight was monitored as a precaution. 
 
The Diabetes and Smoking Cessation Education Programme facilitated the 
study and provided the educational intervention using motivational 
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interviewing (Miller & Rollnick, 2001) and behaviour change techniques 
(Michie, et al., 2011a, 2011b) to encourage participants to discuss their 
smoking behaviours and glycaemic control. This less confrontational method 
was preferred in anticipation it would encourage participants, rather than 
healthcare professionals, to give voice to the argument for change. 
 
The study found positive changes for some of the measures between T1 and 
T2 although none of the participants stopped smoking. Few studies have 
evaluated smoking cessation interventions for people with diabetes (SLR, pg. 
222), nonetheless the limited research available suggests that smokers with 
diabetes may be less successful in quitting than smokers without diabetes 
(Tonstad, 2009; Sherman, 2005; Solberg, Desai, O’Connor, Bishop & Devlin, 
2004). One possible explanation for the lower quit rates among this group is 
that stopping smoking is associated with weight gain and may be of concern 
to people who have diabetes and may already be overweight. It is important 
therefore that this group is provided with intensive emotional and 
psychological support in addition to practical diabetes and smoking cessation 
education, to optimize successful smoking cessation (Tonstad, 2009; 
American Diabetes Association, 2003). 
 
The following section discusses the main findings and follows the order the 
outcomes were presented in Chapters 3 and 4. 
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5.1 Primary Outcomes 
5.1.1 Glycated Haemoglobin (HbA1c, mmol/mol) 
The recommended glycated haemoglobin level is between 48-53mmol/mol. 
The significant reduction (p<0.0005) in participant glycated haemoglobin to 
nearer these levels is encouraging. Elevated blood sugar is known to 
contribute to long-term complications such as coronary heart disease, 
cardiovascular disease, nephropathy, and neuropathy and in some cases, 
amputation of the lower extremities. Maintaining glycated haemoglobin within 
the recommended levels can reduce the risk of developing these 
complications. 
 
There is increased stiffness of the large central arteries in people with Type 2 
diabetes and obesity is a risk factor.  Obesity is thought to account for much of 
the association between insulin resistance and arterial stiffness. Barinas-
Mitchell et al. (2006) demonstrated that a 7.8% weight loss in participants with 
Type 2 diabetes resulted in improvements in HbA1c. There was also a 
significant improvement in aortic pulse wave velocity, which is an indicator of 
arterial stiffness, at completion of weight loss intervention, (P < 0.05). This 
reduction in levels may be linked to changes in participant perceptions of their 
control of diabetes. 
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5.1.2 Perceived Control of Diabetes  
The study aimed to investigate patient levels of control and encourage a shift 
towards an internal locus of control through education. The Perceived Control 
of Diabetes Scale (Appendix E, pg 182) (Bradley, 1993) helped this 
investigation and proved useful for determining existing levels of control and 
the degree to which these levels had changed. It was also useful for 
understanding individual differences between participants and their 
preferences for treatments.  
 
This study found statistically significant effects in a positive direction on the 
Internality (p<0.003), Treatment (p<0.0005), Chance (p<0.003) and Doctor 
Control (p<0.0005) subscales. This change resulted in participants placing 
more emphasis on their own role in their self-management of diabetes, for 
example diet and exercise and regular blood glucose monitoring and less 
emphasis on the role of the healthcare profession, the treatment available and 
sheer luck. There were no significant effects on the Externality, Patient 
Control and Foreseeability subscales.  
 
The results appear contradictory in that there may be an expectation that a 
shift toward an internal locus of control would positively associate with patient 
control and negatively associate with doctor control, which is not the outcome. 
The shift toward an internal locus of control suggests that participants are 
more aware that they could influence their outcomes and perhaps reduce their 
risk of developing long-term complications. The shift toward attributing 
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treatment as the cause of having good diabetes control is contradictory to an 
internal locus of control yet shows that in some cases, participants are aware 
that outcomes may not be due to external control.  
 
There was a positive increase in the means for the externality, patient control 
and foreseeability subscales. This is a positive outcome as the literature 
suggests that individuals demonstrating an internal locus of control are more 
likely to adhere to treatment and are also more likely to be motivated to self-
manage their diabetes effectively.  
 
This is a positive outcome for diabetes care in Forth Valley and while there is 
still further work to be done and more improvements to be made, the 
implications of participants taking more control and ownership of their health, 
are encouraging.  
 
This shift in perceived control of diabetes may be due to the Diabetes and 
Smoking Cessation Education Programme and its aim to raise participant 
awareness of their condition. It could also be attributed to the hypothetical 
scenarios that are aimed at making a situation feel more relevant to the wider 
population than the participant themselves. The scenarios also encourage 
participants to think more in-depth about particular situations and this may be 
the first time that the individual has given these situations any thought at all. 
For example, an individual who is not having problems with their feet and has 
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not had in the past may not think about the risks that poor blood glucose 
control, more specifically high blood glucose levels, can pose to their feet.  
 
Diabetes care currently costs the NHS in Scotland, on average, £1 billion per 
year to treat which equates to 10% of the total NHS budget (Diabetes in 
Scotland, 2014; Scottish Executive, 2010). Much of this cost is spent on 
treating the long-term complications that can arise from poor glycaemic 
control. An intervention or education programme that begins to address these 
issues, encourages patients to take ownership of their own health and is also 
cost effective, should be explored further.  
 
5.1.3Smoking Locus of Control 
The SLoCS was investigating where participants believed the responsibility 
lay for their smoking behaviour. There was a statistically significant change 
between T1 and T2 on the internality subscale (p<0.0005) suggesting that 
participants placed more emphasis on their own role in stopping smoking and 
less emphasis on the input from external factors such as family, friends and 
the healthcare professionals. This is an encouraging finding that suggests 
participants became more aware that their smoking and future cessation was 
within their own control and merits further exploration to inform smoking 
cessation education and techniques. 
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5.1.4 Carbon Monoxide Levels (CO) 
Carbon monoxide testing is mandatory in all smoking cessation services in 
Forth Valley. It is not a definitive measure of cessation, only an indicator of a 
quit attempt or a reduction in cigarette consumption. CO monitoring can be a 
motivational tool when the breath test results are decreasing yet have an 
adverse effect if the opposite occurs. This study used it as a motivator and an 
introduction to tobacco use and cigarette consumption.  In addition it was a 
useful tool for the DSCEP to educate participants as to what the results meant 
in terms of PPM and %’s and in real terms with regard to their diabetes and 
general health. Although none of the participants stopped smoking it was 
encouraging to find a statistically significant decrease in CO levels (p<0.0005) 
post-intervention.  
 
5.2 Secondary outcomes 
5.2.1 Tobacco Use 
Tobacco use data were collected as the level of addiction often becomes 
apparent during these types of discussions. For some the addiction may be 
physiological or pharmacological but for the majority of smokers the addiction 
tends to be psychological. Just under half of the participants in this study 
(45%) demonstrated high levels of nicotine or pharmacological dependence 
by reporting that they smoked their first cigarette within five minutes of waking. 
Contradictory to this, participants did not tend to waken during the night for a 
cigarette (91%) or smoke more during the morning (69%). A greater number 
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of cigarettes smoked in the morning is an indication of a higher level of 
nicotine dependency (Heatherton, Kozlowski, Frecker & Fragerstrom, 1991). 
This question may have been slightly ambiguous as the morning tends to be a 
shorter time frame than the afternoon and evening and the question may have 
been misleading.  
 
Although participants smoked less in the morning, 69% reported that the 
hardest cigarette to give up would be the first one in the morning. This may be 
due to the fact that their nicotine levels would have depleted overnight. By 
morning participants would be in a state of nicotine withdrawal, which for 
some can be a very unpleasant feeling. 
 
Thirty-six percent of participants advised that it would be hard to abstain from 
smoking for a whole day while 58% reported they would have to smoke if 
confined to bed, for example, with illness. Interestingly, 81% advised that they 
would not have to smoke if they were in a restricted area, for example, a long 
haul flight or hospital. This suggests that if the element of choice is removed, 
people can abstain from smoking for long periods.  
 
Cigarettes are highly engineered products designed to ensure that nicotine 
reaches smokers’ brains seconds after they inhale the smoke. Smokers can 
rapidly become dependent on the “hit” they receive from nicotine, which can 
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make it hard for many to stop. Most people smoke to satisfy their habit or to 
alleviate symptoms of withdrawal and craving (ASH Scotland, 2014; Foulds & 
Ghodse, 1995). 
 
As well as this physiological dependence, smoking cigarettes can be 
reinforced and sustained by a range of factors, including sensory, behavioural 
and social conditioning. In his book A Theory of Addiction, West (2006) notes 
that many people who smoke are prompted to do so by cues such as seeing 
others smoke. Others have strong smoking associations with an alcoholic 
drink, ending a meal or talking on the telephone perhaps. Cigarettes can also 
be used as a prompt to take a break, help people to relax or as a reward in 
line with positive reinforcement. These stimuli continue to be present when 
people decide to stop and can often contribute to relapse. To stop smoking 
and to maintain a quit attempt, new behaviours and associations have to be 
established, which can take time and several attempts (West, 2006). 
 
In addition to the issues of behavioural associations, when smokers try to stop 
they can also be affected by unpleasant withdrawal symptoms such as poor 
concentration, irritability, anxiety and depression. Dependence on nicotine is 
classified as an addiction as these strong withdrawal symptoms can make 
stopping extremely difficult.  
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Stopping smoking can be a difficult process because people are required to 
simultaneously overcome their addiction to nicotine, break a long established 
habit and cope with physical withdrawal symptoms. It is this combination of 
challenges that is thought to account for why only 3% of smokers who stop 
using willpower alone, stay stopped. When smokers are given ongoing 
motivational and behavioural support, treatment and follow up, the percentage 
who successfully maintain a quit attempt for twelve months without relapsing 
increases to 20% (West, McNeil & Raw, 2000). 
 
This may be one of the contributing factors as to why none of the participants 
stopped smoking. The pre- and post-interventions were twelve months apart 
and therefore not ongoing. Had the motivational and behavioural support 
been offered on a more regular basis, participants may have felt more 
motivated and confident to stop smoking. The long break in between may also 
have impacted negatively on the participants readiness to stop smoking. 
 
5.2.2 Readiness to Stop Smoking 
5.2.2 Likes and Dislikes of Smoking 
Readiness to change behaviour, as originally defined by Rollnick, Butler and 
Stott (1997), incorporates the concepts of likes and dislikes of smoking and 
motivation and confidence and confidence to stop smoking.  
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A few of the participants liked the fact smoking relaxed them and gave them 
time to themselves. In all cases participants disliked the cost, the smell and 
the negative impact on health associated with smoking, and in that precise 
order. It was interesting to find that there were no statistically significant 
changes with regard to what participants liked about their smoking yet dislikes 
changed significantly (p<0.003) in a positive direction. Most participants at this 
point had a dislike of everything associated with smoking. This contradiction 
may have resulted from a misunderstanding of the question where 
participants thought they were being asked what they liked previously about 
smoking and not what they liked presently. They may also have felt obligated 
to say what they thought the researcher wanted to hear rather than what they 
actually felt. Another consideration is that although levels of motivation and 
confidence to stop smoking increased, perhaps this did not transfer to 
vocalizing feelings.  
 
5.2.2b Motivation and Confidence to Stop Smoking 
Carrying on the readiness to change concept (Rollnick, Butler and Stott, 
1997), examples of motivation and confidence illustrate these concepts and 
their relationship to readiness. Firstly, a male who desperately wants to stop 
smoking but is fearful of the feelings of withdrawal and mood swings and 
secondly, an international sports person who feels they could stop at any time 
but chooses not to stop because smoking is part of their social life. These 
individuals, respectively, are described as being high in motivation but low in 
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confidence and high in confidence but low in motivation. Although motivation 
and confidence are distinct concepts they are clearly interconnected.  
 
One way of beginning to understand a person’s readiness to change their 
health behaviour in greater depth is by exploring their expectations of the 
costs and benefits of change (motivation) and their ability to master the 
demands of abstinence (confidence).  
 
These two concepts have a number of reference points in psychological 
theory, for example, the Stages of Change Model (Prochaska & DiClemente, 
1984). Research on this model has revealed some consistent shifts in these 
expectations as people move through the stages (Rollnick, Morgan & Heather, 
1996; Dixon, 2008). The guiding assumption is that for a person to move into 
the preparation stage (‘I’m ready to try’) they must believe that change is 
worthwhile (motivation) and that they can succeed (confidence). West (2004) 
questions the simplicity of this model in its application to smoking cessation. 
He argues that individuals do not make stable plans and also that the model 
ignores the fact addictive behaviour is often automated. 
 
Even so this study demonstrates a significant change in a positive direction for 
levels of confidence and motivation which may be as a result of the 
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intervention instigating a deeper understanding of the implications of 
continuing to smoke.  
 
The present study explored motivation and confidence by using motivational 
interviewing techniques. The aim was to build participant motivation and 
confidence to stop smoking and to maintain their glycated haemoglobin nearer 
to the recommended levels of 48-53mmol/mol. This was done by encouraging 
participants to identify arguments for change (motivation) and practical and 
achievable steps for stopping smoking (confidence). For example, the DSCEP 
asked participants if they knew the health risks associated with smoking with 
diabetes and proceeded to fill in any gaps in knowledge. They were then 
asked to identify arguments for change that could potentially reduce their risk 
of developing long-term complications and to suggest achievable goals that 
would help them to reduce cigarette consumption or stop smoking completely. 
 
In fact, Tuckett, Boulton and Olsen (1985), have shown that consultations are 
more productive when the doctor is seen as the expert information giver and 
the patient is seen as the expert in his or her own beliefs and daily life. 
Similarly, Stott (1990), in a study of working class women, reports that 
patients are more inclined to be receptive to information sharing than being 
told what to do.  
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More recently, a systematic review has reported that adopting shared 
decision-making protocols has been slow with attitudinal barriers hindering the 
process and patients are finding it hard to speak up. The authors suggest that 
patients need to be prepared for shared decision making and it may not come 
naturally (Joseph-Williams, Edward & Elwyn, 2014) 
 
Nevertheless, motivational interviewing and patient-centred consulting can be 
problematic. For example, healthcare professionals can have a limited 
motivational repertoire and sense of low self-efficacy when it comes to 
influencing patients’ health behaviour change. They can also struggle with 
lack of motivation from patients and pressures of time and resources (Rubak, 
Sandbæk, Lauritzen & Christensen, 2005). The failing is therefore not directly 
related to the technique itself but rather in its implementation. 
 
This study can identify with many of these challenges. Intervention time was 
limited with each patient as it occurred during their annual review. The period 
between study introduction and participation was short, in some cases less 
than one hour. This may not have allowed participants sufficient time to 
internalize all of the information given to them with which to make a fully 
informed decision to participate.  Equally the motivational interviewing skills of 
the researcher may not have been of a standard sufficient enough to instigate 
smoking cessation among the participants. 
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A report by the Picker Institute Europe (2006) shows that despite a strong 
commitment to patient-centred care, people living with long-term conditions in 
the UK were less positive about their care than in other westernized countries.  
 
British people with long-term conditions were the least likely to: 
• say that they had received opportunistic advice from their doctor on 
disease prevention and lifestyle modification, for example, weight, diet 
and exercise 
• be involved in treatment decisions 
• have participated in a treatment review 
• have been given information about the side-effects of their medication 
and  
• have been informed about possible side-effects. 
The survey also showed that within the UK: 
• Fewer than half of people were involved in shared decision-making, 
compared with around two-thirds of people in New Zealand 
• Only 54% of people with chronic conditions were given dietary advice 
Fewer than 1 in 5 people with chronic conditions had been given a plan for 
managing their self-care at home. This fell to 1 in 10 for people diagnosed 
with diabetes. 
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That said, statistically significant differences in levels of motivation (p<0-0005) 
and confidence (p<0.0005) were found between T1 and T2. With regard to 
motivation, this may be due to the fact that the DSCEP informed participants 
of the risks they posed to their health. According to some, it was the first time 
a health professional had discussed smoking and diabetes in detail and not 
merely as additional information given at annual review. Perhaps the 
motivational interviewing technique was the catalyst that motivated 
participants to adopt positive health behaviours.  
 
Being part of a programme designed to inform and support health behaviour 
change with participants central to the discussion and decision making 
process, may have contributed to increased levels of confidence been a novel 
experience for some of them that allowed them to discuss their concerns in a 
safe environment.  
 
5.2.3 Concerns about Smoking and Stopping Smoking 
The Smoking Cessation Guidelines (NHS Health Scotland & Ash Scotland, 
2010), set out the recommendations for those involved in smoking cessation 
in Scotland and includes an evidence base for brief advice. Brief advice to 
stop smoking involves opportunistic advice to smokers to stop and the 
recommendation to use treatment, for example, the NHS Scotland Smoking 
Cessation Service, to help them to do so.  This advice should normally take 
less than three minutes. 
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The evidence suggests that brief advice given by a GP, and lasting less than 
three minutes, results in approximately 5% of all smokers stopping for at least 
six months (ASH Scotland, 2010). This is independent of age, gender and 
whether the person has any smoking-related diseases.  
 
In Forth Valley, this is the most common form of smoking cessation 
intervention as it is quick to administer, reaches a larger number of people 
and is cost effective. In fact, most health care professionals are now trained in 
giving brief advice but it is not an effective intervention for supporting a quit 
attempt. The guidelines emphasize that brief advice is most effective in 
triggering a quit attempt, but that support to actually aid a quit attempt is best 
delivered by trained, specialist staff over a period of time (NHS Health 
Scotland & ASH Scotland, 2010).  
 
The NHS Forth Valley smoking cessation service offers two main services; 
evening drop-in clinics which have a rolling group format and Maudsley 
groups, which are closed and are held weekly for approximately one hour. 
Maudsley groups are based on the service provided at the London Maudsley 
Hospital and training is provided locally by Professor Hajek, a clinical 
psychologist and founder of the Maudsley programme (Hajek, 1994). The 
programme is very prescriptive with weekly topics predefined as follows: 
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Week 1 Introductory Session – housekeeping, introductions, group 
agreement, confidentiality, benefits of group work, set quit date 
Week 2 Preparation for Quitting – CO monitoring, feelings about quitting, 
share previous quit experiences,  
Week 3 Quit Day – share thoughts and feelings about reaching quit day, 
share coping strategies 
Week 4 Responding to group needs, monitoring programme – discuss 
issues and challenges 
Week 5 Responding to group needs, monitoring progress – discuss 
issues and challenges 
Week 6 Preventing relapse, closure – draw on learning from previous 
weeks, define lapse and relapse and offer additional support if 
required 
 
The evening drop-in clinics offer a rolling group service and are not 
prescriptive. They cover most, if not all, of the topics discussed in the 
Maudsley sessions as interventions progress and needs arise. 
 
With personal experience of delivery Maudsley programmes on numerous 
occasions in Forth Valley there is very little time devoted to smoking in relation 
to specific health conditions. The format is very much on the process of 
stopping smoking and focuses on smoking history and patterns, withdrawal 
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symptoms and coping strategies and preventing relapse. Questions are 
answered as fully as possible and additional information provided where 
appropriate but constraints on resources leave very little opportunity for one-
to-one sessions where an individual can raise concerns regarding smoking in 
relation to their specific health conditions such as diabetes, coronary heart 
disease or COPD.  
 
The DSCEP aimed to address this by incorporating questions that asked 
participants what health-related concerns they had about remaining a smoker 
and about stopping smoking. At T1 concerns regarding remaining a smoker 
included: cost and health risks such as cancer and heart disease. By T2 the 
concerns had become more diabetes-specific and included amputation, erratic 
blood glucose levels, neuropathy and nephropathy. This change was not 
statistically significant.  
 
Although none of the participants stopped smoking there was a statistically 
significant positive change in concerns about stopping smoking (p<0.008) at 
T2. Participants were concerned with mood swings; in particular, low mood 
and weight gain (discussed in section 5.2.3, pg. 133). Both of these can be 
quite common for anyone stopping smoking but for an individual with 
diabetes, they can be particularly problematic.  
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Depression affects approximately 20% of people with diabetes and is twice as 
high among this population as it is among the general population. It affects 
more women than men in both the general and diabetic populations but men 
with diabetes are more at risk of developing depression than men in general 
(NICE, 2009; Lin, Katon & von Korffe et al, 2004; Jacobson, Samson, Weinger  
& Ryan, 2002; Anderson, Freedland, Clouse & Lustman, 2001). The nature of 
depression in diabetes is complex and adverse life events, the severity of the 
condition and genetic and personality factors are all likely contributors to its 
occurrence. Whether depression is more common in diabetes than in other 
long-term conditions is far less supported in the literature. 
 
The DSCEP discussed low mood and weight gain at length and strongly 
advised participants to speak to their doctor if they noticed any negative 
effects during a quit attempt. Since levels of motivation and confidence to stop 
smoking both resulted in statistically significant increases therefore mood 
swings and low mood were not an issue for the participants of this study.  
 
5.2.4 Awareness of Smoking Cessation Products and Services 
Participants were asked if they had previously had discussions with 
healthcare professionals with regard to smoking with diabetes. Fifty-nine 
percent (59%) of participants said they had not. This claim was challenged by 
senior staff and consultants, who questioned if participants were in denial. It is 
possible that patients are overwhelmed with information during an annual 
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review and information on stopping smoking gets lost. It is also possible that 
patients have selective memory and retain the information they want to.  
 
Initially there was limited awareness of the range of products available to 
support a quit attempt. Ninety-four percent (94%) of participants were aware 
of NRT transdermal patches while only 35% had heard of NRT gum. None of 
the participants were aware of the NRT nasal spray or of Zyban, an anti-
depressant tablet used as a smoking cessation aid. The DSCEP addressed 
this by providing information and literature on the range of products available 
including patches, gum, tablets, oral and nasal sprays, microtabs and 
inhalators and their instructions for use. 
 
The numbers were lower for awareness of smoking cessation services. Only 
31% were aware of the GP service. Not all GP surgeries in Forth Valley offer 
a specialist smoking cessation service preferring to refer patients to their local 
evening drop-in clinic for specialist advice or directly to the Pharmacy service. 
This practice continues today. Twenty-six percent (26%) of participants 
advised that they had no knowledge of services at all.  
 
This study found statistically significant differences between T1 and T2 for 
awareness of smoking cessation products (p<0.0005) and services 
(p<0.0005) suggesting participants knew what could help them to stop 
smoking and where to go for specialist advice out-with the DSCEP and 
beyond this study. 
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As was mentioned earlier this component was not a test of memory per se. It 
was included simply to determine whether participants were aware of the 
range of help available and an opportunity to discuss developments in 
pharmacotherapy, such as the tablet-treatment Champix, e-cigarettes/ 
vaporizers and expansion of service delivery.  
 
E-cigarettes and vaporizers were released to market after this study finished 
and were therefore not relevant to discussions. However, There has been a 
recent increase in their usage in the UK (3 million sold in 2012, NHS News 
[accessed August 2014]) and ASH Scotland caution their use until regulation 
is granted in January 2016 (ASH Scotland, 2014). 
 
5.2.5 Associated Health risks 
This move to e-cigarettes and vapourisers highlights a growing awareness of 
risk to health that smoking poses, in general. In this case there was also a 
good degree of awareness.  
 
In light of this evidence, atherosclerosis, nephropathy, neuropathy and 
diabetic foot from circulatory problems were described and their causes and 
implications for diabetes were discussed at length throughout the DSCEP.  
 
It is important that people with diabetes are given sufficient information to help 
them self-manage their condition and it is even more important that this 
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information is communicated in a safe environment and in a way that helps 
patients feel part of the discussion and decision making process. 
 
Motivational interviewing was used to elicit these responses from participants 
and to encourage more in-depth discussions. These discussions were 
designed to increase the importance of health behaviour change, from the 
participants’ perspective. This was accomplished by asking specific types of 
questions, for example, open and closed questions, along with selective 
reflections that directed participants toward the discrepancy between their 
negative health behaviour and broader personal values. Motivational 
interviewing is intentionally directive. In line with the Motivational Interviewing 
Network for Trainers Manual (MINT, 2008) and evidence from systematic 
reviews of the efficacy of MI for drugs, alcohol, weight gain, diet and exercise 
and smoking cessation (Lai, Qin & Tang, 2008; Rubak, Sandbæk, Lauritzen & 
Christensen, 2005; Burke, Arkowitz & Menchola, 2003; Knight, Dickens, 
McGowan & Bundy, 2006), the researcher was careful not to explicitly 
advocate for change.  
 
There were also significant effects in awareness of health risks (p<0.0005) 
with the educational input from the DSCEP. Over time this knowledge became 
more diabetes specific.  Participants became more aware of the risks to health 
that their smoking behaviour poses and in terms of an education programme, 
these findings suggest that the intervention may have been effective.  
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5.2.6 Weight (kg) 
In this instance there were no significant changes in weight loss but there was 
a reduction in the weight means, suggesting a small degree of weight loss. 
Weight gain can contribute to diabetes complications and should be monitored 
closely.  
 
Weight gain is associated with smoking cessation and tends to concentrate in 
the central subcutaneous regions (Aubin, Farley, Lycett, Lahmek & Aveyard, 
2012; Fillizof, Fernandez-Pinilla & Fernandez-Cruz, 2004). Increased 
abdominal fat is a risk factor for coronary heart disease and Galal, van 
Domburg, Feringa and Shouten (2007) reported that body mass index is an 
independent predictor of long-term mortality.  
 
Nicotine is known as an appetite suppressant and smoking is often used, 
among other things, as a mechanism to control weight. Haire-Joshu and 
Thomas (2005) suggest that people with diabetes believe that excessive post 
cessation weight gain will interfere with their self-management and that this 
may contribute to fears about stopping smoking.  
 
The participants in this study voiced their concerns regarding weight gain 
stating that they thought stopping smoking may adversely affect their blood 
glucose levels which they wanted to avoid. With none of them stopping 
smoking, weight gain was not an issue for this study. 
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5.3 Study limitations and Methodological Weaknesses  
The group under investigation was not representative of the general public 
and is the main reason the study was exploratory in nature. Despite this the 
study had a great deal of support in Forth Valley from the diabetes care 
department, the smoking cessation department, the health promotion 
department, the Forth Valley Tobacco Action Group and also from health 
psychology colleagues at Queen Margaret University and Stirling University. 
In addition, the project won the first ever Cardiovascular and Diabetes Award 
from Servier Laboratories in collaboration with the Royal College of Nursing. 
 
Despite this support, the study was beset with challenges from the outset. The 
process to gain ethical approval should take approximately two – three 
months to complete. It was sixteen months before approval was granted. The 
delays were partly due to naivety of the researcher and to confusion within the 
NHS Forth Valley Research and Development Department (R&D) relating to 
the research objectives and the sample available. The researcher 
misunderstood that the NHS ethics application form should also have been 
sent to R&D for both process to run concurrently. As this did not happen it 
caused more delays.  
 
The study was due to run in Falkirk Royal Infirmary (FRI) and Stirling Royal 
Infirmary (SRI) on Friday and Wednesday mornings respectively which should 
have given access to a sufficient sample. Because of the delays SRI could not 
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host the study as the dedicated room had been booked for other purposes. 
This meant the only timeslot was Friday mornings in FRI greatly reducing 
access to patients.  
 
During initial meetings with diabetes care and smoking cessation mentors the 
researcher was asked to focus the research on participants with Type 2 
diabetes who smoked cigarettes. It was explained the intervention could have 
a negative impact on patients with Type 1 diabetes or using insulin. Initially 
this did not appear problematic. When the study began it became evident that 
most patients with Type 2 diabetes are managed in primary care and not 
secondary care, again narrowing the sample. As a result participants became 
difficult to find.  
 
Twenty-nine participants were required for statistical power. Due to potential 
attrition, forty-five participants were sought. Participant recruitment did not 
prove problematic and thirty-one participants took part at baseline. All of them 
agreed to return to FRI for 3-month follow-up. None of them did despite 
agreeing to an appointment. To collect 3-month data, the researcher posted 
questionnaires to the participants with a covering letter of explanation and a 
stamped addressed envelope. None of the participants returned their 
questionnaires.  
 
Matriculation Number: 05008241  Professional Doctorate in Health Psychology  
Doctoral Thesis 2015   144 
It was agreed with diabetes care and QMU that 3-month follow-up would be 
removed from the study and 6-month and 12-month follow-up data would be 
collected. It was anticipated this would be less of an issue as some of the 
participants were due for diabetes review at 6-months and all would return for 
annual review at 12-months. As suggested seventeen participants returned at 
6-month and twenty-nine returned at 12-month. One participant died soon 
after entering the study.  Further guidance from statisticians at QMU advised 
to remove the 6-month follow-up data and to concentrate on baseline and 12-
month follow-up data.  
 
At the beginning of the study participants were slow to complete the 
questionnaires and it was difficult to have a discussion while they were 
concentrating. The sessions became lengthy which left less time to recruit 
new participants. In order to leave time to build rapport and not to rush the 
intervention the researcher felt it prudent to read the questions aloud to 
participants and populate the forms with their responses during the 
intervention. In doing so the session was more effective and allowed time for 
interaction and discussion.  
 
Although this format was followed for all participants, it is contradictory to the 
advice given by Bradley (1993), who advises that participants must complete 
the questionnaires by themselves and in the time it naturally takes them. It is 
acknowledged that, while every effort was made to ensure that each 
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participant received the same intervention, the researcher may have 
introduced bias by reading and completing the questions for the participants 
and thus may have given variations in explanations.  
 
On reflection the intervention was perhaps too long, particularly after a 
diabetes review which in itself could be lengthy and tiring. It was evident that 
some participants were becoming disinterested and may have given answers 
for the sake of saying something as opposed to what they really felt. There is 
also the possibility that some responded with what they thought the 
researcher wanted to hear in case it negatively affected their diabetes care. 
The Perceived Control of Diabetes Scale perhaps could have been abridged 
and would not have taken up so much of the DSCEP leaving more time for 
discussions. 
 
Other issues arose depending on the number of consultants holding clinics at 
the same time. Some Friday mornings there would be one consultant clinic 
and other Friday mornings three consultant clinics. With one consultant, the 
research ran smoothly with sufficient time for the intervention. With three 
consultants it could, and did, become chaotic.  The waiting room became very 
busy and patients who had been approached with the information letter were 
being called in to consultations before they had time to consent. Others who 
were returning at 12-month follow-up would present to the research room and 
half-way through the intervention, would be called by the consultant for their 
diabetes review. This happened mostly when clinics were running late and the 
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researcher attempted to maximize time. Such a disjointed approach was not 
conducive to an effective study but as the DSCEP did not want to encroach on 
diabetes care or consultant time, the researcher did what they could to keep 
participants motivated. This was not a weekly issue but did happen quite often 
and had not been anticipated. 
 
There was no control group included in this study. Although many of the 
effects were statistically significant, without a control group it is difficult to 
attribute the behaviour change to the intervention and is possible the changes 
may have occurred naturally with time.  
 
It was decided not to include a control group for the ethical reasons discussed 
earlier and also because of time and resources. The research received 
funding from Servier Laboratories and the Forth Valley Tobacco Action Group 
but the funding only supported one researcher. Other doctoral competencies 
limited the researcher’s availability to Friday and Wednesday mornings which 
was further limited to Friday mornings when SRI could not accommodate the 
study. Under these circumstances to try to accommodate a control group 
would not have been practical and is why the research became an exploratory 
study.  
 
Although the research aimed to motivate participants to stop smoking and 
anticipated gaining control of smoking behaviours would have a positive 
impact on glycaemic control in patients with Type 2 diabetes, these goals 
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were not attained in their entirety. None of the participants stopped smoking 
although some reported cutting down. The carbon monoxide readings 
supported this to some extent but since carbon monoxide depletes from the 
body as soon as the last cigarette has been smoked, these readings cannot 
be taken as definitive proof of a reduction in cigarette consumption. A 
fundamental flaw of the study was not to capture cigarette consumption at T2. 
This was a complete oversight on the part of the researcher with no rationale. 
 
The DSCEP invited participants to return to FRI any Friday morning should 
they wish smoking cessation support. It was recognized that FRI is not always 
easy to get to and parking is an issue. With this in mind the DSCEP informed 
participants of smoking cessation clinics and groups running in their own area. 
Disappointingly, none of the participants returned for smoking cessation 
support out with their diabetes review or attended a clinic nearer home.  The 
reasons for this are not clear.  
 
When patients arrived for their annual diabetes review they would have no 
prior knowledge that a study was running in the department. Whilst the 
researcher did not knowingly coerce anyone into taking part, it is possible that 
some patients may have felt obliged to take part, worried that their diabetes 
care would be compromised if they did not. It is not known what advice or 
information the consultants gave patients regarding the research and taking 
part or if any other healthcare professionals advised patients to take part. 
Stopping smoking may not have been on the patient’s agenda and the 
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timescale between being invited to participate and actual participation may 
have been too brief for some. 
 
It is fair to say the research was too ambitious for one person, particularly a 
student with limited research experience. The research and DSCEP was well 
intentioned and had many supporters. On reflection, there were too many 
components and at times it felt fragmented. The statistical analysis, repeated 
measures ANOVA, could have been supported by additional research 
methods to provide a broader understanding of the findings. For example, the 
non-parametric Friedman Test although this is a less sensitive measure, 
factor analysis could perhaps have identified patterns of correlations between 
variables (was SLoC correlated to levels of motivation and confidence?). 
Equally linear regression may have helped uncover a relationship between 
variables not evident from ANOVA alone. 
 
The preceding pages offer the building blocks of an important and valuable 
research programme that with the appropriate levels of funding and expert 
guidance will help people with Type 2 diabetes in their attempt to stop 
smoking. The impact will be a reduction in risk of developing long-term 
complications and premature morbidity and mortality. It is cost-effective and 
will reduce the burden on NHS resources both locally and nationally. 
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Chapter 6 - Conclusions 
Although the study proved challenging at times there were some interesting, if 
not contradictory statistically significant outcomes. For example, significant 
effects were found for the SLoCS internality but not externality subscales, 
dislikes of smoking but not likes of smoking, concerned about stopping 
smoking yet not concerned with smoking and PCDS internality but not 
externality subscales. An in-depth exploration of these particular outcomes 
was beyond the scope of this study. 
 
These findings suggest a positive outcome for healthcare. The literature 
reports that people who are more inclined to take control of their own health 
behaviour are more likely to adhere to their medicine and engage with the 
healthcare profession. In terms of diabetes care, this can only be a positive 
step in reducing the potential risk of patients developing long-term 
complications which in turn should reduce the burden on overstretched 
resources. This merits further investigation.  
 
In response to the research question “Does gaining control of smoking 
behaviours have a positive impact on glycaemic control in patients with Type 
2 diabetes?” the findings suggest it does. 
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6.1 Why the DSCEP is a good example of shared practice 
Many research papers call for intensive smoking cessation support for people 
with diabetes. This Diabetes and Smoking Cessation Education Programme 
responded to this call without encroaching on consultant or specialist nurse 
time, allowing the health professionals to focus on delivering diabetes care. 
 
6.2 Recommendations 
In light of the current findings, the following recommendations are suggested:  
• The DSCEP becomes an integral part of routine diabetes care in 
primary and secondary care 
• The DSCEP be developed to include patients with Type 1 diabetes 
• A randomized controlled trial is developed 
• Explore the impact and efficacy of e-cigarettes and vaporizers 
 
6.3 Accountability 
The study was granted ethical approval from:   
• NHS Lothian Research Ethics Committee 
• NHS Forth Valley Research and Development Department 
• Dr Norman Peden Senior Diabetes Consultant NHS Forth Valley 
Diabetes Care Department 
• Queen Margaret University Ethics Committee 
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and supported by: 
• Sister June Currie Senior Diabetes Specialist Nurse, NHS Forth Valley 
• Sister Gillian Bruce Specialist Lead Nurse in Smoking Cessation, NHS 
Forth Valley 
• Dr. Vivien Swanson CPsychol., MSc Health Psychology Course 
Director, University of Stirling 
and was supervised by: 
• Dr. Michèle Hipwell CPsychol. Professional Doctorate in Health 
Psychology Deputy Course Director, Queen Margaret University, 
Edinburgh 
• Dr. Vivienne Chisholm CPsychol. Senior Lecturer, Queen Margaret 
University 
6.4 Resources 
The project secured funding via the first ever Servier RCN Diabetes/CHD 
Award for 2006. This enabled the project to employ a trainee health 
psychologist for 3 hours per week for the first year and to purchase a carbon 
monoxide monitor. NHS Forth Valley Health Promotion awarded funding to 
continue the project for a further 12 months on the same basis. The project is 
currently seeking additional funding. 
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Participant Information Letter 
 
Protocol version: 2 
 
REC Reference Number: 07/S1102/50 
 
Study Title: Does gaining control of smoking behaviours have a positive 




The research is being conducted as part of the Professional Doctorate in 
Health Psychology with Queen Margaret University (QMU) and Forth Valley 
Diabetes Care. The study aims to determine whether gaining control of 
smoking behaviours i.e. cutting down cigarette consumption or stopping 
smoking completely, will have a positive impact on blood sugar levels in 
patients with Type 2 diabetes.  The study aims to recruit 45 participants in 
Forth Valley and you are being invited to participate because you have been 
identified from your case notes as a patient with Type 2 diabetes who smokes 
cigarettes.  
 
The researcher will describe the study and go through this information sheet, 
which will then be given to you. You will be asked to sign a consent form to 
show you have agreed to take part. Your participation is entirely voluntary and 
you are free to withdraw at any time, without giving a reason. Please be 
assured that this will not affect the level of diabetes care you receive.  
 
What will my involvement be? 
The study will be conducted over a 12 month period. You will meet with the 
researcher for 30 minutes at an appointed time, once every 3 months (4 times 
in total). At these meetings you will be required to: 
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• give demographic information (age, gender, ethnicity, education level) 
• discuss your smoking history and smoking patterns 
• complete perceived control of diabetes questionnaire 
• complete smoking locus of control questionnaire 
• participate in carbon monoxide testing 
• participate in HbA1c testing 
• be weighed 
 
What happens to the information gathered on me? 
All information gathered will be stored in a locked cabinet in Diabetes Care 
and will only be viewed by the researcher and the researchers’ Director of 
Studies at QMU. The data will be entered into a secure database at Queen 
Margaret University and analyzed using repeated measures ANOVA. This is a 
research method that allows researchers to track changes in participants’ 
behaviour over time. The findings will be written up as a dissertation and 
submitted to QMU’s examination board. All participants will receive a letter 
advising them of the results of the study. 
 
Confidentiality 
Your confidentiality will be safeguarded in accordance with the Data 
Protection Act, 1988. All information gathered will be held in the strictest 
confidence and viewed only by those directly involved with the study. You will 
be allocated with an identification number that will be recorded on all of the 
paperwork associated with your participation. This will ensure that you cannot 
be identified by name or address, guaranteeing anonymity. The study follows 
British Psychological Society Ethical Guidelines and has been reviewed and 
given a favourable opinion by Lothian Local Research Ethics Committee 02. 




How can I benefit from taking part? 
The study is not guaranteed to help you but the information gathered from the 
study will help develop an education programme aimed at helping patients to 
manage their diabetes more effectively and to stop smoking. If the information 
in Part 1 has interested you and you are considering participation, please read 
the additional information in Part 2 before making any decision.  
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PART 2 
 
Withdrawal from the study 
 
Participation in the study is entirely voluntary and you are free to withdraw at 
any time without giving a reason. Withdrawal from the study will not affect 
your level of diabetes care. Data given by you, up until your time of 
withdrawal, will be included in the study. 
 
Who do I complain to if I am not happy with the study? 
 
If you have a concern about any aspect of this study, you should ask to speak 
to the researcher who will do their best to answer your questions (01324 
624000 ext 6094). If you remain unhappy and wish to complain formally, you 
can do this through the NHS Complaints Procedure. Details can be obtained 
from Falkirk District Royal Infirmary, Diabetes Care Department. Additionally, 
Queen Margaret University is indemnifying participants in this study for any 
harm arising to them from the management, design and conduct of the 
research. Please contact Queen Margaret University on 0131-474-0000 if you 
feel you have grounds to complain under these arrangements. 
 
Involvement of your GP 
 
If you participate in the study, a letter will be sent to your GP advising of this. 
Stopping smoking can affect your blood sugar levels and may lead to weight 
gain therefore your GP may wish to monitor you more closely. 
 
Further information and contact details 
 
Please direct all enquiries to Margaret-Anne MacMillan, Trainee Chartered 





Matriculation Number: 05008241  Professional Doctorate in Health Psychology  




Participant Consent Form 
Protocol version: 2 
REC Reference Number: 07/S1102/50 
Study Title: Does gaining control of smoking behaviours have a positive 
impact on glycaemic control in patients with Type 2 diabetes? 
 
Researcher: Margaret-Anne MacMillan 
Participant ID: DSCEP/F««««« 
 
Please read the Participant Information Letter and then complete the following 
(initial the boxes and sign and date the Participant Consent Form at the 
bottom).          
  
1.I confirm that I have read and understand the information sheet dated 
15.3.08 (version 3) for the above study. I have had the opportunity to consider 
the information, ask questions and have had these answered satisfactorily.   
2.I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal rights 
being affected.  
3.I understand that data collected during the study, may be looked at by 
individuals directly involved with the study. I give permission for these 
individuals to have access to my records.  
4. I agree to my GP being informed of my participation in the study. 
5. I agree to take part in the above study.  
 
Name of Participant  Date    Signature     
 _______________  __________  ________________________  
Name of Person   Date    Signature   
taking consent  
 
_________________ ___________ ________________________ 
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APPENDIX C – GP LETTER 
Forth Valley NHS Board 
Diabetes Care Centre 











Our Ref   Diabetes and Smoking Cessation Education 
Programme 
Enquiries   Margaret-Anne MacMillan 
Extension 6094 
Tel 01324 616041 
Email  
Dear Dr.  
Patient attending Diabetes and Smoking Cessation Education Programme 
I am writing to inform you that your patient «««««««««««««««««««««« 
(DOB) ««««««« has entered the Diabetes and Smoking Cessation Education 
Programme at Falkirk/Stirling Royal Infirmary. The programme is aimed at patients with 
diabetes who smoke. The programme is delivered by myself, a trainee Health Psychologist 
and is supervised by June Currie, Diabetes Specialist Nurse and Gillian Bruce, Smoking 
Cessation Specialist Nurse. The education programme aims to motivate patients to self-
manage their diabetes more effectively and to quit smoking, by raising awareness of the 
health risks associated with diabetes and smoking. The programme discusses coronary heart 
disease, ischemic heart disease, atherosclerosis, stroke and circulation and advises on NRT, 
Zyban and Champix and smoking cessation services available within Forth Valley. 
I have discussed with your patient the areas of support that are available and as such they 
may contact you regarding NRT and other therapies.  
As you will be aware, stopping smoking can affect glycaemic control and your patient may 
need careful monitoring. However, NRT is known to be a safe and effective method of 
smoking cessation support for patients with diabetes and I would therefore ask that you 
consider prescribing NRT for your patient should they choose to stop.  
Should you have any queries regarding the Diabetes and Smoking Cessation Education 
Programme please contact Margaret-Anne MacMillan, Trainee Health Psychologist on 01324 





Trainee Health Psychologist 
Queen Margaret University 
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Appendix 





SCOTTISH SMOKING CESSATION MINIMUM DATA SET  
         
         
Participant ID: DSCEP/F         
         
         
Contact Details:   General Practitioner Details: 
         
         
Title   Mr    Mrs   Ms   Miss  Name:       
First Name      Address       
Surname              
Address              
         Town       
Postcode      Tel No       
D.O.B.            
Tel No        Referral  
Case 
notes 
Mob No      by   Consultant
         
   Personal Details:    
         
Gender   Male  Diabetes  Type 1 
   Female  Type  Type 2 
    
Pregnant       
Y/N 
       
Y/N      Unknown 
         
         
Education  Secondary  Ethnic Origin     
Level  College      
    University  Employment Status   
         
         
Biomedical Measures    Information given tick 
Date: HBA1c CO Weight  Participant information form   
         Ash factsheet 11 & 23   
         NRT, Zyban & Champix  info   
         SCS signpost leaflet   
         How to stop smoking book   
         
         
Follow-up arranged 
 
Yes*  *Date of follow-up   
      
 
No          
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Participant ID: DSCEP/F     Tobacco Use 
First cigarette     Average number      
on waking?     smoked per day?       
Wake for cigarette  Yes How easy/hard to        
during night?  No abstain for a day?       
Smoke more  Yes  Cigarette hardest to       
during morning?  No give up?        
Smoke if    Yes  Difficulty in not smoking in  Yes 
confined to bed?  No restricted area?    No 
Other 
 
      Pipe 
 







      Cigars 
 





      Rolls 
 
Smoking?      months? 
 Not 
good 
No of quit attempts     Date of last quit     _ _/ _ _/ _ _ 
in last year?     attempt?       
      Readiness to Quit         
What do you like about your smoking? What do you dislike about your smoking?   
             
             
             
                  
On a scale of 1-10, (1=not at all motivated On a scale of 1-10, (1=not at all confident to quit, 10= 
to quit, 10=100% motivated to quit) what 100% confident to quit), what number would you give  
number would you give yourself just now? yourself just now?     
             
             
      Concerns           
What concerns you about What concerns you about  What concerns you about 
remaining a smoker?   stopping smoking?   remaining abstinent?   
               
               
      Awareness         
Have you had previous discussions with On a scale of 1-10, (1=not at all motivated to quit, 10= 
health professionals regarding diabetes 100% motivated to quit), did this previous advice  






No        
             
*please specify           
What smoking cessation services are you Have you used any of these services?   
aware of?      Yes*   No 
             
        *please specify       
What types of NRT are you aware of? Have you used any of these treatments?   
       Yes*   No 
            
      *please specify       
Please list  the health risks associated with diabetes and smoking     
           
           
           
      Goals           
What are your goals for 3-month follow-up? What can I do to help you achieve these goals? 
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Participant ID: DSCEP/F         
          
      6/12-month follow-up        




No conducted       
Quit date Smoked since intervention?   CO reading confirms quit?    
__/__/__  Yes  No  Yes  No  
              






NRT   
 






Zyban   
 




One to One 
 
Champix   
 




Pharmacy   
 
Other   
 
Pharmacy    
      Readiness to Quit          
What do you like about your smoking? What do you dislike about your smoking?    
              
              
                   
On a scale of 1-10, (1=not at all motivated to quit, 
10=100% motivated to quit) what number would you 
give yourself just now? 
On a scale of 1-10, (1=not at all confident to quit, 10= 100% 
confident to quit), what number would you give yourself just 
now?  
    
              
              
      Concerns            
What concerns you about What concerns you about What concerns you about  
remaining a smoker?   stopping smoking?   remaining abstinent?    
                
                
                
      Awareness          
What smoking cessation services are you Have you used any of these services?    
aware of?      Yes*   No  
             
      *please specify      
                   
What types of NRT are you aware of? Have you used any of these treatments?    
      Yes*   No  
             
     *please specify      
                   
Please list the health risks associated If still smoking, have you made any positive changes  
with smoking and diabetes.   regarding your smoking?     
              
              
              
      Goals            
What are your goals for 6/12-mth follow-up? What can I do to help you achieve these goals?  
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APPENDIX E 
Instructions for Completion of 
 





The following questions are about the causes of situations which might 
happen to you. We ask you to imagine that the events described have 
happened to you recently. 
 
While events may have many causes, we want you to pick one only – the 
major cause of the situation as you see it. Please write this cause in the 
space provided after each event. 
 
Next, we want you to answer some questions about the cause by circling the 














Perceived Control (type 2) © Prof Clare Bradley 11.9.93. Standard UK English (rev. 2/96) 
Health Psychology Research, Dept of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK 
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Imagine that you have recently become unacceptably overweight. 
 





Now rate this cause on the following scales: 
 
1. To what extent was the cause due to something about you? 
 
Totally due to me  6 5 4 3 2 1 0 Not at all due to me 
 
 
2. To what extent was the cause due to the treatment recommended by your doctor? 
 
Totally due to        6 5 4 3 2 1 0 Not at all due to  
treatment                treatment 
recommended     recommended 
 
     
3. To what extent was the cause something to do with other people or circumstances? 
 
Totally due to  6 5 4 3 2 1 0 Not at all due to  
other people         other people or 
or circumstances       circumstances  
 
  
4. To what extent was the cause due to chance? 
 
Totally due to  6 5 4 3 2 1 0   Not at all due to 
chance         chance 
 
 
5. To what extent was the cause controllable by you? 
 
Totally   6 5 4 3 2 1 0 Totally 
controllable         uncontrollable 
by me         by me 
 
 
6. To what extent was the cause controllable by your doctor? 
 
Totally  6 5 4 3 2 1 0 Totally 
controllable        uncontrollable by 
by my doctor        my doctor 
 
 
7.To what extent do you think you could have foreseen the cause of becoming overweight? 
 
Totally  6 5 4 3 2 1 0 Totally 
foreseeable        unforeseeable 
by me         by me  
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Imagine that for several days you have found high levels of sugar when 
you tested your blood or urine. 
 





Now rate this cause on the following scales: 
 
1. To what extent was the cause due to something about you? 
 
Totally due to me  6 5 4 3 2 1 0 Not at all due to me 
 
 
2. To what extent was the cause due to the treatment recommended by your doctor? 
 
Totally due to        6 5 4 3 2 1 0 Not at all due to  
treatment                treatment 
recommended     recommended 
 
     
3. To what extent was the cause something to do with other people or circumstances? 
 
Totally due to  6 5 4 3 2 1 0 Not at all due to  
other people         other people or 
or circumstances       circumstances  
 
  
4. To what extent was the cause due to chance? 
 
Totally due to  6 5 4 3 2 1 0   Not at all due to 
chance         chance 
 
 
5. To what extent was the cause controllable by you? 
 
Totally   6 5 4 3 2 1 0 Totally 
controllable         uncontrollable 
by me         by me 
 
 
6. To what extent was the cause controllable by your doctor? 
 
Totally  6 5 4 3 2 1 0 Totally 
controllable        uncontrollable by 
by my doctor        my doctor 
 
 
7.To what extent do you think you could have foreseen the cause of high levels of sugar? 
 
Totally  6 5 4 3 2 1 0 Totally 
foreseeable        unforeseeable 
by me         by me  
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Imagine that you have been able to keep your weight at an acceptable 
level for a period of several weeks and you have felt fit and well. 
 
Write down, in the space below, the single most likely cause of this period of good 





Now rate this cause on the following scales: 
 
1. To what extent was the cause due to something about you? 
 
Totally due to me  6 5 4 3 2 1 0 Not at all due to me 
 
 
2. To what extent was the cause due to the treatment recommended by your doctor? 
 
Totally due to        6 5 4 3 2 1 0 Not at all due to  
treatment                treatment 
recommended     recommended 
 
     
3. To what extent was the cause something to do with other people or circumstances? 
 
Totally due to  6 5 4 3 2 1 0 Not at all due to  
other people         other people or 
or circumstances       circumstances  
 
  
4. To what extent was the cause due to chance? 
 
Totally due to  6 5 4 3 2 1 0   Not at all due to 
chance         chance 
 
 
5. To what extent was the cause controllable by you? 
 
Totally   6 5 4 3 2 1 0 Totally 
controllable         uncontrollable 
by me         by me 
 
 
6. To what extent was the cause controllable by your doctor? 
 
Totally  6 5 4 3 2 1 0 Totally 
controllable        uncontrollable by 
by my doctor        my doctor 
 
 
7.To what extent do you think you could have foreseen the cause of feeling fit and well? 
 
Totally  6 5 4 3 2 1 0 Totally 
foreseeable        unforeseeable 
by me         by me  
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Imagine that you have successfully avoided the complications of 
diabetes such as problems with your feet. 
 
Write down, in the space below, the single most likely cause of the successful 





Now rate this cause on the following scales: 
 
1. To what extent was the cause due to something about you? 
 
Totally due to me  6 5 4 3 2 1 0 Not at all due to me 
 
 
2. To what extent was the cause due to the treatment recommended by your doctor? 
 
Totally due to        6 5 4 3 2 1 0 Not at all due to  
treatment                treatment 
recommended     recommended 
 
     
3. To what extent was the cause something to do with other people or circumstances? 
 
Totally due to  6 5 4 3 2 1 0 Not at all due to  
other people         other people or 
or circumstances       circumstances  
 
  
4. To what extent was the cause due to chance? 
 
Totally due to  6 5 4 3 2 1 0   Not at all due to 
chance         chance 
 
 
5. To what extent was the cause controllable by you? 
 
Totally   6 5 4 3 2 1 0 Totally 
controllable         uncontrollable 
by me         by me 
 
 
6. To what extent was the cause controllable by your doctor? 
 
Totally  6 5 4 3 2 1 0 Totally 
controllable        uncontrollable by 
by my doctor        my doctor 
 
 
7.To what extent do you think you could have foreseen the cause of problems with your feet? 
 
Totally  6 5 4 3 2 1 0 Totally 
foreseeable        unforeseeable 
by me         by me  
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Imagine that you have reduced your weight to a satisfactory level after a 
period when you gained too much weight. 
 





Now rate this cause on the following scales: 
 
1. To what extent was the cause due to something about you? 
 
Totally due to me  6 5 4 3 2 1 0 Not at all due to me 
 
 
2. To what extent was the cause due to the treatment recommended by your doctor? 
 
Totally due to        6 5 4 3 2 1 0 Not at all due to  
treatment                treatment 
recommended    recommended  
 
     
3. To what extent was the cause something to do with other people or circumstances? 
 
Totally due to  6 5 4 3 2 1 0 Not at all due to  
other people         other people or 
or circumstances       circumstances  
 
  
4. To what extent was the cause due to chance? 
 
Totally due to  6 5 4 3 2 1 0   Not at all due to 
chance         chance 
 
 
5. To what extent was the cause controllable by you? 
 
Totally   6 5 4 3 2 1 0 Totally 
controllable         uncontrollable 
by me         by me 
 
 
6. To what extent was the cause controllable by your doctor? 
 
Totally  6 5 4 3 2 1 0 Totally 
controllable        uncontrollable by 
by my doctor        my doctor 
 
 
7.To what extent do you think you could have foreseen the cause of gaining too much 
weight? 
 
Totally  6 5 4 3 2 1 0 Totally 
foreseeable        unforeseeable 
by me         by me  
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Imagine that you have managed our diabetes successfully, living life as 
you wished while also keeping your glucose (sugar) levels under control 
 






Now rate this cause on the following scales: 
 
1. To what extent was the cause due to something about you? 
 
Totally due to me  6 5 4 3 2 1 0 Not at all due to me 
 
 
2. To what extent was the cause due to the treatment recommended by your doctor? 
 
Totally due to        6 5 4 3 2 1 0 Not at all due to  
treatment                treatment 
recommended    recommended  
 
     
3. To what extent was the cause something to do with other people or circumstances? 
 
Totally due to  6 5 4 3 2 1 0 Not at all due to  
other people         other people or 
or circumstances       circumstances  
 
  
4. To what extent was the cause due to chance? 
 
Totally due to  6 5 4 3 2 1 0   Not at all due to 
chance         chance 
 
 
5. To what extent was the cause controllable by you? 
 
Totally   6 5 4 3 2 1 0 Totally 
controllable         uncontrollable 
by me         by me 
 
 
6. To what extent was the cause controllable by your doctor? 
 
Totally  6 5 4 3 2 1 0 Totally 
controllable        uncontrollable by 
by my doctor        my doctor 
 
 
7.To what extent do you think you could have foreseen the cause of keeping your sugar 
under control? 
 
Totally  6 5 4 3 2 1 0 Totally 
foreseeable        unforeseeable 
by me         by me  
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Appendix F 
 
Smoking Locus of Control Scale 
 
 
The following is a questionnaire that considers some of the reasons why 
people may or may not succeed in giving up smoking. (For the purpose of this 
scale, to ‘succeed in stopping smoking’ means having stopped for at least six 
months without starting again.) 
 
 
Listed below are a number of statements about giving up smoking. We would 
like you to indicate the extent to which you agree or disagree with each 
statement, by placing a circle around the number on the scale which best 
represents your view. The scale ranges from ‘Strongly Disagree’ (0) to 
‘Strongly Agree’ (5). Thus the more strongly you agree with a statement, then 
the higher will be the number you circle; and the more strongly you disagree 
with a statement, then the lower will be the number you circle. 
 
 
Please make sure you consider every statement and that you circle only one 
number per statement. 
 
 
As much as you can, try to respond to each statement independently and try 
not to be influenced by your previous choices. This is a measure of your 
personal views; there are no right or wrong answers. Just respond according 
to how you really feel. 
 
 
It may be that at the moment you have no wish to stop smoking. If this is so, 
please fill out the scale anyway – imagining yourself at a time when you do 
wish to stop smoking. 
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Strongly       Moderately     Slightly Slightly Moderately        Strongly 
      Disagree      Disagree        Disagree Agree  Agree           Agree 
 
1. For me, stopping depends on       0         1  2    3        4  5 
encouragement to give up from 
society as a whole  
2. If I want to stop smoking, I’ve got to       0         1                       2                 3                  4                        5 
make it happen myself  
3. If I fail to stop smoking, it’s because 
the people closest to me didn’t help me 
enough         0          1                   2     3         4       5 
4.If I succeed in stopping smoking, it will 
be because of my own determination      0          1    2     3         4                       5 
5. There is no such thing as a  
technique or treatment which can make 
it  easy for me to stop smoking      0          1    2     3         4                  5 
6. I was destined not to stop smoking      0          1    2     3         4  5   
7. For me, to stop smoking would  
depend on having the support of 
someone I care a lot about 0                   1    2     3         4   5 
8.  I could stop smoking if I attended 
a good stop smoking clinic                           0                  1                        2               3                   4                       5 
9. There’s nothing that my family or 
friends can do to help me stop 
smoking                                                        0                   1                      2                3                   4                       5 
10. If I fail to give up smoking, it’s 
because I wasn’t meant to be a non- 
smoker                                                          0                   1                       2                3                   4                     5 
11. There is nothing that health 
professionals (e.g. doctors,  
psychologists) can do to help me   
stop smoking 0                    1                      2                3                   4                      5      
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Appendix G – Fagerstrom Small Test for Nicotine Dependence 
 






1. How soon after you wake do you smoke 
your first cigarette 
Within 5 minutes 
   6 – 30 minutes 
 30 – 60 minutes 
After 60 minutes 




2. Do you find it difficult to refrain from 
smoking in places where it is forbidden 







3 Which Cigarette would you most hate 
to give up? 






4. How many cigarettes in a day do you 
smoke? 
31 or more 
21 – 30 
11 – 20 
10 or less 




5 Do you smoke more frequently during 
the first hours after waking than during 







6. Do you smoke if you are so ill that you 
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Points Total     1 – 3 
You have a low dependence on nicotine and may benefit from using NRT 
occasionally to supplement your willpower.  Use low strength 2 mg Gum or Microtab 
or if you think you are likely to miss the physical act of smoking, try an Inhalator. 
 
Points Total    4 – 5  
You have a medium dependence on nicotine.  If you smoke at regular intervals 
throughout the day, try using a patch.  Alternatively, if you have a less regular 
smoking pattern, low strength 2mg Gum or Microtab may be more appropriate.  If 
you are likely to miss the hand-to-mouth action of smoking, try the inhalator.  
 
Points Total    6 – 7 
You have a high dependence on nicotine.  If you smoke regularly throughout the day, 
you may find the Patch helpful.  If you prefer to control how much nicotine you use 
and when you use it, try the full strength 4mg Gum or Microtab at the higher dose. 
 
Points Total    8 - 10 
You have a very high dependence on nicotine.  You would benefit from using an NRT 
product with a high nicotine content that offers you flexibility such as the Nasal 
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APPENDIX H 
INTERVENTION METHOD DURING CONSULTATION: 
(to be used in conjunction with Diabetes and Smoking Cessation Education Programme) 
PHASE I: Quick Assessment 
Rapport –  “What sort of smoker are you?”, “Tell me a bit about your smoking?”, 
“You may well be fed up with people lecturing about your smoking. I 
won’t do that but it would help me if I understood how you really feel 
about your smoking”  
   Motivation/Confidence to quit – On a scale of 1 – 10 
******************************************************************************************************* 
PHASE II: Patient identifies problems and solutions 
Motivation/Confidence: Useful questions: 
• “Why are you at (chosen number) and not at 1?”  
• “What would need to happen to get you from (chosen number) to (higher number)?” 
Useful strategies: 
• Pros and cons: “What you like/dislike about smoking?”  
• How can I help you get from (chosen number) to (higher number)?” Brainstorming 
• Help patient select general problem area first 
• Encourage patient to say what could work 
• DO NOT offer a solution 
• Patient chooses best option 
• Non-judgemental information regarding: 
1. Health risks- CHD, STROKE, HIGH BP, CIRCULATION, NERVE DAMAGE 
2. Services- HOSPITAL, DROP-IN CLINICS, GP, PHARMACY   
 3. NRT - PATCHES, GUM, INHALATOR, MICROTAB, LOZENGES, NASAL SPRAY 
 4. Other- ZYBAN, CHAMPIX 
********************************************************************************************************** 
PHASE III: Goals and follow-up 
Goals: Reinforce value in small gains and openness. Patient set manageable goal? 
• May relate to number of cigarettes smoked 
• May relate to factors that influence smoking 
• If not ready to set any goals, keep communication open; “Things do change«Can we 
agree to leave the door open on that one?” 
Follow-up: 
• Find out how best they think I can help them attain their goals, i.e. follow-up, support, 
NRT  
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DIABETES AND SMOKING: 
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Smoking is an independent risk factor for diabetes and can 
aggravate the risk of serious disease and premature death.  









People with diabetes are at greater risk of: 
 
 
Atherosclerosis    Angina   
 
Heart Attack      Stroke 
 
High Blood Pressure   Mini Stroke 
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What Is Atherosclerosis? 
Atherosclerosis is the hardening and narrowing of the arteries. It is caused by 
the slow buildup of plaque on the inside of walls of the arteries. Plaque is 
made up of fat, cholesterol, calcium, and other substances found in the blood. 
As it grows, the buildup of plaque narrows the inside of the artery and, in time, 
may restrict blood flow. When this happens, the organ supplied by the blocked 
artery starves for blood and oxygen. The organ's cells may either die or suffer 




What Is Angina? 
Angina is a symptom of heart disease that can cause chest pain or discomfort 
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What Is a Heart Attack?  
A heart attack occurs when blood flow to a section of heart muscle becomes 
blocked due to plaque build up. If the flow of blood isn’t restored quickly, the 





What is Stroke? 
 
A stroke can occur when the blood supply to part of the brain is suddenly 
interrupted or when a blood vessel in the brain bursts, spilling blood into the 
spaces surrounding brain cells. Brain cells die when they no longer receive 
oxygen and nutrients from the blood or there is sudden bleeding into or 
around the brain.  
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What is Retinopathy? 
 
Retinopathy is the name given to 'disease of the retina' due to diabetes. 
Blindness from retinopathy can be prevented by having regular eye checks 
and controlling sugar levels. Smoking triples the retinopathy progression rate 






What is Nerve Damage (Neuropathy)? 
 
Diabetes can cause damage to nerves throughout the body. Neuropathies 
lead to numbness and sometimes pain and weakness in the hands, arms, 
feet, and legs. Problems may also occur in the digestive tract, heart, and sex 
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Peripheral Neuropathy 
This type of neuropathy damages nerves in the 
arms and legs, hands and feet. Symptoms of 
peripheral neuropathy may include 
• numbness or insensitivity to pain or 
temperature 
• a tingling, burning, or prickling sensation 
• sharp pains or cramps  
• extreme sensitivity to touch, even a light 
touch 







Smoking significantly increases the risk of 
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YOU CAN REDUCE YOUR RISK OF DEVELOPING 
THESE COMPLICATIONS BY 
 






Smoking Cessation Advisor 
Suite B, Falkirk Royal Infirmary 
Friday mornings 9 am - 12 noon 
 
Or 
Smoking Cessation Specialist Nurse 
Hut 5, Falkirk Royal Infirmary 
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APPENDIX J  
 
factsheet no:23 
Smoking and diabetes 
  
Action on Smoking and Health – November 2002
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What is diabetes? 
Diabetes occurs when the glucose level in the blood is too high because the body 
cannot use it properly.  Glucose is a sugar that the body makes mainly from the 
carbohydrates in food.  Glucose comes from the digestion of starchy foods such as 
bread, potatoes, chapatis, from sugar and other sweet foods and from the liver 
which makes glucose   Glucose levels are controlled by the hormone insulin which 
is made and stored in the pancreas.  Insulin helps glucose to enter the cells where 
it is used as fuel by the body and consequently the amount of glucose left in the 
bloodstream goes down.  
  
Types of Diabetes 
There are two types of diabetes:  People with Type 1 diabetes (insulin-dependent) 
do not produce any insulin.  People with Type 2 (non-insulin dependent) diabetes 
do not produce enough insulin, or the insulin that the body does produce doesn’t 
work properly.  
  
Type 1 diabetes is the less common form.  This type usually develops in children 
and young adults but can occur at any age.  It is thought that Type 1 diabetes 
occurs when the body’s immune system destroys the cells that produce insulin but 
it’s not known what causes this to happen.  
  
About 90% of people with diabetes have Type 2 diabetes.  This condition tends to 
develop gradually after the age of 40.  However, increasingly, Type 2 diabetes is 
being diagnosed in younger people, including children.  It appears that this is 
largely due to the fact that individuals have less active lifestyles and an increasing 
number are overweight.   Both genetic and environmental factors contribute to the 
development of diabetes but  the development of Type 2 diabetes is more likely if 
some or all of the following factors are also present:  physical inactivity; being 
overweight; family history of Type 2 diabetes; previous diabetes in pregnancy. The 
condition is also more common in people of Asian and African-Caribbean origin. [1] 
  
Prevalence of diabetes 
In the UK, there are about 1.4 million people diagnosed with diabetes and a further 
1 million are believed to be undiagnosed.  It is estimated that there will be up to 3 
million people with diabetes by 2010.  There are about 33,000 deaths in the UK 
attributable to diabetes – about 1 in 7 of all deaths.  At least half of these deaths are 
from cardiovascular disease. [2]  
  
Health consequences 
People with diabetes are at greater risk of raised blood pressure, heart disease, 
stroke, kidney disease, nerve damage and eye complications such as retinothapy 
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(disorders of the retina). [3]    
  
Links between smoking and diabetes 
There is a growing body of evidence to suggest that smoking is an independent risk 
factor for diabetes and that among people with diabetes, smoking aggravates the 
risk of serious disease and premature death.  
  
In the US Nurses’ Health Study, 114,247 women were followed for 8 years and 
2,333 cases of type 2 diabetes were confirmed.  After controlling for multiple risk 
factors, the relative risk of diabetes was 1.42 among women who smoked 25 or 
more cigarettes a day compared with non-smokers, suggesting a moderate 
association between smoking and the subsequent development of diabetes. [4]  
A similar study of 41,810 middle aged men found that those who smoked more than 
25 cigarettes daily had a relative risk of diabetes of 1.94 compared with non-
smokers. [5]    
 A prospective study of Japanese men concluded that age of smoking initiation and 
number of cigarettes smoked were major risk factors for developing diabetes. [6]    
Similarly, data from the US Cancer Prevention Study 1 found that as smoking 
increased so the rate of diabetes increased for both men and women. [7] 
 People with diabetes already have an increased risk of heart disease, which is 
further elevated if they smoke.  Diabetes acts in several ways to damage the heart: 
high glucose levels affect the walls of the arteries making them more likely to 
develop fatty deposits which in turn makes it more difficult for the blood to circulate. 
People with diabetes are more likely to have high blood pressure and high levels of 
fats such as triglycerides.  They are also more likely to have lower levels of the 
protective HDL cholesterol. 1 
  
Insulin Resistance 
Smoking has also been identified as a risk factor for insulin resistance which can 
lead to diabetes.  People with insulin resistance cannot properly use insulin and 
such people may initially have higher than normal amounts of insulin circulating in 
their blood, a condition known as hyperinsulinemia.   
Several factors, including genetics and obesity, increase a person’s risk of insulin 
resistance and smoking has also been shown to increase the risk of this condition.  
It is believed that catecholamines, a type of hormone, are produced in greater 
quantity in smokers and act as an antagonist to insulin action. 3   A study of 40 
patients with Type 2 diabetes found insulin resistance was markedly aggravated 
among those who smoked. [8]      
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Smoking, diabetes and premature death
The elevated risk of heart disease among people with diabetes increases the risk of 
premature death.  In one study of women aged 60 to 79 who smoked and 
developed Type 2 diabetes, an estimated 65 per cent of the cardiovascular disease 
deaths among the subjects was attributed to the interaction of cigarette smoking 
and diabetes. [9]  The same study suggested that smoking may trigger fatal events 
in people with diabetes whose circulation has been compromised due to vascular 
disease, or blood vessels damaged by a combination of smoking and diabetes.  A 
large prospective study of US nurses found that among those with diabetes the 
relative risks of mortality were 1.31 for past smokers, 1.43 for current smokers of 1-
14 cigarettes per day, 1.64 for smokers of 15-34 cigarettes per day, and 2.19 for 
current smokers of 35 or more cigarettes per day. [10]   
  
The effect of smoking on complications of diabetes  
Smoking is associated with multiple complications of diabetes.  Nephropathy 
(kidney disease) has been shown to be common in Type 1 diabetic patients who 
smoke [11]  and smoking increases the risk of albuminuria in both types of 
diabetes. [12] [13] (Albuminuria refers to the presence of protein  in the urine and 
can indicate signs of kidney disease.)  Another small study of 33 people with type 2 
diabetes with kidney disease found that smokers’ kidney function declined more 
rapidly than that of non-smokers, despite drug treatment, suggesting that smoking 
cessation could slow the progression of kidney disease in people with diabetes who 
use ACE inhibitors. [14] 
  
The relationship between cigarette smoking and retinothapy (disorders of the 
retina) is less well defined than that of other microvascular complications of 
diabetes.[15]  However, some studies have found an association between smoking 
and diabetic retinopathy. [16]  11 
     
Smoking is also a documented risk factor for both the development and progression 
of various types of neuropathy (damage to the peripheral nervous system).  A 
retrospective case control study of type 1 and type 2 diabetic patients found that 
current or ex-smokers were significantly more likely to have neuropathy than 
individuals who never smoked (64.8% vs. 42.8%).[17]  A more recent prospective 
study found that cigarette smoking was associated with a 2-fold increase in 
risk.[18]     
  
Benefits of smoking cessation 
There is overwhelming evidence that stopping smoking reduces the risk of 
cardiovascular disease, lung disease, cancer and stroke. [19]  (See also ASH Fact 
sheet 11: What happens when you give up smoking.)   As diabetes increases the 
risk for heart disease and stroke, it follows that stopping smoking will reduce the 
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risk of complications from diabetes such as heart disease.   Few studies have 
evaluated smoking cessation treatment specifically for people with diabetes but the 
limited research available suggests that smokers with diabetes may be less 
successful in quitting than smokers without diabetes and that intensive strategies 
should be considered to optimise successful cessation. 15 
  
One possible explanation for the lower quitting rates among people with diabetes is 
the fact that stopping smoking is associated with weight gain and this is likely to be 
of concern in people who have diabetes and are already overweight.  One US study 
found that concerns about weight gain among smokers with Type 1 diabetes were 
particularly prevalent among women, obese smokers, and those in poor metabolic 
control. [20]  Fear of weight gain was cited by 49% of smokers.  
  
A recent British prospective study of 7,735 men aged 40-59 years found that 
cigarette smoking was associated with a significant increase in risk of diabetes, 
even after adjustment for age, body mass index, and other potential confounding 
factors.  The benefit of giving up smoking was only apparent after  5 years of 
smoking cessation and risk reverted to that of never-smokers only after 20 years.  
Men who gave up smoking during the first 5 years of follow-up showed significant 
weight gain and subsequently higher risk of diabetes than continuing smokers.  
However, the authors concluded that in the long term, the benefits of giving up 
smoking outweigh the adverse effects of early weight gain. [21] 
  
Stopping smoking also reduces the risk of premature death.  The US Nurses’ Study 
found that among women with Type 2 diabetes who had stopped smoking for 10 or 
more years had a mortality relative risk of 1.11 compared with diabetic women who 
were never smokers.10 
  
In the light of the growing evidence demonstrating that smoking is an independent 
risk factor for diabetes and that it is also an aggravating factor for diabetes 
complications, smoking cessation advice should be a routine component of diabetic 
care.  Concerns about weight gain should be addressed by health care providers 
whilst emphasising the fact that the health benefits of smoking cessation far 
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What happens when you stop smoking 
  
Action on Smoking and Health – July 2001
  
The desire to stop smoking 
Many smokers continue smoking not through free choice but because they are 
addicted to the nicotine in cigarettes.  A report by the Royal College of Physicians 
found that nicotine complied with the established criteria for defining an addictive
substance. The report states: “On present evidence, it is reasonable to conclude 
that nicotine delivered through tobacco smoke should be regarded as an addictive
drug, and tobacco use as the means of nicotine self-administration.” [1] 
  
Surveys have consistently shown that at least 70% of adult smokers would like to
stop smoking. [2] A 1999 survey found that, of those who expressed a desire to
quit, a third were very keen to stop. 2 The same survey found that the more a 
person smokes the less faith that person has that he or she can stop. The most
important element of the cessation process is the smoker's decision to quit, with the
aid or method of secondary importance.  However, those who use aids such as 
nicotine replacement therapy double their chances of successfully quitting. [3]
Smokers wishing to quit may find it helpful to telephone the national helpline on 
0800 169 0169.  Pregnant women seeking help in stopping smoking should call
0800 169 9169 where specialist counsellors are available from 1pm to 9pm, 7 days
a week, to give advice.   QUIT also operates specialist advice lines in the main 
Asian languages and in Turkish and Kurdish.    
  
BENEFICIAL HEALTH CHANGES WHEN YOU STOP SMOKING 
Stop smoking and the body will begin to repair the damage done almost 
immediately, kick-starting a series of beneficial health changes that continue for 
years. [4] 
  
Time since quitting 
Beneficial health changes that take place 
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20 minutes 
Blood pressure and pulse rate return to normal. 
 
8 hours 




Carbon monoxide will be eliminated from the body. 
Lungs start to clear out mucus and other smoking debris. 
 
48 hours 
There is no nicotine left in the body. 
Ability to taste and smell is greatly improved. 
 
72 hours 
Breathing becomes easier. 
Bronchial tubes begin to relax and energy levels increase. 
 
2 - 12 weeks 
Circulation improves. 
 
3 - 9 months 
Coughs, wheezing and breathing problems improve as lung function is increased 
by up to 10%. 
 
1 year   
Risk of a heart attack falls to about half that of a smoker. 
 
10 years 
Risk of lung cancer falls to half that of a smoker. 
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15 years 
Risk of heart attack falls to the same as someone who has never smoked. 
 
 Withdrawal symptoms 
Withdrawal symptoms are the physical and mental changes that occur following
interruption or termination of drug use. They are normally temporary and are a
product of the physical or psychological adaptation to long-term drug use,
requiring a period of re-adjustment when the drug is no longer ingested. In the




Proportion of those trying to quit who are affected 
 
Irritability / aggression -  Less than 4 weeks - 50% 
 
Depression - Less than 4 weeks - 60% 
 
Restlessness - Less than 4 weeks - 60% 
 
Poor concentration - Less than 2 weeks - 60% 
 
Increased appetite - Greater than 10 weeks - 70% 
 
Light-headedness - Less than 48 hours - 10% 
 
Night-time awakenings - Less than 1 week - 25% 
 
Craving - Greater than 2 weeks - 70% 
 
 Weight gain 
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The possibility of weight gain is often of particular concern to those who want to
give up smoking. More than 80% of smokers will gain weight once they quit 
smoking, but the long-term weight gain is on average only 6-8lbs for each smoker 
who quits. [6] However, this is the weight gain made without recourse to any 
special attempts at dieting or exercise and it presents a minor health risk when
compared to the risk of continued smoking.  In addition, improved lung function 
and some of the other health benefits of giving up smoking are likely to make 
exercise both easier and more beneficial. 
  
Pipes & cigars 
Some smokers switch to pipes or cigars in the belief that this is a less dangerous
form of smoking.  However, such smokers may incur the same risks and may even
increase them, especially if they inhale the pipe or cigar smoke. [7] 
  
Smoking cessation aids 
There are two proven pharmaceutical aids to stopping smoking: nicotine
replacement therapy and bupropion, known by its tradename, Zyban.   
 
Nicotine replacement therapies (NRT), such as chewing gum, skin patch, tablet, 
nasal spray or inhaler, are designed to help the smoker to break the habit while
providing a reduced dose of nicotine to overcome withdrawal symptoms such as 
craving and mood changes. Studies have shown that NRT roughly doubles the
chances of a smoker successfully quitting compared to someone using no therapy.
[8] 
  
Bupropion, (Zyban) works by de-sensitising the brain’s nicotine receptors and has
shown promising results in clinical trials.  The course of treatment lasts around 8 
weeks.  It is only available on prescription under medical supervision.   Zyban is 
safe for most healthy adults but there are side effects, the most serious of which is
the risk of seizures (fits).  This risk is estimated to be less than 1 in 1000 but other
less serious side effects such as insomnia, dry mouth and headaches are more
common.   An independent review by the Consumers’ Association concluded that
“when used in a specialist setting and in conjunction with regular counselling,
bupropion is at least twice as effective as placebo in helping patients to stop
smoking”. [9] 
 
Other cessation aids 
Acupuncture and hypnosis.  A review of alternative methods of aids to stopping
smoking found little evidence to support the effectiveness of either acupuncture or
hypnosis as a means of stopping smoking, but such methods may suit some
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smokers. [10]  
  
Herbal cigarettes.  These are not recommended as an aid to giving up smoking
because they produce both tar and carbon monoxide. Some brands have a tar 
content equivalent to tobacco cigarettes. In addition, the use of herbal cigarettes
reinforces the habit of smoking, which smokers need to overcome. 
  
Clinics and self-help groups.  Smokers who are motivated to quit the habit may 
benefit from cessation clinics or self-help groups, although smokers should be 
cautious about claims of high success rates made by some clinics. A review of
smoking cessation products and services found that smokers are up to four times
more likely to stop smoking by attending specialist  smokers’ clinics than by using 
willpower alone. [11]   As part of the Government’s review of the NHS, more
smoking cessation clinics are being established by health authorities and primary
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APPENDIX L 
Nicotine Replacement Therapy (NRT), Zyban and Champix 
 
ALWAYS CHECK THE SUITABILITY OF NRT, ZYBAN AND CHAMPIX 
WITH YOUR GP OR PHARMACIST, AS IT WILL BE USED WITH 
DIABETES MEDICINES. 
 
Nicotine Replacement Therapy (NRT), Zyban and Champix are products that 
are used to help smokers quit. They are not cures but they do make it easier 
to stop. 
 
Smokers using NRT, Zyban or Champix are twice as likely to quit as smokers 
who do not. NRT, Zyban and Champix are available on prescription from your 
GP and most types of NRT can also be bought over the counter from your 
local Pharmacy. 
 
NRT, Zyban and Champix are most effective when used with support. e.g. 
The Diabetes and Smoking Cessation Education Programme. However you 
will still need lots of willpower and determination to quit smoking.  
 
What is NRT? 
NRT products contain nicotine but not the disease causing tar or carbon 
monoxide found in tobacco smoke. Different types of NRT are available: 
 
• Skin Patches – Look like sticking plasters and are stuck onto the skin. 
The nicotine is absorbed through the skin.  
• Chewing Gum – Chewed carefully and rested between teeth and gum. 
Nicotine is absorbed through the mouth lining.  
• Inhalator – Looks like a plastic cigarette and is inhaled like a cigarette. 
Nicotine is absorbed through the mouth and throat lining. 
• Microtab – Tiny nicotine pills which are allowed to dissolve in the 
mouth. Nicotine is absorbed through the mouth lining. 
• Lozenge – Large nicotine pills which dissolve in the mouth. Nicotine is 
absorbed through the mouth lining. 
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• Nasal Spray – A nicotine mist is sprayed into the nose and is absorbed 
through the nasal lining. (This is available by prescription only and is 
not commonly used). 
How Does NRT Work? 
NRT gives you a lower dose of nicotine than tobacco smoke but without the 
harmful effects of tar and carbon monoxide. It provides your body with a safe, 
regular dose that prevents or reduces the urge to smoke.  
 
You will not get the same ‘hit’ as you get from a cigarette, because the 
nicotine takes longer to be absorbed than from inhaled tobacco smoke. 
 
Most NRT products are designed to be reduced over time, to wean you off 
nicotine. 
When Do I Start NRT? 
You should start NRT on your quit day. For the first week use the full dose.  
All types of NRT (except the patches which are left on all day) should be 
taken every hour, about 15 times a day. You can top up in between if you feel 
you need more, as it is important to use enough NRT to prevent you smoking. 
Is NRT Safe? 
NRT is very safe. It does not cause cancer and has no long-term adverse 
effects. 
Will I Get Addicted To NRT? 
NRT will not cause addiction, as you are already addicted to nicotine. While 
using NRT you will switch your addiction from cigarettes to the NRT itself. 
This is safe and you will gradually reduce your use of NRT over time to wean 
yourself off it.  
What Happens If I Smoke When Using NRT? 
Smoking with NRT is not dangerous, as you won’t overdose on nicotine. 
However, to be successful the programme asks participants not to smoke at 
all when using NRT.  
 
If you are smoking occasionally it may be that you need a higher dose of NRT 
to reduce withdrawal symptoms. (e.g. Heavy smokers may need to use a high 
strength patch and a supply of gum, Microtabs or lozenges to get through the 
bad times).  
Matriculation Number: 050008241  Doctoral Thesis 
Professional Doctorate in Health Psychology 2014 214  
If you are smoking regularly then this quit attempt will be unsuccessful. Stop 
taking the NRT and leave it at least six months before you make another quit 
attempt. This break is important as it enables you to recover before making a 
second attempt.  
Can NRT have side effects? 
Side effects can occur: 
 
Patches cause reddening of the skin where they’ve been worn. They may 
also cause sleep disturbances. (Removing your patch before you go to bed 
can reduce this). 
Chewing Gum can cause throat irritation and indigestion. 
Inhalators, Microtabs and Lozenges can all irritate the throat and mouth. 
Nasal Sprays can irritate the nose and throat. 
 
It takes a few days to get used to using any NRT product. However most side 
effects are minor and will improve over time.  
How Long Should I Use NRT For? 
NRT should be used for 2 – 3 months, but you can continue to use it for as 
long as you feel you need it. However, you will only get a prescription for the 
first three months, after that you will have to pay the full amount for your 
treatment. After they’ve quit, many people find that it helps to keep some 
nicotine gum, Microtabs or lozenges in their pocket or handbag for 
‘emergencies’. 
Are There Long Term Risks With NRT? 
NRT is very safe and can be continued for long periods of time if necessary. 
 
Who Can Use NRT? 
Almost all smokers can use NRT, but only the Microtab is licensed for use in 
pregnancy. Smokers who smoke less than 10 cigarettes a day may find that the 
gum, Microtabs or lozenges suit them best as they can be taken when needed 
after the first week of quitting. (During the first week it is recommended that the 
full dose be taken. This means using the gum, lozenge or Microtab every hour, 
about 15 times a day).  
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What Types Of NRT Are Available? 
Product Dosage Pros Cons 
16-hour PATCH 
Designed for wearing 
during the day. 
Best used for 8 -12 
weeks 
(Use for at least 4). 
Amount of nicotine in each patch 
varies for each manufacturer but 
there are usually 2 or 3 different 
sizes.  Start with the largest patch 
and change to smaller patches 
over a 2-3 month period.   
Easy to use – put on in the morning and 
remove at night.  
Very discreet. No one need know. 
Good for heavy smokers who can ‘top 
up’ using gum, Microtabs or lozenges.  
Might find you have early morning cravings.  
No oral satisfaction.  
Possible skin reaction. 
Takes 4-8 hours to reach a steady level. 
Can be used in any workplace.  
24-hour PATCH 
Wear constantly during the 
day and night. Remove old 
patch and apply new one 
every morning. Used for 8 
-12 weeks (Use for at least 
4). 
Amount of nicotine in each patch 
varies for each manufacturer but 
there are usually 2 or 3 different 
sizes.  Start with the largest patch 
and change to smaller patches 
over a 2-3 month period. 
Easy to use – Remove old patch and 
replace with a new one every morning. 
Helps to avoid cravings first thing in 
Morning. Good for heavy smokers who 
can ‘top up’ using gum, Microtabs or 
lozenges. 
Some users experience sleep disturbances (vivid 
dreams or nightmares). 
No oral satisfaction.  
Possible skin reaction. 
Takes 4-8 hours to reach a steady level. 
Can be used in any workplace. 
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GUM 
Use for at least 4 weeks 
then whenever you feel you 
need it. 
2mg or 4mg.
Use at least 15 pieces a day for 
the first week. Then gradually cut 
down. 
Ensure you are using the correct 
chewing technique. 
Use as and when required. Fairly 
discreet. 
Easy to carry with you for emergencies 
and difficult times both during and after 
quitting. 
Good for light to moderate smokers (or 
used in conjunction with patches for 
heavy smokers). 
Some people don’t like the taste, as it is a medicine 
not a sweet.  Others don’t like using gum as it takes a 
long time to chew. Nicotine absorbed through mouth 
lining therefore you should not swallow or it is wasted. 
Unsuitable for use in workplaces where eating is not 
allowed on duty. (E.g. Working with chemicals, food 
manufacturing, call centres, etc) 
SPRAY 
Use for 8 weeks then 
reduce dose for 2 weeks. 
 
Can be used once or twice and 
hour for first week (no more than 
40 doses in 24 hours) then 
gradually cut down. 
 
Fast relief for heavy smokers with easy 
control of dose. 
Can feel self-conscious using it in public. Can cause 
irritation to the nose. More likely to lead to 
dependence. 
Only available on prescription - some GP’s unlikely to 
prescribe. May be difficult to use in public workplaces 
(E.g. shops). Unsuitable for use in workplaces where 
eating is not allowed because of risk of contamination 
(E.g. working with chemicals or food manufacturing, 
etc).   
INHALATOR 
Use for 8 weeks then 
reduce dose for 2 weeks. 
6-12 cartridges for first eight 
weeks then 3-6 for two weeks, 
reducing to 0 over the next two 
weeks.  
Keeps your hands and mouth occupied 
and easy to control dose. 
Can feel self-conscious using it in public. Not 
recommended for heavy smokers. Can maintain the 
habit of putting cigarette substitute in the mouth.  
Unsuitable for use in workplaces where eating is not 
allowed on duty. (E.g. Working with chemicals or food 
manufacturing, etc).  
MICROTAB/ 
LOZENGE 
Use for 12 weeks then 
gradually reduce dose.  
8-24 per day depending on 
whether a heavy or light smoker. 
(Use at least 15 pieces a day for 
the first week). 
Very discreet and easy to control dose. 
Side effects minimal. 
Microtab is the only NRT licensed for 
use with pregnant women. 
Some people don’t like the taste, as it is a medicine 
not a sweet. Must not swallow or nicotine is wasted.  
Unsuitable for use in workplaces where eating is not 
allowed on duty. (E.g. Working with chemicals or food 
manufacturing, etc).  
Zyban (Bupropion) 
What Is Zyban? 
Zyban is a drug that has been shown to reduce the urge to smoke and has  
been licensed to help people to quit smoking. 
 
How Does It Work? 
Zyban was originally developed as an antidepressant. In low doses it was 
found to be effective in helping people to quit smoking. Zyban reduces the 
desire to smoke and some withdrawal symptoms associated with stopping 
smoking. It is believed that it does this by acting on pathways in the brain that 
play a key role in nicotine addiction. 
 
When Do I Start Using Zyban? 
You start taking Zyban at least a week before you plan to stop smoking as it 
takes a while to have an effect.  
 
Is Zyban Safe? 
Zyban is available on prescription from your GP and is safe and effective 
when used correctly. However, there are some side effects: Approximately 1% 
of users will experience mild side effects such as insomnia, headaches or dry 
mouth. Zyban can also cause a slight sense of disorientation, so beware of 
this if driving or operating machinery.  These mild effects usually reduce over 
time. Rare but serious side effects can also happen, including seizure (fits), 
rashes and severe allergic reactions. If these occur then you must stop using 
Zyban immediately. Zyban may also react with other medicines including 
some that can be bought over the counter from Pharmacies. Therefore always 
tell your Pharmacist that you are using Zyban before buying any medicines.  
 
How Long Should I Use Zyban For? 
In total a 9 Week course of Zyban is given. For the first 6 days, one 150 mg 
tablet is taken per day. From day 7 this is increased to two 150mg tablets per 
day, taken 8 hours apart. As the drug starts to take effect the desire to smoke 
is reduced. Patients can quit smoking anytime from day 7 to day 14.  
 
Your GP will give you a prescription for the first 2 – 4 weeks and will check 
that you are not experiencing problems with it before prescribing any more.   
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Is Zyban More Effective Than NRT? 
Current research indicates that Zyban and NRT are equally effective at 
helping smokers quit. 
 
Who Can Use Zyban? 
Many people can safely use Zyban but it is not suitable for all people. It is not 
recommended for: Pregnant or breast-feeding women. Young people aged 
under 18. Patients with a history of epilepsy or seizures (fits). Patients with a 
history of head injury. Patients with a history of tumour of the brain or spinal 
column. Heavy drinkers or patients undergoing alcohol withdrawal. Patients 
withdrawing from benzodiazepines (a type of tranquillizer). Patients with 
eating disorders. Patients with cirrhosis of the liver. Patients with bipolar 
disease (manic depression). Patients taking monoamine oxidise inhibitors 
(MAOI’s - a type of antidepressant). Patients with diabetes. Elderly people or 
those with impaired liver of kidney function can use Zyban, but in a reduced 
dose. (Only one 150 mg tablet is taken per day throughout the course of 
treatment). The use of certain other drugs or the presence of other medical 
conditions may also mean that Zyban cannot be taken. Your GP will advise.  
 
Champix (Varenicline) 
What is Champix? 
Champix is the trade name of a drug called varenicline. It is a non-nicotine 
based medicine designed to help people stop smoking. It is available as a 
tablet, usually taken once a day at a lower dose for the first few days building 
up to a stronger dose taken twice a day after a week. People start taking it 
one to two weeks before they plan to stop smoking, and it is usually taken for 
about three months. 
 
What does it do? 
Champix can help reduce the cravings and withdrawal symptoms associated 
with stopping smoking.  Also if someone taking Champix smokes a cigarette 
they may find it less satisfying and less pleasurable than before, which can 
reduce the risk of a complete relapse. 
 
Does it work? 
Published research shows that Champix does increase a smoker’s chance of 
stopping smoking. The results from these studies are very encouraging, but 
more research is needed. Based on the available evidence Champix has been 
licensed for use in the NHS in Scotland as a prescription option. 
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Where can I get it? 
Champix is available on prescription in Scotland from your doctor. 
 
Can anyone use it? Champix is not recommended for: 
• Children under the age of 18 
• Pregnant women or during breast-feeding 
• Anyone who may be allergic to varenicline or any of the other 
ingredients 
• Champix should be used with caution in people with kidney disease 
 
It’s important that you tell your doctor what other medicines you are taking 
(including those bought without a prescription) before Champix is prescribed 
for you, and to tell your doctor or pharmacist that you are taking Champix 
before you take any new medicines. 
 
Are there side effects? 
Some people may experience nausea (feeling sick), difficulty sleeping, 
abnormal dreams or headaches. People who experience side effects should 
seek their doctor’s advice, since this is a new drug it is especially important 
that you report any side effects. 
 
How does Champix compare with Nicotine Replacement Therapy and 
Zyban? 
Research shows that the best success rates for stopping smoking are 
achieved through specialist advice and support from trained professionals in 
combination with the use of stop smoking medications. Champix, NRT and 
Zyban have all been shown to work in helping people to stop smoking. In 
clinical trials Champix was found to be more effective than Zyban in helping 
patients to stop smoking. NRT can be bought over the counter and is also 
available on prescription, while Champix and Zyban are only available on 
prescription. Your doctor or pharmacist will be able to advise which is the 




Stopping smoking is the best thing that you can do for your health.  
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APPENDIX M   - HOW TO STOP SMOKING AND STAY STOPPED –  
(NHS BOOKLET SUBMITTED IN HARD COPY) 
 
 
APPENDIX N - READY TO STOP SMOKING? WHERE TO FIND HELP 
NEAR YOU –  
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APPENDIX O - PARTICIPANT DEBRIEF LETTER 
Forth Valley NHS Board 
Diabetes Care Centre 











Our Ref     Diabetes and Smoking Cessation Education 
Programme 
Enquiries   Margaret-Anne MacMillan 
Extension 6094 
Tel 01324 616041 
  
Dear   
Diabetes and Smoking Cessation Education Programme 
I would like to thank you for participating in the Diabetes and Smoking Cessation Education 
Programme in Falkirk Royal Infirmary and for completing the somewhat lengthy 
questionnaires throughout the programme. Twenty-nine with Type 2 diabetes who smoked 
cigarettes took part. This letter is to inform you of the results.  
The study was investigating whether participants believed their smoking and blood sugar 
control was under their own control (internality) or under the control of significant others, for 
example, doctor, nurse, (externality) and aimed to motivate participants to move toward taking 
control of their own health outcomes through the education programme, where appropriate. 
The study achieved this to some extent but not to significant levels. Previous research 
suggests that people demonstrating internality are more likely to take medicine and attend 
appointments.  
The study found that participants’ blood sugar levels had significantly reduced to nearer 
recommended levels, particularly among female participants. Carbon monoxide levels had 
also significantly reduced. The group were more motivated and more confident to stop 
smoking and disliked more about their smoking behaviour. Female participants were more 
concerned about smoking than the male participants were. Another significant result was in 
participant awareness of smoking cessation services and smoking cessation products that 
can help a quit attempt.  
The information collected during the study will be used to write a thesis which satisfies one of 
the competencies of the professional doctorate in health psychology. You have my personal 
guarantee that all of the information will be used anonymously and that none of your personal 
information be disclosed.  
Should you have any questions please contact me on 01324 616041 ext 6094. 
Yours sincerely 
Margaret-Anne MacMillan 
Trainee Health Psychologist, Queen Margaret University 
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Abstract 
 
Aim: To critically appraise the evidence for the effectiveness of behaviour change 
interventions that support good glycaemic control and smoking cessation. 
 
Background: The World Health Organisation (WHO) has projected the prevalence of 
diabetes will double to an estimated 300 million people by 2025. Several studies suggest that 
smoking is associated with the development of diabetes and that insulin resistance is 
markedly aggravated among those who smoke. The major cause of morbidity and mortality 
associated with diabetes is from atherosclerotic macrovascular disease, which is intensified if 
the patient is a smoker. There is limited evidence for smoking cessation interventions aimed 
at patients with diabetes. 
 
Methods: A systematic literature review was conducted using the following major inclusion 
criteria: systematic reviews and meta-analyses, randomized controlled trials with definitive 
and non-definitive results, cohort studies, case-controlled studies, cross-sectional surveys, 
case-reports, observational study, Type 2 diabetes, glycaemic control, smoking locus of 
control, perceived control of diabetes, motivational interviewing, adults over 25 years of age.  
Two reviewers independently assessed methodological quality using the Scottish 
Intercollegiate Guidelines Network (SIGN) critical appraisal checklist. 
 
Results: The search strategy identified 4 smoking cessation intervention studies aimed at 
people with diabetes with a total of 940 participants, the majority being male. The timescale of 
the interventions ranged from 6 months to 4 years. The evidence ranged from 1+ to 1++ 
(SIGN, 2001). Statistically significant effects were found across all 4 studies suggesting that 
interventions are effective in raising awareness of the associated health risks and for initiating 
health behaviour change. The review found higher efficacy among interventions where those 
involved in delivery received training in smoking cessation and motivational interviewing 
techniques. 
 
Conclusions: The review forms an evidence base for the efficacy of smoking cessation 
interventions aimed at people with diabetes. The results are presented in terms of 
recommendations for those developing interventions and directions for future research.  
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Introduction 
 
As a result of an aging, increasingly obese and decreasingly physically active 
population, the global incidence and prevalence of diabetes mellitus is 
exploding (Eschwege et al., 1997; King et al., 1998; Boyle et al., 2001). Type 
2 diabetes mellitus represents 90% of all cases. The medical and public 
health challenges are further compounded by the observation that patients 
with diabetes have considerable risk for cardiovascular disease (CVD) with up 
to 80% of deaths attributable to CVD (Harris et al., 1987). 
 
The World Health Organisation (WHO) has projected that the prevalence of 
diabetes will double over the next 22 years to an estimated 300 million people 
by 2025 (King et al., 1998). Sadly it is feared that these figures are grossly 
underestimated (Harris et al., 1987; Saydah et al., 2001; Taubert et al., 2003).  
 
Where the health of patients with diabetes who smoke cigarettes is 
concerned, the statistics are much worse. Several prospective cohort studies 
suggest that smoking is associated with the development of diabetes (Rimm 
et al., 1993; Rimm et al., 1995; Kawakami et al., 1997). Further evidence 
suggests that insulin resistance is markedly aggravated among those who 
smoke. It is believed that catecholamines are produced in greater quantities in 
smokers and act as an antagonist to insulin action (Targher et al., 1997).  
 
 
The major cause of morbidity and mortality associated with diabetes is from 
atherosclerotic macro vascular disease, which is intensified if the patient is a 
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smoker. The combination of smoking and diabetes appear to heighten the 
development of macro vascular complications (UKPDS, 1991; Yudkin, 1993). 
 
Changing these behaviours can reduce the risk of developing diabetes and 
delay the onset of long-term complications. Health locus of control has been 
shown to be related to whether an individual changes their health behaviour 
and moreover, to the communication style of the health professional. It is 
generally assumed that those who believe that they have control over their 
health will be more likely to perform a range of health promoting behaviours 
which in turn may reduce the patients risk of developing long-term 
complications (Rotter, 1966). 
 
Patient ambivalence to behaviour change is a common problem faced by 
health care professionals (Rollnick, Heather and Bell, 1992). The main focus 
of motivational interviewing (MI) is facilitating behaviour change by helping 
patients to explore and resolve their ambivalence about their behaviour 
change (Rollnick and Miller, 1994) and consultations are more successful 
when there is a sharing of ideas (Tuckett et al., 1985). MI appears consistent 
with a number of models of health behaviour including Locus of Control 
(Rotter, 1966). The greatest support for the efficacy of MI applied to health 
behaviour change is from smoking cessation studies (Stotts et al., 2002; 
Valanis et al., 2001; Eammonns et al., 2001).  
 
Previous research reports that Internal Health Locus of Control is the pivotal 
Health Locus of Control belief when predicting health behaviours (O’Hea et 
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al., 2005) and these findings are supported by Gillibrand and Stevenson 
(2006), in a study of patients with diabetes. ASH Scotland advises, ‘In the light 
of the growing evidence demonstrating that smoking is an independent risk 
factor for diabetes and that it is also an aggravating factor for diabetes 
complications, smoking cessation advice should be a routine component of 
diabetic care’(ASH, 2002).  
 
Few studies have evaluated the effectiveness of health behaviour change 
interventions for patients with diabetes who smoke, that help them quit 
smoking. However, there is evidence to suggest that a structured intervention 
managed by a single smoking cessation/behaviour change advisor is effective 
in changing the smoking behaviour of patients with diabetes (Canga et al., 
2000; Glasgow, 2000).  
 
This review aims to evaluate the effectiveness of health behaviour change 
interventions specifically aimed at motivating patients with Type 2 diabetes to 






As this study has a narrow, specific research question, the research design 
chosen is a systematic review of the literature (Cook and Mulrow et al., 1997). 
Systematic reviews use explicit and reproducible methods in an attempt to 
reduce reviewer bias (Collins and Fauser, 2005). Systematic reviews do 
however have a number of limitations. The quality of the review findings are 
dependent on the quality of the literature being reviewed (Kunz and Oxman, 
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1998). The studies included in a systematic review should if possible be of 
high methodological quality and free from bias to allow any differences in 
outcome measures to be confidently attributed to the intervention being 
examined (Kunz and Oxman, 1998; Egger and Dickinson et al., 2001). The 
comprehensiveness of the literature search is also a crucial factor in the 
quality of a systematic review.  
 
Intervention 
Interventions of interest were ones where glycaemic control and smoking 
cessation were components of the intervention and also behaviour change 
interventions that were derived from perceived control of diabetes and 
smoking locus of control. 
 
Participants 
The review considered studies that included adults aged 25 years and over 
who had Type 2 diabetes and smoked cigarettes regularly.  
 
 
Type of study 
Randomised controlled trials, prospective studies and controlled trials were 
included in this review. There is general consensus that well planned and 
properly executed randomised controlled trials provide strong evidence on the 
efficacy of health behaviour change interventions (Jadad, 1998; Watson et al., 
2002). However, with so few studies available regarding smoking cessation 
interventions for people with diabetes other methodologies were included, for 
example, non-randomized controlled trials such as prospective studies can 
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often represent the best available evidence and can give an estimate of the 
nature, direction and size effects on which future research could be based 
(Petticrew and Roberts, 2006) 
 
Outcome measures 
Smoking cessation and glycaemic control within recommended levels were 
the outcome measures of the studies included in this review. 
 
Electronic databases 
Before the main search was conducted a small pilot search was carried out to 
test the effectiveness of the proposed search terms. Trial and error methods 
and the advanced search and thesaurus were used to modify the search 
terminology. The final search terms used were: smoking cessation 
intervention, smoking cessation programme, Type 2 diabetes, randomized 
controlled trial. For a more comprehensive list and overview of the process, 
please see the search strategy (Appendix A, pg39) and flowchart of the review 
process (Appendix B, pg41) 
.  
As different databases have different strengths and weaknesses and to 
increase coverage, more than one database was selected to carry out the 
final search. Searches were carried out electronically on PsychInfo, Cochrane 
Library, Cinahl, PubMed, Medline, Science Direct, British Medical Journal, 
Lancet, Science Direct, Diabetes UK and ASH. Each of these databases were 
searched from 1989- 2009.  
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Searching by hand 




Information about the individual study characteristics included in the review 




Quality was assessed independently by two reviewers. The Scottish 
Intercollegiate Guidelines Network (SIGN 50) critical appraisal checklists and 
accompanying notes were used in this review to critically appraise the 
identified studies (SIGN, 2001). The SIGN critical appraisal tool was chosen 
because it provides a checklist for assessing the methodological quality of 
randomised controlled trials and gives an overall indication of the level of 
evidence provided through the use of a grading system which takes into 
consideration the complexity of the relationship between study type and 
quality. The methodological quality of the studies included judgements on: the 
randomisation process; allocation concealment; blinding; and the percentage 
of participants followed up, Table 1. Discussion between the two reviewers 
was used to resolve any differences in grades. In addition, a third reviewer 
was available in case disagreements could not be resolved.  
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Table 1: Methodology checklist and coding system (SIGN, 2001) 
Checklist: 
1. The study addresses an appropriate and clearly focused question. 
2. The assignment of subjects to treatment groups is randomised 
3. An adequate concealment method is used 
4. Blinding 
5. The treatment and control groups are similar at the start of the trial. 
6. The only difference between groups is the treatment under investigation. 
7. All relevant outcomes are measured in a standard, valid and reliable way. 
8. What percentage of the individuals or clusters recruited into each treatment arm of 
the study dropped out before the study was completed? 
9. Intention to treat analysis 
10.  Results are comparable for all sites (where the study is carried out at more than one 
site). 
Coding system: 
1++ All or most of the criteria have been fulfilled 
1+ Some of the criteria have been fulfilled 






A total of 7 potentially relevant articles were identified and screened for 
retrieval. These were then assessed to see whether they met the inclusion 
criteria or not. A total of 3 articles were then excluded for a number of reasons 
including: methodology reasons; benefits of smoking cessation to diabetes 
were not an outcome measure; study focussed more on smoking with little 
mention of diabetes. This process of attrition left 4 articles. The 4 articles 
included in this review are detailed in Table 2. 
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A total of 940 participants aged between 30 years and 75 years of age were 
included in the studies, with 640 of them being male. The studies were global 
and originated in Australia (Fowler et al., 1989), Denmark (Gaede et al., 
2001), Spain (Canga et al., 2000) and Sweden (Persson and Hjalmarson, 
2005). All of the participants had a clinical diagnosis of diabetes mellitus and 




The length of the intervention periods ranged from 6 months to 4 years. There 
was considerable variation in the type of intervention and in the amount of 
information the authors provided.   For example, in one study the participants 
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were not only randomized into control and intervention groups but also 
randomized into newly diagnosed with diabetes groups and pre-existing 
diabetes groups. These groups were then randomized further into one of two 
treatment groups where the study not only investigated the effects of the 
content of the anti-smoking programme but also the effects of the timing of the 
invitation to join the programme. The intervention lasted 6 months and 
involved face-to-face patient education using a portable visual display unit of 
coloured photographs. There is no description of what these photographs 
were or how and when they were used.  Nonetheless, smoking cessation was 
validated by plasma cotinine levels (Fowler et al., 1989). 
 
In another study participants were randomized into a control group or an 
intervention group lasting 4 years. There was no further randomization which 
made this study much easier to follow. However, smoking cessation was 
measured by self-report and no biomedical markers such as cotinine levels or 
carbon monoxide levels were measured (Gaede et al., 2001). 
 
There was also considerable variation in the training and expertise of the 
health professionals delivering the interventions. For example, Fowler et al., 
(1989) do not mention the level of training required to deliver the 
Smokescreen programme whereas participants in the lifestyle education 
programme (Gaede et al., 2001) were invited to take part in a standardized 
smoking cessation programme delivered by specialists who were already 
trained in smoking cessation techniques.  
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Canga et al., (2000) and Persson and Hjalmarson, (2005) differ to the 
previous studies. They factored smoking cessation training into their protocol 
although to varying degrees. Canga et al., (2000) report that the nurse 
delivering the intervention in their study spent two months studying the 
scientific literature on counselling on smoking cessation and had three weeks 
of practical training of her counselling skills by giving advice on smoking 
cessation to colleagues. Persson and Hjalmarson (2005) report that the nurse 
in their study received one half-day of training on motivational interviewing 





An overview of the methodological quality assessments of the studies is 
presented in Table 3.  All of the studies had appropriate and clearly focussed 
questions and within each population the groups were similar at baseline. In 
these studies as with many public health studies, blinding of the participants 
and of those delivering interventions can be difficult. However, blinding of the 
outcome assessors should still have been possible. In only one study blinding 
was rated as ‘well covered’,  (Canga et al., 2001), in two studies it was rated 
as ‘not applicable’ (Gaede et al., 2001; Persson and Hjalmarson, 2005) and in 
the final study blinding was ‘not addressed’, (Fowler et al., 1989). 
 
With regard to drop-out rates and participants lost to follow-up the numbers 
varied greatly. They are particularly high in the anti-smoking programme with 
14/16 lost to follow-up according to the timing of joining the programme and 
29/34 lost to follow-up according to the content of the anti-smoking 
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counselling (Fowler et al., 1989). In contrast the remaining three studies 
experienced very low attrition. The lifestyle education programme lost 11/149 
participants (Gaede, et al ., 2001), the intervention study lost 2/280 
participants (Canga et al., 2000) and the intervention study in primary 
healthcare lost 21/368 participants (Persson and Hjalmarson, 2005). It should 
be noted that in some cases participants withdrew voluntarily or were lost to 
follow-up and in some instances they passed away. 
 
Overall two studies were rated ‘1++’ and two studies were rated ‘1+’. 
Table 3: Overview of methodological quality 
Author 
(date) 
1 2 3 4 5 6 7 8 9 10 Level of 
evidence

















































WC = Well covered, AA – Adequately addressed, PA – Poorly addressed, NAD – Not 
addressed (i.e. not mentioned, or indicates that this aspect of study design was ignored), NR 
– Not reported (i.e. mentioned but insufficient detail to allow assessment to be made). NA – 
Not applicable 
 





All four studies report statistically significant effects, more so those where 
intervention groups were compared to control groups. Fowler et al., (1989), 
found that the timing of the invitation to join the anti-smoking programme for 
patients with diabetes had a significant effect. Agreement to participate was 
higher in the group invited two months after the diagnosis of diabetes with 
attrition significantly higher in the group approached to join without delay 
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following diagnosis (p<0.02).  According to the self-reported data, cigarette 
consumption fell after the first session of the anti-smoking programme but 
could not be validated by the plasma cotinine measurements. Nor was the 
reduction statistically significant. 
 
The results of the lifestyle education programme conducted in Denmark report 
a statistically significant effect of diet intervention but not for exercise and 
smoking cessation (Gaede et al, 2001). The decrease in total fat intake was 
significantly higher in the intervention group than it was in the control group. 
The intake of saturated fats decreased significantly in the intervention group 
as did the increase of polyunsaturated fatty acids intake. Six participants from 
the intervention group stopped smoking and had remained stopped by the 
end of the study as did five participants from the control group. Although 
welcome outcomes in themselves, these findings were not reported, as 
changes in smoking habits were not found to differ between groups.  
 
The well conducted intervention study for smoking cessation in patients with 
diabetes (Canga et al, 2000), found that at 6-month follow-up, the incidence of 
smoking cessation was 17% in the intervention group compared with 2.3% in 
the control group. This was a 14.7% difference (95% CI 8.2 – 21.3%). A 
significant reduction was found in cigarette consumption at 6-month follow-up 
among participants who had continued to smoke. The mean number of 
cigarettes smoked per day in the intervention group decreased from 20 at 
baseline to 15.5 compared to 19.7 to 18.1 in the control group (p < 0.01).  
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The study by Persson and Hjalmarson (2005), also found statistically 
significant differences between the intervention group and the control group. 
At 12-month follow-up 20% of participants in the intervention centres and 7% 
of participants in the control centres had stopped smoking (p < 0.01). 
Smokers who participated in group treatment reported 40% smoking 
cessation whereas smokers in the intervention group who did not take part in 
the group treatment reported 14% smoking cessation. This result is 
significantly lower than for group treatment (p < 0.01). 
 
Although the studies found statistically significant outcomes for smoking 
cessation, Fowler et al., (1989), did not find the anti-smoking programme to be 
cost effective.  They found the intervention to be extremely time-consuming 
and suggest that such an intervention may be beyond the financial resources 
available to most specialist diabetes departments. The study recommends 
that patients with diabetes be encouraged to attend a community-based 
specialist smoking cessation programme.  
 
This is the format that Gaede et al’s., (2001), lifestyle education intervention 
followed which may account for the impressive 43% smoking cessation 
success rate at 2-year follow-up. 
 
Although the intervention study conducted by Canga et al (2000), does not 
mention cost effectiveness per se, they acknowledge that their protocol was 
also very time-consuming. This may indicate that the intervention was not cost 
effective to implement.  
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Discussion 
 
The aim of this systematic review was to critically appraise the evidence of the 
effectiveness of smoking cessation interventions for patients with diabetes 
mellitus. Four studies were identified from the literature search, 1 prospective 
study, 2 randomized controlled trials and 1 controlled study and appraised for 
methodological quality. Smoking cessation and lifestyle interventions were 
found to be effective in motivating people with diabetes to stop smoking. 
However, the evidence suggests that the outcomes may be dependent on the 
timing of the intervention, who delivered the intervention and their level of 
training, location, the health professionals’ commitment to the intervention in 
terms of both time and resources, and the commitment of the participants 
(Fowler et al, 1989; Gaede et al, 2001; Canga et al, 2000; Persson and 
Hjalmarson, 2005).  
 
More importantly, what is evident from these articles is the lack of a patient-
centred approach and a psychological focus. The lifestyle interventions and 
education programmes measure smoking cessation outcomes and report that 
stopping smoking may reduce the risk of developing the long-term 
complications associated with diabetes. Three of the present studies do not 
allude to psychological elements or measure psychosocial outcomes even 
although Gaede et al., (2001) advise that a psychologist was involved in 
planning the lifestyle education programme. Canga et al., (2000), did use the 
Stages of Change model in their study to measure participant attitudes toward 
smoking cessation but apart from this there is no psychological component 
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such as motivation to stop smoking or confidence to maintain behaviour 
change.  
 
Motivation and confidence are key concepts when using motivational 
interviewing techniques as are readiness to change behaviour and resolving 
ambivalence (Rollnick et al., 1992). The nurse in the intervention study 
conducted across Sweden received one half-day training in motivational 
interviewing and smoking cessation, however, according to the results, none 
of these concepts were measured or reported (Persson and Hjarmarlson, 
2005). 
 
Psychology and Diabetes 
 
 
In the past diabetes and psychology were not always thought of as being 
complementary. This perspective is changing and with the use of psychology, 
the experience of the individual self-managing diabetes can be greatly 
improved. The role of the psychologist is useful when the individual with 
diabetes is required to change their lifestyle and adopt health enhancing 
behaviours, sometimes almost overnight. These changes may include moving 
from a sedentary lifestyle to an active one with more exercise, swapping 
unhealthy food for healthy food and stopping smoking. It will certainly include 
blood glucose monitoring.  
 
The procedures required to monitor blood sugar levels and control diabetes 
can be very complicated and time-consuming and for many people can be 
overwhelming. As the majority of diabetes treatment is self-managed outside 
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the medical setting serious problems can result if the person lacks motivation 
and confidence. Their condition can deteriorate and result in amputation of 
limbs or blindness (Bradley, 1994).  
 
In addition to the behavioural demands of diabetes emotional and social 
problems can arise. Diabetes is often perceived as a burden by those 
affected. It can be hard to accept the disease and feeling overwhelmed can 
result in depression. Individuals can become anxious through fear of 
complications or hypoglycemia and can become frustrated with the demands 
of self-management.  
 
Social problems can result from diabetes as well. Many individuals who do not 
have diabetes can find it difficult to understand the needs of someone with 
diabetes. The knowledge, beliefs and behaviours of people with diabetes and 
their health care professionals may all affect diabetes control. Psychological 
perspectives can therefore be valuable in enhancing self-management.  
Several important interventions have been developed and evaluated by multi-
disciplinary teams that include psychologists (Norris et al., 2001; Ismail et al., 
2004).  
 
The DAFNE study highlighted the benefits of measuring psychological 
outcomes in its evaluation of the diabetes education and training programme 
developed by Mulhauser’s team and found that psychological outcomes 
improved markedly with glycaemic control. When only metabolic outcomes 
such as blood sugar levels are measured, health care professionals and 
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funding bodies may value new treatments if only blood sugar control 
improves. There may be little or no emphasis placed on psychological 
improvements and these therapies may not be offered as they are not 
deemed important. (DAFNE Study Group, 2002).  
 
Generic measures focus on health and illness rather than the impact of 
diabetes. For example, measures of perceived health cannot be expected to 
detect diabetes related quality of life impairments or the psychological angst 
often associated with the demands and restrictions of long-term self-
management and the risk of developing long-term complications. (Bradley 
1994).  
 
In contrast, questionnaires measuring psychological outcomes take into 
account issues important and relevant to people with diabetes (Bradley, 1994; 
Bradley and Speight 2002; Polonsky 2000; Pouwer et al., 2000). Those 
designed to be completed by study participants and patients, that ask 
appropriate and relevant questions, can highlight reasons for poor glycaemic 
control and indicate preferences for treatment and for complementary 
therapies such as relaxation techniques. Where problems are identified in one 
or more biomedical or psychological outcome, measures of psychological 
processes such as diabetes-related knowledge, self-management skills and 
behaviour, locus of control and coping strategies can indicate what action 
might be appropriate (Bradley 1994). 
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Psychological perspectives are already evident in many innovative 
approaches to diabetes care in hospital and community settings, in policy 
documents such as the Nationals Service Framework for Diabetes 
(Department of Health, 2003) and in clinical trial reports, demonstrating how 
psychologists can work with health care professionals to improve the lives of 
people with diabetes. It is imperative that this trend continues and 
psychologists become an integral part of the diabetes care team. Health 
behaviour change interventions and lifestyle education programmes must be 
informed by psychology and more importantly, measure psychological 
outcomes, through developing effective and relevant research projects. 
 
Psychology and Smoking 
Cigarette smoking is a highly addictive behaviour that can and does work on 
many levels. People can be physically addicted to the nicotine in cigarettes 
and psychologically addicted to the behavioural routines and rituals 
associated with smoking with the latter generally thought to be the stronger of 
the two. 
The reasons people start smoking and continue to smoke can be wide and 
varied with many starting smoking in childhood or early adulthood.  Some anti-
smoking organizations claim that adolescents engage in smoking behaviours 
due to peer pressure and cultural influences. However, one study found that 
direct pressure to smoke cigarettes did not significantly affect adolescent 
smoking and consequently participants reported low levels of both normative 
and direct pressure to smoke cigarettes (Urberg et al., 1990). 
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A similar study showed that individuals play a more active role in starting to 
smoke than has previously been thought and that social processes other than 
peer pressure need to be taken into account (Michell and West, 1996). 
Another study revealed that peer pressure was significantly associated with 
smoking behavior across all age and gender cohorts, but that intrapersonal 
factors were significantly more important to the smoking behavior of 12–13 
year-old girls than same-age boys (Barber et al., 1999).  
 
Hans Eysenck developed a personality profile for the typical smoker. 
Extraversion was the trait found to be most associated with smoking, and 
smokers tend to be sociable, impulsive, risk taking, and excitement seeking 
individuals (Eysenck et al., 1960). Although, personality and social factors 
may make people more inclined to smoke, the behaviour is a function of 
operant conditioning. During the early stages, smoking provides pleasurable 
sensations because of its action on the dopamine system and thus serves as 
a source of positive reinforcement (Skinner, 1938). 
 
Because they are engaging in behaviour that has negative health effects, 
people who smoke tend to rationalize their behaviour and can develop 
convincing reasons why smoking is acceptable. For example, a smoker could 
justify the behaviour by concluding that everyone has to die eventually and 
therefore cigarettes do not actually make any difference. Additionally they 
could believe that smoking relieves stress or has other benefits that justify its 
risks. The reasons people give for this behaviour are broadly categorized as 
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addictive smoking, pleasure from smoking, tension reduction/relaxation, social 
smoking, stimulation, habit/automatism, and handling. Females are more 
inclined to report tension reduction/ relaxation, stimulation and social aspects 
as reasons for smoking (Berlin et al., 2003).  
 
 
Some people who smoke often argue that the depressant effect of smoking 
allows them to calm their nerves and relieve stress, allowing for increased 
concentration. However, Imperial College London advises that, "Nicotine 
seems to provide both a stimulant and a depressant effect, and it is likely that 
the effect it has at any time is determined by the mood of the user, the 
environment and the circumstances of use. Studies have suggested that low 
doses have a depressant effect, while higher doses have stimulant effect. “ 
(Montgomery et al., 2003).  
 
A number of studies have shown that cigarette sales and smoking follow 
distinct time-related patterns. For example, in America cigarette sales have 
been shown to follow a strongly seasonal pattern, with increased sales in the 
summer months and decreased sales in the winter months (Chandra and 
Chaloupka, 2003).  Similarly, smoking has been shown to follow distinct 
circadian patterns during the waking day with the high points usually occurring 
just after waking in the morning and just before going to sleep at night 
(Chandra et al., 2007).  
 
It is clear from the evidence that smoking cigarettes is a complex behaviour 
that may require more than nicotine replacement therapy to aid cessation. 
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Brief psychological therapies for smoking cessation based on cognitive 
behavioural therapy, such as QUIT FOR LIFE (Marks, 1993) have shown to 
be effective with high efficacy and cost effectiveness compared to nicotine 
replacement therapies (Marks, Murray, Evans and Willig, (2002). Health care 
systems need to continue to build their capacity and infra-structure to increase 
public access to psychological therapies.  
 
The final solution to tobacco control will require a multi-level approach 
consisting of economic, political, social and psychological interventions based 
on empirical evidence from research that measures, among other things, 
psychological outcomes. 
 
Strengths and limitations of the review 
A strength of this review is that a pre-defined system, i.e. the SIGN 
methodology checklist and level of evidence rating, was identified and used to 
critically appraise the quality of the included research (Scottish Intercollegiate 
Guidelines Network, 2001). Another strength of the review is that two 
reviewers were independently involved in the critical appraisal process.  
A limitation of this review is that only English language papers were selected 
for inclusion due to resource constraints. This may be an issue because the 
prevalence of diabetes and smoking is high among the Asian population and it 
may be expected that a number of papers investigating smoking cessation 
interventions for people with diabetes have been published in the appropriate 
languages. Therefore, this review may suffer from language bias (Egger et al., 
2001). However, when searching the reference lists of the studies included, 
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no Asian publications that had smoking cessation rates for people with 
diabetes as an outcome measure, were identified. 
 
Implications for practice 
 
From the evidence presented in this review it is suggested that smoking 
cessation should be promoted among individuals with diabetes. There are 
many smoking cessation services operating across the UK at present but 
there is very little evidence for services specifically aimed at people with 
diabetes. One pilot programme has been running in Scotland, the Diabetes 
and Smoking Cessation Education Programme, and preliminary results are 
encouraging.  It is important that health professionals are made aware of the 
health risks associated with smoking with diabetes and how behaviour change 
interventions can reduce the risk of developing long-term complications. It 
may be appropriate for health professionals to promote smoking cessation 
both in primary and secondary care and to offer support in both settings.  
 
Implications for research 
 
In the studies identified in this review the majority of participants were male. It 
is unclear whether the lower rate of female participants was due to the fact 
they were unavailable or if there is a lower incidence of smoking with diabetes 
among the target populations.  
 
None of the studies identified for inclusion were set in the United Kingdom. 
There is a need for rigorous and robust randomized controlled trials in the UK 
that examine the impact of smoking cessation interventions and lifestyle 
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education programmes on people with diabetes. The studies should be 
designed in such a way that they aim to include more female participants and 
the studies should incorporate a psychological measure as it underpins 




Diabetes and smoking, singly, are a major public health issue and a leading 
cause of morbidity and mortality worldwide. The statistics for smoking with 
diabetes are even more of a concern and are projected to increase as the 
westernised world continues to gain weight and adopt a sedentary lifestyle. 
The burden placed upon the health service is also a concern and it too is 
expected to increase significantly. The evidence presented in this review 
suggests that smoking cessation interventions and lifestyle education 
programmes for adults with diabetes may be beneficial in reducing the 
prevalence of individuals smoking cigarettes which may, in turn, reduce the 
economic burden facing the NHS. 
 
However, the literature in this review suggests that these programmes and 
interventions need to be designed in such a way that they engage the target 
audience and reduce attrition rates. Interventions should be designed to 
measure biochemical markers such as plasma cotinine and carbon monoxide 
levels and not rely on participants self-reports and should engage health 
behaviour change specialists instead of offering limited training to the health 
professionals responsible for delivering the intervention. More importantly the 
interventions need to include psychological measures as they will underpin 
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the intervention and affect the outcomes.  Health professionals in a variety of 
healthcare settings have an important role to play in health promotion and 
need to be made aware of the evidence base for specialist smoking cessation 
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Appendix A – Search Strategy 
 
MAM – Margaret-Anne MacMillan  NM – Neil McLean 
 
Search Keyword and phrases No of hits No of hits 
    
PsychInfo  MAM NM 
    
1 Diabetes 10269 10269 
2 Diabetes and smoking 587 587 
3 Diabetes and perceived control 34 34 
4 Type 2 diabetes and perceived control 6 6 
5 Type 2 diabetes and perceived control and 
smoking 
0 0 
6 Type 2 diabetes or perceived control or 
smoking 
26968 26968 
7 Type 2 diabetes or perceived control and 
smoking 
1410 1410 
8 Type 2 diabetes and smoking 62 62 






10 Smoking cessation and type 2 diabetes 6 6 
11 Smoking intervention and type 2 diabetes 1 1 
12 Smoking intervention and type 2 diabetes 
and perceived control 
0 0 
13 Smoking cessation intervention and type 2 
diabetes and perceived control 
0 0 
14 Smoking cessation intervention and type 2 
diabetes 
245898 245898 
15 Type 2 diabetes and locus of control 13 13 
16 Type II diabetes and locus of control 7 7 
17 Type 2 diabetes and locus of control and 
smoking 
0 0 
18 Smoking and locus of control 196 196 
19 Smoking and locus of control and type 2 
diabetes 
138 138 
20 Smoking cessation and locus of control 
and type 2 diabetes 
0 0 






Search Keywords and phrases No. of Hits No. of 
Hits 
    
CINAHL  MAM NM 
    
1 Diabetes 354,620 354,620 
2 Diabetes and smoking 17,339 17,339 
3 Diabetes and perceived control 29 29 
Matriculation Number: 05008241  Research Competency 
Professional Doctorate in Health Psychology 2009  255 
4 Type 2 diabetes and perceived control 7 7 
5 Type 2 diabetes and perceived control and 
smoking 
0 0 
6 Type 2 diabetes or perceived control or 
smoking 
36,767 36,767 
7 Type 2 diabetes or perceived control and 
smoking 
8306 8306 
8 Type 2 diabetes and smoking 373 373 
9 Type 2 diabetes and smoking and 
perceived control 
0 0 
10 Smoking cessation and type 2 diabetes 42 42 
11 Smoking intervention and type 2 diabetes 1 1 
12 Smoking intervention and type 2 diabetes 
and perceived control 
0 0 
13 Smoking cessation intervention and type 2 
diabetes and perceived control 
0 0 
14 Smoking cessation intervention and type 2 
diabetes 
1 1 
15 Type 2 diabetes and locus of control 14 14 
16 Type II diabetes and locus of control 1 1 
17 Type 2 diabetes and locus of control and 
smoking 
0 0 
18 Smoking and locus of control 62 62 
19 Smoking and locus of control and type 2 
diabetes 
0 0 
20 Smoking cessation and locus of control 
and type 2 diabetes 
0 0 





Search Keywords and phrases No. of Hits No. of 
Hits 
    
MEDLINE  MAM NM 
    
1 Diabetes 306319 306319 
2 Diabetes and smoking 14791 14791 
3 Diabetes and perceived control 23 23 
4 Type 2 diabetes and perceived control 8 8 
5 Type 2 diabetes and perceived control and 
smoking 
0 0 
6 Type 2 diabetes or perceived control or 
smoking 
177,666 177,666 
7 Type 2 diabetes or perceived control and 
smoking 
38,824 38,824 
8 Type 2 diabetes and smoking 1468 1468 
9 Type 2 diabetes and smoking and 
perceived control 
0 0 
10 Smoking cessation and type 2 diabetes 119 119 
11 Smoking intervention and type 2 diabetes 1 1 
12 Smoking intervention and type 2 diabetes 
and perceived control 
0 0 
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13 Smoking cessation intervention and type 2 
diabetes and perceived control 
0 0 
14 Smoking cessation intervention and type 2 
diabetes 
2 2 
15 Type 2 diabetes and locus of control 16 16 
16 Type II diabetes and locus of control 0 0 
17 Type 2 diabetes and locus of control and 
smoking 
0 0 
18 Smoking and locus of control 104 104 
19 Smoking and locus of control and type 2 
diabetes 
0 0 
20 Smoking cessation and locus of control 
and type 2 diabetes 
0 0 





Search Keywords and phrases No of hits No of hits 




 MAM NM 
    
1 Diabetes 10269 10269 
2 Diabetes and smoking 587 587 
3 Diabetes and perceived control 34 34 
4 Type 2 diabetes and perceived control 6 6 
5 Type 2 diabetes and perceived control and 
smoking 
0 0 
6 Type 2 diabetes or perceived control or 
smoking 
26968 26968 
7 Type 2 diabetes or perceived control and 
smoking 
1410 1410 
8 Type 2 diabetes and smoking 62 62 






10 Smoking cessation and type 2 diabetes 6 6 
11 Smoking intervention and type 2 diabetes 1 1 
12 Smoking intervention and type 2 diabetes 
and perceived control 
0 0 
13 Smoking cessation intervention and type 2 
diabetes and perceived control 
0 0 
14 Smoking cessation intervention and type 2 
diabetes 
245898 245898 
15 Type 2 diabetes and locus of control 13 13 
16 Type II diabetes and locus of control 7 7 
17 Type 2 diabetes and locus of control and 
smoking 
0 0 
18 Smoking and locus of control 196 196 
19 Smoking and locus of control and type 2 
diabetes 
138 138 
20 Smoking cessation and locus of control 
and type 2 diabetes 
0 0 
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Search Keywords and phrases No of hits No of hits
    
Bmj.com  MAM NM 
    
1 Type 2 diabetes and smoking cessation 
and education programme 
0 0 
2 Type 2 diabetes and smoking cessation 
and intervention 
0 0 
3 Smoking and type 2 diabetes 0 0 
 
 
Search Keywords and phrases No of hits No of hits 
    
    
Wileyinterscience.com    
1 Smoking and diabetes 2104 2104 
2 Smoking cessation and diabetes 172 172 
3 Effectiveness of ‘and’ smoking 
cessation intervention ‘and’ 
glycaemic control 
0 0 
4 Smoking ‘and’ diabetes ‘and’ 
provider advice 
0 0 
5 Tobacco control ‘and’ diabetes 


















Appendix B – Flowchart of Review Process 
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Grading system of studies in accordance with SIGN, (2001): 
 
1++ = All or most of the criteria have been fulfilled 
1+   = Some of the criteria have been fulfilled 
Full text articles included in review 
(n=4) 
1++ studies included 
(n= 2) 
1+ studies included 
(n=2) 
Full text articles retrieved 
(n=7) 
Titles and abstracts identified through searches 
(n = 19) 
Published in abstract form only 
(n=2) 
Full text not obtained 
(n=10) 
Full text articles 
excluded: 
 
Review of interventions: 2 
Sample size too small: 1 
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Appendix C - Characteristics of Included Studies 
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Fowler, P.M., Hoskins, P.L., McGill, M., 
Dutton, S.P., Yue, D.K. and Turtle, J.R.  
Article/report title 
Anti-smoking Programme for Diabetic 




Diabetic Medicine, 1989. 6: 698-702 
Aims of study 
1.) To gather information by carrying out a 
survey of diabetic patients smoking habits 
and their knowledge of the health effects of 
smoking.  
2.) To determine the optimal time and 
content of an anti-smoking intervention 
based on the outcome of the survey. 
Methods 
Design of study 
 Knowledge Survey – individuals attending a 
diabetes outpatient clinic were randomly 
selected form the clinic waiting list by a 
diabetes specialist nurse and asked to 
complete a standardized questionnaire which 
investigated their past and present smoking 
habits. Interviewees were asked if they knew 
smoking was detrimental to their health and 
were asked to state how health could be 
affected by smoking. Ex-smokers were 
questioned as to the major reason for 
stopping smoking.  
 
Prospective Study –  
1.) To investigate the effects of timing of 
invitation of join the anti-smoking programme 
– patients with newly diagnosed diabetes 
(ndd) were randomized to one of two 
treatment groups: (1) those approached to 
join the anti-smoking programme immediately 
upon presentation and (2) those approached 
to join the anti-smoking programme 2 months 
after initial presentation 
2.) To investigate the effects of content of the 
anti-smoking programme – patients were 
randomized to one of two treatment groups: 
(1) counselling on general health risks of 
smoking according to the Smokescreen 
protocol and (2) counselling on the 
interaction between smoking and diabetic 
complications. 
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Follow up 
 
1 month, 3 months and 6 months.  
Sampling (voluntary?) 
 
Patients with newly diagnosed diabetes and 
patients with pre-existing diabetes identified 





Newly referred diabetic patients who were 
current cigarette smokers 
Gender 
Knowledge Survey – 70 male, 62 female 
Prospective Study - details of numbers and 
group allocation not specified 
Number of eligible individuals 
 
 
Number of included individuals 
 
n = 70 (n = 33 – ndd, n = 37 – ped) 
 
 
n = 18 ndd 
n = 16 ped 
 











Age of individuals 
ndd = 47 ± 9 yrs 
 





Royal Prince Albert Hospital, Diabetes c 
Centre, Sydney, Australia, 
Details of intervention Smokescreen programme was designed for 
use by health professionals and involves 
face-to face patient education using a 
portable visual display unit of coloured 
photographs. Follow-up visits were used to 
reinforce knowledge and to encourage any 
successful quit attempts. 18 ndd and 8 ped 
participants were counselled according to 
Smokescreen. The remaining 8 ped 
participants received a modified programme 
characterized by specific information 
stressing the effects of smoking on diabetic 
complications.  
Duration of intervention 30 minutes 
Number of sessions 4 
Randomisation 
How was randomisation 
undertaken? 
Not specified 
Details of randomisation 18 ndd participants were randomized equally 
to two treatment groups: (1) join anti-smoking 
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group immediately after presentation and (2) 
join anti-smoking group 2 months after 
presentation 
 
16 ped participants were randomized equally 
to two treatment groups: (1) counselling 
about general health risks of smoking and (2) 
counselling about diabetes specific health 







 Variable Measured by 
Primary Effects of timing of 
invitation to join anti-
smoking programme 
 
Effects of content of anti-
smoking programme 







Type of analysis used Chi Square 
Statistical techniques Percentages, means ± standard deviation, effect size,  
Do techniques adjust for 
confounding? 
No – there was a reduction in self-reported smoking levels which 
was not supported by the mean plasma cotinine levels. No 
further investigation of this was conducted 




gh – general health 
 





 Content of 
programme 
    
baseline n=0 ndd 
n=0 ped 
 n=0 gh 
n=0 ds 
1 month follow-up n=9 ndd 
n=5 ped 
 n= 1gh 
n=4 ds 
3-month follow-up n=14 ndd 
n=12 ped 
 n=3 gh 
n=9 ds 
6-month follow-up n=15 ndd 
n=14 ped 
 n=4 gh 
n=10 ds 
    
    
Results 
Outcome 
Newly diagnosed group Pre-existing diabetes group 
Baseline: 
 
Knowledge Survey – 
n=132: 
 
89% already aware that 
smoking is detrimental to 
health 
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smoking can worsen 
diabetic complications.  
 
Ex-smokers reasons for 
stopping – n=51: 
 



















Plasma continine levels 
and self-reported smoking 
levels 
 
Reduction in cotinine levels 
( 1311-431) and cigarette 




Reduction in cotinine levels 
(1147 – 431) and cigarette 
consumption (27 – 5) for 












Agreement to participate 
significantly higher in ndd 
participants 2 months after 
diagnosis (p< 0.10)  
 
Drop-out rate significantly 
higher in ndd participants invited 
immediately after diagnosis (p < 
0.02) 
 






























High attrition rate in both 
counselling groups: gh = 4 lost 
to follow-up; ds = 10 lost to 
follow-up 
 
No test of significance was 
conducted 
Authors conclusions 
This study was difficult to follow with groups, subgroups and no clear definition of who was the 
intervention group and who was the control group, although further investigation suggests they 
may all have been intervention groups. Participants appeared to receive different interventions 
at different times therefore it is difficult to ascertain causality. For example, ndd participants were 
randomized to one of two intervention groups (1) those approached to join the anti-smoking 
programme immediately upon diagnosis and (2) those approached to join the programme 2 
months after diagnosis. Formal anti-smoking information was omitted from the standard 
diabetes education programme for the latter group. It is therefore difficult to gauge whether the 
timing caused the effect or whether the anti-smoking programme caused the effect. It may have 
been more beneficial to have given both groups the same intervention while keeping the 
timelines the same.  
 
Ped participants were randomized to one of two intervention groups (1) counselling on general 
health risks according to Smokescreen and (2) counselling on interaction between smoking and 
diabetes complications. All (n=18) ndd participants and 8 ped participants received 
Smokescreen while the remaining 8 ped participants received a modified programme 
emphasizing the interaction between smoking and diabetes complications. There is no indication 
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of what the modifications were and no mention of timing of intervention delivery, bearing in mind 
that all ndd participants had previously been subdivided by time.  
 
It is difficult to draw conclusions based on the results presented. This may be due to the fact that 
this is a case control study and these have a high risk of confounding and a significant risk of 
relationships not being causal. It could also be due mainly to the inability to link interventions to 
outcomes because of generality of results and the lack of significance testing of results overall. 
Moreover, this study appeared to have a lot going on and focussed more on high attrition rates 
than the content of the education programme. Consequently the lack of effects may be due to 
study design or poor write up.  
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Gaede, P., Beck, M., Vedel, P., and 
Pedersen, O. 
Article/report title 
Limited impact of lifestyle education in 
patients with Type 2 diabetes mellitus and 





Diabetic Medicine, 2001, 18, 104-108 
Aims of study 
To assess the effect of intensified education 
on lifestyle (diet, exercise and smoking) as 
part of an intensified multifactorial 
intervention over a 4-year period in patients 
with Type 2 diabetes mellitus and 
microalbuminuria 
Methods 
Design of study 
Randomized intervention study 
 
Patients were randomly assigned to either an 
intensive group focussing on change of 
behaviour as well as polypharmacological 
treatment or to a control group receiving 
conventional treatment.  
 




Mean = 3.8 years 
Sampling (voluntary?) 
160 participants who had previously been 




Patients with Type 2 diabetes who had 




M = 120 (75%), F = 40 (25%) 




Total  Control  Intervention 
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Number randomised 
160 80 80 
Age of individuals 




Steno Diabetes Centre, Gentofte, Denmark 
Details of intervention Diet – Individual consultations were delivered 
by clinical dietitian combined with group 
interventions delivered by the whole team – 6 
consultations in first year. 
 
First 3 consultations were individual 
interviews discussing patient risk profile and 
goals for diet, exercise and smoking were 
set. 
 
Next 2 consultations were groups of 20, 
including spouses and discussed lifestyle 
attitudes, beliefs and habits. Educational 
approach was based on needs of patient and 
their spouse.  
 
1st step - patients advised to trade high fat 
for low fat foods and simple for complex 
carbohydrates 
2nd step – patients advised to reduce portion 
sizes 
3rd step – introduce new foods and menu 
ideas 
4th step – monitor effect of changes in diet 
 
Exercise – advice on exercise was given as 
part of the 6 educational sessions described 
above. Patients were advised to start 
exercising although no training sessions 
between patients and diabetes team were 
performed. 
 
Smoking – all patients in the intervention 
group who smoked, and their spouses, were 
invited to take part in a standardized smoking 
cessation programme 
 
5 meetings in 8 weeks – group consultation 
for 14 people with follow-up at 3 and 6 month 
 
Patients advised on benefits of cessation, 
how to manage cravings, pharmacotherapy 
Duration of intervention 4 years 
Number of sessions 20 (baseline, 6 educational sessions in yr 1, 4 
sessions in yr, 2, 3 & 4, 4-year follow-up) 
Randomisation 
How was randomisation Not specified 
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undertaken? 
Details of randomisation Patients were randomized to an intensive 
multifactorial intervention comprising 
behaviour modification and 
polypharmacological therapy by a diabetes 
team consisting of a physician, a clinical 
dietitian and a nurse from Steno Diabetes 
Centre or randomized to a standard 







Diet – permanent 
qualitative and 
quantitative change 
in dietary fat with a 
high intake of 
polyunsaturated and 
monounsaturated 
fatty acids; low intake 
of saturated fatty 
acids; increase in 






























Blood sugar levels 
 






Self- report although 




specific details not 
specified 
Analysis 
Type of analysis used Descriptive and inferential statistics 
Comparison of numerical variables between and within groups, 
comparison of categorical variables  
Statistical techniques ANCOVA, Mann-Whitney, t-test, Wilcoxon, Chi-square 
Do techniques adjust for 
confounding? 
No – during the study period from 1993 to 1997 there were 
several national campaigns focusing on healthy lifestyle which 
may have contributed to the significant reduction in fat intake in 
both groups.  
The advice to take more exercise did not take into account that 
some of the participants were amputees, had painful neuropathy, 
coronary disease and intermittent claudication and offered no 
suggestions on how these participants could exercise safely.  
The high success rate for smoking cessation may have been 
confounded by national campaigns and well-implemented advice 
at the community level 
The study design does not allow conclusions as to whether 
behaviour modification or drug therapy was the most effective in 
reducing diabetes complications 
Intervention comprised of individual interviews and group 
sessions with no indication of format participants preferred 
Unit of analysis Evaluation interviews, procedure for measuring clinical and 











Voluntary withdrawal 5 2 3 
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Died 6   









Changes in exercise and 
smoking did not differ 
between groups 




















N = 73 
 
Decrease in total fat intake was 
larger than in control group 
(41.2-34.2 vs. 41.9-38.3, p = 
0.0001)  
 
Decrease in saturated fat 
compared with increase in 
control group (47-44 vs. 45-46, 
p = 0.001) 
 
Increase in polyunsaturated 
fats compared with controls 
(14-18 vs. 16-14, p<0.0001) 
 
Increase in carbohydrate 
intake larger although not 
statistically significant. 
Authors conclusions 
 A good and interesting study although the authors mention that a psychologist was involved in 
the planning process but no psychosocial outcome was included. This may have been missed 
opportunity and weakened the study as the success for permanent lifestyle change is dependent 
on the participants’ degree of motivation, psychosocial condition and compliance. Apart from 
measuring fasting serum cholesterol, it is not evident what other measurements are in place 
other than self-reports. The study may have benefited from using carbon monoxide or cotinine 
testing equipment. Moreover, there was no measure of participants’ levels of motivation and 
confidence particularly with regard to exercising. Developing an exercise class designed 
especially for the participants may have benefited many of them, particularly those who had 
experienced amputation.  
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Canga, N., De Irala, J., Vara, e., Duaso, M.J., 
Ferrer, A. and Martinez-Gonzalez, M.A. 
 
Article/report title 





Diabetes Care, 2000, 23, 10, 1455-1460 
Aims of study 
To evaluate the effectiveness of a nurse-
managed smoking cessation intervention in 
diabetic patients 
Methods 
Design of study 
Randomized controlled trial in clinical and 
primary care setting.  
Follow up 
Day before cessation – telephone call 
2 weeks – follow-up visit 
3 weeks – a letter sent 
2 months – second follow-up visit 
6 months – final evaluation 
Sampling (voluntary?) 
Yes – all patients with diabetes who were 
registered either in the two primary care 
centres or in the two hospitals during the 
intervention period   
Participants 
Inclusion criteria 
Patients with Type 1 and Type 2 diabetes 
who were current smokers or who had 
stopped for less than one year 
Gender 
 
Males = 240, Females = 40 
Number of eligible individuals 
 







Total  Control  Intervention 
Number randomised 
280 133 147 
Age of individuals 
Mean =  55.8 yrs 54.4 yrs 
Intervention 
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Setting 
 
University Clinic of Navarre and the Hospital 
of Navarre, Pamplona, Navarre, Spain 




Intervention consisted of a 40-minute nurse-
led visit that included counselling, education 
and a negotiated cessation date. The follow-
up consisted of telephone calls, letters and 
visits.  
Duration of intervention 6 months 
Number of sessions 5 
Randomisation 
How was randomisation 
undertaken? 
Randomization was by a computer-generated 
allocation method and the process was 
blinded.  
Details of randomisation The nurse opened a sealed envelope that 
determined which condition the eligible 

















The difference in the 
proportion of participants 
who stopped smoking 




Mean number of 
cigarettes smoked and 
stage of change 
 








Type of analysis used Descriptive and inferential statistics 
Statistical techniques Two-tailed Fishers exact tests, two-tailed paired t-tests, 
Do techniques adjust for 
confounding? 
No – participants who wanted it were given nicotine replacement 
therapy  





Total Control Intervention 
Failed to keep appointment 23   
Died 1   
Lost to follow-up 1   
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incidence validated by 
cotinine) 
 
Falsely reported smoking 
cessation 
 
Proportion of participants in 
relapse stage (TTM) 
 
 
Mean number of cigarettes 






No significant differences in 
the proportion of quitters 






























































A well thought out study that endeavoured to minimise bias. However, there is no mention of 
participant motivation or confidence to stop smoking. The amount of training the nurse received 
may have had a negative impact on the results and perhaps a more experienced smoking 
cessation advisor would have benefited the study.  It is not clear how the nurse determined the 
stage, of the stages of change model that each participant found themselves in, which may also 
have led to high rates of relapse. Having said that, 17% cessation after only 6-months is a good 
result. 
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Persson, L.G. and Hjalmarson, A. 
Article/report title 
Smoking cessation in patients with diabetes 
mellitus: Results from a controlled study of an 





Scandinavian Journal of Primary Health 
Care, 2006, 24, 75-80 
Aims of study 
To evaluate an intervention programme on 
smoking cessation in patients with diabetes 
mellitus in primary healthcare 
Methods 
Design of study 
Regional controlled intervention study 
Follow up 
6 months and 12 months 
Sampling (voluntary?) 
Yes – patients registered with the primary 
care centres taking part in the study 
Participants 
Inclusion criteria 
Patients with diabetes mellitus aged 30 – 75 
years of age who smoked cigarettes every 
day. 
Gender 
Males = 210, Females = 158 
Number of eligible individuals 
 












Age of individuals 
 








Sweden – 17 primary healthcare centres 
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1 telephone interview and follow-up 
telephone calls at 6 and 12 months. The 
structured telephone interview consisted of 
questions about length and amount of 
smoking and chronic diseases were 
registered.  
 
The intervention programme consisted of 
eight group sessions in a 2-month period, 
lasting 45-60 minutes, led by nurses 
educated in smoking cessation. Issues 
discussed were motivation to stop smoking, 
advice on how to break the habit, how to 
prevent relapse, pharmacotherapies and their 
use. After the group treatment participants 
received individual follow-up telephone calls 
and 3, 6 and 12 month follow-up. Smokers in 
the intervention group that did not want to be 
part of the group sessions received 
telephone calls at 6 and 12 months and were 
asked about their smoking habit.  
Duration of intervention 12 months 
Number of sessions 8 
Randomisation 





























Type of analysis used Descriptive and inferential statistics 
Statistical techniques Chi-square using Yates correction or Fishers exact test, t-test 
Do techniques adjust for 
confounding? 
No – participants in the intervention group that did not want to be 
part of the group sessions received a modified version of the 
intervention. This suggests that they did not receive the same 
level of intervention. No biochemical markers were measured 
therefore all smoking cessation rates were by self-report. 
Unit of analysis questionnaires 
Attrition 
 
C = 223 
I = 145 
Reasons 
Total Control Intervention 
Failed to keep appointment    
Died 14 5 9 
Lost to follow-up 4 2 2 
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N=10 participants stopped 
smoking 
 
N=42 participants self-reported 
stopping smoking (p<0.01): 
 
N=19 with group support 
 













The authors advise that the intervention was delivered by a diabetes nurse who was given one 
half day of training in motivational interviewing and smoking cessation. Both these topics are 
vast and cannot possibly be covered in one afternoon therefore the integrity of the intervention 
and the rigour of the study may have been compromised because of this. No biochemical 
markers were measured which was a missed opportunity as self-reports may have been 
exaggerated or misleading, even although the authors conclude that deception rates tend to be 
low. Participants should have received the same intervention and should all have received 
telephone interventions or received group interventions, not one format for some and a different 
format for others. Also the intervention was conducted across 11 primary healthcare centres 
with the resident diabetes nurses delivering the intervention. This equates to at least 11 people 
delivering the intervention therefore it is difficult to say whether the participants in each centre 
received the exactly the same intervention. Participants were encouraged to use 
pharmacotherapy to aid smoking cessation therefore it is difficult to attribute the success rate to 
the intervention. No consideration was given to participants levels of confidence to stop 
smoking. Although participant motivation was discussed during the telephone interviews, the 
findings have not been reported or discussed. All things considered, the success rate was good. 
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